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Summary 
Functional biological proteins are gaining interest with potential application in medicine and 
biotechnology. The methylotrophic yeasts, especially Pichia pastoris and Hansenula polymorpha, 
have been successfully used for the production of heterologous proteins with high industrial and 
medicinal importance. The aim of this study was to explore the production of self-assembly proteins 
in methylotrophic yeasts. The specific proteins investigated were the Human Papilloma virus (HPV) 
and Rotavirus (RV) proteins that self-assemble into virus-like particles (VLPs), and the α-chain 
proteins that assembles into procollagen.  
Cervical cancer is ranked the fourth most common cancer in women worldwide. Human 
Papilloma virus types 16 and 18 account for 70% of all cervical cancers worldwide. Despite the 
availability of two commercial prophylactic vaccines, it is unaffordable for most women in 
developing countries. We compared the optimized expression of monomers of the unique HPV type 
16 L1/L2 chimeric protein (SAF) in two yeast strains of P. pastoris, KM71 (MutS) and GS115 
(Mut+), together with H. polymorpha NCYC 495, to determine the preferred host in bioreactors. 
SAF was uniquely created by replacing the h4 helix of the HPV type 16 capsid L1 protein with a 13-
amino acid peptide from the L2 protein. Two different methanol-feeding strategies in fed-batch 
cultures of P. pastoris MutS were evaluated: a predetermined feed rate versus feeding based on the 
oxygen consumption by maintaining constant dissolved oxygen levels (DO stat). All cultures 
showed a significant increase in biomass concentrations when methanol was fed using the DO stat 
method. In P. pastoris, the SAF concentrations were higher in the MutS strains than in the Mut+ 
strains. Our results showed the maximum concentration SAF expressed in both yeasts reported to 
date with H. polymorpha the best producer of all the yeasts evaluated. Further, accurate 
quantification of SAF was obtained through direct comparison with known concentrations of 
purified HPV16 L1. Quantification is usually inferred from ELISA results using standards not 
always compatible to the L1 monomer. 
Previous research in insect cells showed that the HPV16 L1/L2 chimeric protein self-
assembled in capsomeres or capsomer aggregates during expression in insect cells. With the human 
codon-optimized chimeric gene, occational T=7 VLPs were visible in the insect cells. Similarly, 
when SAF was expressed in both methylotrophic yeasts, the majority of heterologous protein was 
observed as capsomeres (10 nm in diameter) with the occasional T=1 VLPs (25-30 nm in diameter) 
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assembled. This is the first report showing the formation of T=1 VLPs in H. polymorhpa. SAF 
proteins displaying L2 epitopes offer simultaneously high titres of L1 specific neutralizing 
antibodies, as well as cross-neutralizing antibodies against L2. 
Gastroenteritis is one of the leading causes of deaths in children under the age of five years 
worldwide and caused by RV. We expressed a RV VP6 protein, derived from a prevalent South 
African RV strain (G9P), intracellularly in Escherichia coli, P. pastoris and H. polymorpha. Despite 
producing the lowest biomass levels of all the expression systems in shake flasks, the highest VP6 
concentration was obtained with E. coli. In the controlled environment of bioreactors, all three 
expression systems attained higher cell densities and increased growth-associated VP6 production, 
in comparison to shakeflasks. Unlike in shake flask expressions, H. polymorpha outperformed both 
P. pastoris and E. coli during bioreactor cultivation. In contrast to yeast expressions, bacterial 
expressed VP6 protein was found to be insoluble upon analysis. This is the first report of VP6 
expressed in methylotrophic yeast and holds the promise for the inexpensive production of VP6 as a 
possible vaccine candidate, booster dose or drug delivery mechanism.  
Collagen is the main structural protein of various animal connective tissues and also has the 
natural ability to self-assemble; therefor, it poses similar expression challenges than VLPs. 
Treatment of burn victims can benefit from combining a collagen α-chain with an antimicrobial 
peptide (AMP) in wound dressings. The collagen can aid in wound healing and the AMP in fighting 
infectious agents present. This collagen-AMP fusion protein was extracellularly produced by H. 
polymorpha. Presence of a correctly-sized single band on tricine-SDS PAGE gels revealed the 
successful expression of the putative fusion protein. Proteomic analysis of this protein species only 
identified part of this fusion. This is the first evidence of the possible successful expression of a 
recombinant collagen-AMP fusion protein in yeast.  
This study suggests that H. polymorpha is the preferred host, among the host cells tested, for 
the production of self-assembly proteins, such as the protein-components of virus-like particles and 
structural fusion proteins, such as collagen-AMP. 
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Opsomming 
Funksionele biologiese proteïene met potensiële toepassing in medisyne en biotegnologie wek al 
hoe meer belangstelling. Metilotrofiese giste, veral Pichia pastoris en Hansenula polymorpha, word 
suksesvol aangewend vir die vervaardiging van heteroloë proteïene met hoë industriële en 
medisinale belang. Die doel van hierdie studie was om die produksie van self-monterende proteïene 
in metilotrofiese giste te ondersoek. Die spesifieke proteïene wat ondersoek is, was die Menslike 
Papilloomvirus (MPV) en Rotavirus (RV) proteïene wat self-monteer in virusagtige partikels 
(VAPs), asook die α-kettingproteïene in prokollageen. 
Servikale kanker is die vierde mees algemene kanker by vroue wêreldwyd. Menslike Papilloomvirus 
tipes 16 en 18, verteenwoordig 70% van alle servikale kankers wêreldwyd. Ten spyte van die 
beskikbaarheid van twee kommersiële voorkomende  entstowwe, is dit vir die meeste vroue in 
ontwikkelende lande onbekostigbaar. Ons het die geoptimiseerde uitdrukking van die unieke MPV 
tipe 16 L1 / L2 chimeriese proteïen (SAF) monomere in twee gisstamme van P. pastoris, KM71 
(MutS) en GS115 (Mut+), vergelyk tesame met H. polymorpha NCYC 495, om die voorkeurgasheer 
in bioreaktors te bepaal. SAF was uniek geskep deur die h4-helix van die HPV tipe 16 kapsied L1 
proteïen met 'n 13-aminosuurpeptied van die L2 proteïen te vervang. Twee verskillende 
metanolvoedingstrategieë in P. pastoris MutS kulture is geëvalueer: 'n voorafbepaalde voertempo 
versus voeding gebaseer op die suurstofverbruik deur konstante opgeloste suurstofvlakke (OS) te 
handhaaf. Alle kulture het 'n beduidende toename in biomassa getoon toe metanol met behulp van 
die OS metode gevoer is. Die SAF konsentrasies was hoër in P. pastoris MutS-kulture as in Mut+-
kulture. Ons resultate toon dat albei giste die maksimum konsentrasie SAF wat gerapporteer is, 
oortref het met H. polymorpha wat die hoogste vlakke het van al die giste wat geêvalueer was. 
Verder is akkurate kwantifisering van SAF verkry deur direkte vergelyking met bekende 
konsentrasies van suiwer HPV16 L1. Kwantifisering word gewoonlik afgelei uit ELISA resultate 
deur gebruik te maak van standaarde wat nie altyd met L1 monomere ooreenstem nie. 
In vorige studies in insekselle het hierdie HPV16 L1 / L2 chimeriese proteïen self gemonteer om 
kapsomere of kapsomeer-aggregate te vorm tydens uitdrukking. Met die menskodon-geoptimiseerde 
chimeriese geen was T = 7 VAPs soms sigbaar in insekselle. Soortgelyk, toe SAF in beide 
metilotrofiese giste uitgedruk is, was die meerderheid heteroloë proteïen as kapsomere (10 nm in 
deursnee) waargeneem met hier en daar ‘n T = 1 VAP (25-30 nm in deursnee). Dit is die eerste 
verslag wat die vorming van T = 1 VAPs in H. polymorhpa demonstreer. SAF proteïene wat L2-
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epitope vertoon, bied gelyktydig hoë titers van L1-spesifieke neutraliserende teenliggame, sowel as 
kruis-neutraliserende teenliggame teen L2. 
Gastro-enteritis is wêreldwyd een van die grootste oorsake van sterftes by kinders onder die 
ouderdom van vyf jaar en word deur RV veroorsaak. Ons het 'n RV VP6 proteïen, gebasseer op 'n 
Suid-Afrikaanse RV stam (G9P), intrasellulêr in Escherichia coli, P. pastoris en H. polymorpha 
uitgedruk. Ten spyte van E. coli se lae biomassavlakke in skudflesse, het hierdie uitdrukkingsisteem 
die hoogste VP6 konsentrasie gelewer. In vergelyking met skudflesse, het al drie uitdrukkingstelsels 
in die beheerde omgewing van bioreaktors tipiese hoër seldigtheid en groeiverwante VP6 produksie 
gelewer. Anders as in skudflesuitdrukkings, het H. polymorpha beter as beide P. pastoris en E. coli 
in bioreaktor kulture presteer. In teenstelling met gisuitdrukkings, was bakteriële uitgedrukte VP6 
proteïene onoplosbaar. Dit is die eerste verslag van VP6 wat in metilotrofiese giste uitgedruk is en 
toon belofte vir bekostigbare VP6 produksie wat as moontlike entstofkandidaat kan dien, of as 
aanvullende vaksien of die moontlike draer van sekere teikenmedisyne. 
Kollageen is die hoof strukturele proteïen van verskeie diere bindweefsels en het ook die natuurlike 
vermoë om self te monteer; dus stel dit soortgelyke uitdagings as VAPs om uitgedruk te word. 
Behandeling van brandslagoffers kan baat vind by die kombinasie van 'n kollageen-α-ketting met 'n 
antimikrobiese peptied (AMP) in wondbedekkings. Die kollageen kan help met wondgenesing en 
die AMP om aansteeklike patogene te beveg. Hierdie kollageen-AMP-fusie-proteïen is 
ekstrasellulêr in H. polymorpha vervaardig. Teenwoordigheid van die korrekte grootte proteïenband 
op trisien-SDS PAGE-jels het die suksesvolle uitdrukking van die vermeende fusie-proteïen 
bevestig. Proteomiese analise van hierdie proteïenspesie het slegs ‘n gedeelte van die fusie proteïen 
geïdentifiseer. Nietemin, dit is die eerste bewys van die moontlike suksesvolle uitdrukking van 'n 
rekombinante kollageen-AMP-fusie-proteïen in gis. 
Hierdie studie dui daarop dat H. polymorpha die voorkeurgasheer is vir die produksie van self-
monterende proteïene, soos die proteïen-komponente van virusagtige deeltjies, asook strukturele 
fusieproteïene, soos kollageen-AMP. 
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Chapter 1 
General introduction 
In developing countries such as South Africa, approximately 83% of the population of 50 million do 
not have health insurance and rely primarily on the public health system when challenged with 
health issues (Blecher et al., 2012). Worldwide cervical cancer is the second most prevalent cancer 
amongst women aged between 15 and 44 years with the highest rate amongst black women (Mqoqi 
et al., 2004; Bruni et al., 2017). Although routine screening using cervical cytology significantly 
reduced the number of new cases of invasive carcinoma, limited resources and capacity could not 
sustain frequent screening and did not significantly impact on mortality statistics in South Africa 
(Sankaranarayanan et al., 2001; South African HPV Advisory Board 2011). Development of two 
prophylactic vaccines, Cervarix (GlaxoSmithKline, 2011) and Gardasil (Merck and Co. 2011) 
targeted against the Human Papillomavirus (HPV), the etiological agent in cervical cancer (Muñoz 
et al., 2006), offer great potential for primary prevention, but until recently was only available in the 
private sector (South African HPV Advisory Board, 2011). To obtain maximum effectiveness, these 
vaccines need to be administered prior the onset of sexual activity during which the virus can be 
transmitted. Modelling studies estimated that vaccination of 70% of girls aged 9-12 years against 
HPV 16 and 18 with Gardasil will reduce the lifetime risk of cervical cancer with 43%. This 
percentage will increase to 61% with 100% coverage of schoolgirls in that age group (Sinanovic et 
al., 2009). The World Health Organization (WHO) has recommended that routine HPV vaccination 
be included in the national immunisation programme, making it available to the public sector as 
well. This resulted in the launch of the government’s HPV vaccine campaign in 2014 where girls 
between 9-12 years old were vaccinated with two doses, six months apart (Richter, 2015). 
In developing countries, diarrhoea is a major contributor to the high rates of childhood 
mortality, estimated at 1.34 million deaths each year (Black et al., 2010). Rotavirus (RV) is the 
single most common cause of severe diarrhoea in children under 5 years of age, constituting about 
527 000 deaths annually (World Health Organization, 2010). In South Africa alone, diarrhoea 
causes more than 10 000 deaths a year, of which almost half is due to rotavirus infection (Ngcobo, 
2009). Despite the availability of two licensed rotavirus vaccines, Rotarix® and RotateqTM, rotavirus 
remained the most common cause of severe diarrhoea due to the absence of targeted vaccination 
(Wang et al., 2013). During August 2009, the World Health Organization made a global 
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recommendation to include the rotavirus vaccine (at birth, 6 and 14 weeks) into the routine 
Expanded Program on Immunization (EPI) of all infants in South Africa (World Health 
Organization, 2009). South Africa is the first country in Africa to introduce the RV vaccine in its 
EPI. A follow-up vaccine efficacy study on RV vaccine observed 73% protection against severe 
rotavirus gastroenteritis among African infants during the first year of life (Madhi et al., 2010). 
The cost of vaccines has become a major burden in most countries. In 2009, the vaccine cost 
of a fully immunised child was estimated at R1 338 in the public sector and R4 103 in the private 
sector, with a 10-fold increase forecasted in the next 10 years (Ngcobo and Cameron, 2010). An 
HPV vaccine dose costs R542 each (between R700 and R1000 in the private sector) and after three 
doses, which provides for 98%-100% effectiveness in preventing the virus (Paavonen et al., 2009; 
The FUTURE II Study Group, 2007), the total cost could be between R1 500 and R1 620. Also, the 
South African government increased its budget allocation from approximately R200 million to 
R1.25 billion per annum to implement the addition of the rotavirus vaccine (Madhi et al., 2014). 
South Africa remains the only country in the World Health Organization Africa region that does not 
qualify for donor support from the Global Alliance for Vaccines and Immunisation (GAVI) (Eastern 
and Southern Africa EPI Managers Meeting, 2016). Hence, South Africa is liable to finance its own 
immunization programmes. 
Another health challenge in developing countries is the high mortality rate due to thermal 
injuries. Collagen is widely used in the management of severe burn wounds as it enhances wound 
healing. However, animal collagen, the most abundant protein in mammals, used as substitute in 
wound dressings can be allergenic to humans. Commercialized wound dressings are very expensive 
and not freely available to most people in developing countries. In addition, bacterial resistance 
against conventional antibiotics poses an increasing threat. One possible solution to antimicrobial 
resistance might be antimicrobial peptides (AMPs), which form part of the innate immunity and 
possess antimicrobial activity against bacteria, viruses, fungi and parasites. In order to produce 
affordable wound-dressings, large quantities of both human collagen and AMP are needed. A more 
cost-effective production method would be to express recombinant collagen-AMP fusions. 
Structural proteins, such as HPV, RV and collagen, which self-assemble into either VLPs or 
structured fibrils, have shown increasing potential as modern vaccine substitutes or medical 
applications for treating burn wounds. In the light of high production costs and the demand for high 
expression quantities, there is a great urge to consider cheaper options to manufacture high yield 
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self-assembling protein components. Downstream processing of recombinantly expressed proteins 
can result in significant losses to the final yield. For this reason, large enough quantities of the 
desired protein are needed prior to purification. A minimum of 1 g protein per litre culture broth is 
required for cost-effective manufacturing of vaccines (Melinda Scanlen, The Biovac Institute, 
personal communication). High-yielding production will enable us to push the boundaries of 
expression and determine whether it is also possible to reach high enough yields of the product to be 
cost-effective. A broad spectrum of expression systems is available, but the methylotrophic yeasts is 
an established system for the production of heterologous proteins, particularly biopharmaceuticals 
and industrial enzymes.  
1.1 Aim of the study 
In this study, we investigated the methylotrophic yeast expression system for the production of self-
assembling proteins with biological applications. Both Pichia pastoris (P. pastoris) and Hansenula 
polymorpha (H. polymorpha) have successful track records as cost-effective production hosts of 
various industrial and pharmaceutical proteins, including vaccines. All of this attests to the 
favourable characteristics of these two yeast species, such as their ability to reach cell densities of 
several grams per litre in defined media during fermentation, subsequently expressing high levels of 
recombinant protein (Stratton et al., 1998). Despite the availability of current vaccines in the fight 
against cervical cancer and gastroenteritis, developing countries have limited access to these 
vaccines due to the high costs involved. Also, South Africa has included both the HPV as well as 
Rotavirus vaccines recently in its Expanded Programme on Immunization (EPI). It is quite evident 
that there is an urgent need to supply these vaccines in large scale. This significant vaccine demand 
places a huge financial burden on the country’s health system. There is therefore a need to explore 
the possibility of a more cost-effective expression system to produce large quantities of these 
vaccine proteins. Also, inclusion of the cross-neutalizing L2 epitope into the HPV L1 protein could 
add further value to the current HPV vaccine. 
The methylotrophic yeasts were also considered for the production of an unique collagen-
AMP fusion protein, which can be applied to wound-dressings used for the effective treatment of 
burn wounds. In developing countries such as South Africa, the fatality rate due to burns in children 
is seven times higher than in developed countries as a the result of candles and kerosene stoves 
falling over in overcrowded houses (World Health Organization, 2017). Treating severe burn 
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wounds require expensive wound dressings and hospitalization is often needed to minimize 
morbidity and mortality due to infection. Bacterial resistance against antibiotics hamper 
conventional treatment. We designed an antimicrobial peptide (AMP) linked to a human α-1(type I) 
collagen fusion protein of which the collagen part can self-assemble. The envisaged outcome would 
be a product that can be applied to existing wound dressings. This will then aid in wound healing as 
well as serve as a prophylactic against possible wound pathogens.  
 
1.2 Specific objectives of the study 
1.2.1 To evaluate the potential to achieve high-yielding production systems for monomers of the 
unique HPV type 16 L1/L2 chimeric protein (SAF) in two yeast strains of P. pastoris, 
GS115 (Mut+) and KM71 (MutS), and compare it to the production thereof in H. 
polymorpha. 
1.2.1.1 Two different methanol feeding strategies to induce protein expression were 
compared in fed-batch cultures of P. pastoris_KM71 strain, due to the high 
sensitivity of this strain to methanol under- or over-feeding. In the first strategy, 
methanol was supplied at a predetermined exponential rate according to the Pichia 
Fermentation Protocol (Invitrogen Life Technologies, 2002). The second strategy 
was based on the oxygen consumption of the microorganism, where methanol 
feeding was controlled by the dissolved oxygen level (DO) in the culture. Cultures 
were done in 3 L bioreactors. 
1.2.1.2 The preferred method of methanol feeding was applied in 10 L bioreactors to 
compare the P. pastoris_GS115 (Mut+) strain with the P. pastoris_KM71 (MutS) 
strain.  
1.2.1.3 The best performing P. pastoris strain was then compared to H. polymorpha for the 
production of SAF in 1.3 L bioreactors.  
1.2.2 To semi-purify the SAF protein and visualize the possible formation of virus-like particles 
(VLPs).  
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1.2.3 To evaluate the expression of rotavirus VP6 protein in Escherichia coli (E. coli), P. pastoris 
and H. polymorpha. 
1.2.3.1 Firstly, the expression of RV VP6 in E. coli, P. pastoris and H. polymorpha was 
compared in shake flasks.  
1.2.3.2 Subsequently, the expression of RV VP6 in E. coli, P. pastoris_GS115 and H. 
polymorpha was compared in 1.3 L bioreactors. 
1.2.4 To design, synthesize and produce fused collagen-AMP cassette in at least one of the 
methylotrophic yeasts. 
1.3 Implications of the study 
The main focus of this study was to develop high-yielding expression of self-assembling proteins in 
methylotrophic yeasts. Different methanol feeding strategies and yeast strains were compared, also 
relative to E. coli, in order to optimize the expression of these biological proteins. High yields of 
sub-unit vaccine proteins can alleviate the vaccine burden in South Africa, while the proposed 
collagen-AMP fusion protein can significantly contribute to burn-wound treatment. 
The addition of a 13 amino acid L2 peptide to the chimeric HPV-16 L1/L2 protein can elicit 
cross-neutralizing antibodies and could therefore be included in HPV VLP-based vaccines (Kawana 
et al., 1998; Kawana et al., 1999; Kawana et al., 2001a; Kawana et al., 2001b). In addition, the 
production of a cheaper alternative for the treatment of burn wounds can save the lives of many 
victims who cannot afford the expensive treatment during serious burn injuries. 
Knowledge gained during the optimization of these fermentation processes led to a better 
understanding of the different hosts investigated and how the expression of different self-
assembling proteins was affected.  
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Chapter 2 
Literature overview 
This section will highlight the use of strains of the methylotrophic yeasts P. pastoris and H. 
polymorpha as expression systems for viral structural proteins used as vaccine subunits, and all the 
factors contributing to optimize the protein yield. The current status and additional demands for 
both HPV and RV vaccines will be discussed. Also, a novel approach using collagen and an 
antimicrobial peptide used in burn wound dressings will be considered. Both viral proteins as well 
as collagen can self-assemble into well-ordered structures, but can face degradation in the host if not 
folded properly. 
2.1 Heterologous gene expression in yeast 
Yeast has gained widespread interest as one of the expressing systems of choice for the production 
of commercially valuable proteins. It shares the molecular, genetic and biochemical features of 
higher eukaryotes, and is ideal for large-scale industrial fermentation. Initially, baker’s yeast, 
Saccharomyces cerevisiae, was used successfully as host for heterologous gene expression, but the 
system has various limitations, such as S. cerevisiae tends to hyperglycosylate recombinant proteins, 
which might hinder protein folding and subsequently protein activity (Tang et al., 2016), it has a 
limited variety of carbon sources to use during its metabolism that restricts the fermentation process 
(Gellissen, Strasser and Suckow, 2005) as well as lower cell density growth and lower secreted 
protein yield than Pichia pastoris (Tran et al., 2017). In addition, glycosylated proteins secreted by 
both P. pastoris and H. polymorpha do not have the terminal α-1,3-oligosaccharides linkages added 
by S. cerevisiae and is subsequently less allergenic than hyperglycosylated recombinant proteins 
expressed in S. cerevisiae. The hyper-antigenic nature of these proteins makes them unsuitable for 
therapeutic use (Gellissen et al., 2005; Trimble et al., 1991). 
As a result of these limitations of S. cerevisiae, methylotrophic yeasts such as P. pastoris 
and H. polymorpha, have been successfully exploited to offer cost-effective expression of various 
pharmaceuticals, including vaccines, antibodies fragments, hormones, cytokines and matrix proteins 
(Table 2.1). They both are able to utilize methanol as sole energy and carbon source during their 
metabolism. Methylotrophic yeasts pose several advantages as the ideal expression system, such as 
that expression of recombinant proteins is under tightly regulated and highly productive promoters 
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(AOX in P. pastoris and MOX in H. polymorpha) (Cregg et al., 1989 ; Van Dijk et al., 2000). In 
addition, P. pastoris can utilize a broad range of carbon sources (Gellissen et al., 2005), can reach 
high-cell densities of 150 g.l-1 dry cell weight in bioreactors (Cereghino and Cregg, 1999), relatively 
low levels of endogenous protein are secreted into the medium (Cereghino and Cregg, 2000), 
increased expression levels are achieved, up to 100 times more than that of E. coli (Faber, Harder 
and Veenhuis, 1995), and tend not to hyperglycosylate recombinant proteins (Sudbery, 1996). 
Unlike bacterial expression systems, methylotrophic yeasts have the ability to perform many of the 
post-translational modifications usually performed in higher eukaryotes, e.g. correct folding, 
disulfide bond formation, O- and N-linked glycosylation, processing of signal sequences and certain 
types of lipid addition (Cereghino and Cregg, 2000; Macauley-Patrick et al., 2005). The latter 
makes methylotrophic yeasts an useful alternative to the bacterial expression of eukaryotic proteins 
that requires post-translational modifications or disulfide bridges (Cereghino et al., 2002). 
 
Hansenula polymorpha is also known as Pichia angusta. The former genus Hansenula was renamed 
Ogataea but since it is still not widespread in use, more investigators prefer to use the old name 
Hansenula (Stoyanov and Lahtchev, 2016). H. polymorpha is more thermo-tolerant than P. pastoris 
(37°C versus 30°C) and capable of faster high-yield fermentation on simple, defined media, making 
this yeast the preferred choice for industrial applications (Hollenberg and Gellissen, 1997). The 
higher growth temperature may be favourable for the production of mammalian (including human) 
proteins. In addition, this expression system allows a better cooling management and reduces the 
risk of contaminations in large scale fermentations (Van Dijk et al., 2000). Although these two 
yeasts genera are phenotypically identical, only H. polymorpha is able to assimilate nitrogen (Mack 
et al., 2009). 
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Table 2.1. Examples of foreign proteins produced in P. pastoris and H. polymorpha. 
Protein expressed Expression level  Reference 
P. pastoris   
Bacterial:   
Clostridium botulinum serotype F heavy chain fragment C 205 mg.kg-1 of cells (Johnson et al., 2003) 
Escherichia coli AppA 117±1 U.mL-1 (Stahl, Wilson and Lei, 2003) 
Escherichia coli phytase  6.4 g.L-1 (Chen et al., 2004) 
Fungal:   
Aspergillus oryzae tannase 72 mg.L-1 (Zhong et al.,2004) 
Candida parapsilosis lipase/acyltransferase 5.8 g.L-1 (Brunel et al., 2004) 
Trametes versicolor cellobiose dehydrogenase (CDH) 225 U.mL-1 (Stapleton et al., 2004) 
Invertebrates:   
Boophilus microplus BM95 antigen 550.0 mg.L-1 (Boue et al., 2004) 
Pandalus borealis (shrimp) cathepsin L 60.0 mg.L-1 (Aoki, Ahsan and Watabe, 2003) 
Vertebrates (non-human):   
Bovine enterokinase light chain (EKL) 350.0 mg.L-1 (Peng et al., 2004) 
Ovine interferon-τ (r-oIFN-τ) 391.7 mg.L-1 (Sinha et al., 2003) 
Mouse endostatin 133.33 mg.L-1 (Trinh, Phue and Shiloach, 2003) 
Spider silk fusion protein  (Jansson et al., 2016) 
Undecapeptide P11-2 β-sheet tapes  (Moers et al., 2010) 
Human:   
Granulocyte-macrophage colony-stimulating factor 180.0 mg.L-1 (Wu et al., 2003) 
Serine protease inhibitor SERpin C1-INhibitor 180.0 mg.L-1 (Bos et al., 2003)6 
Angiostatin 108.0 mg.L-1 (Xie et al., 2003) 
Human type I collagen 0.5 g.L-1 (Nokelainen et al., 2001) 
Human type I/II/III collagen 200-600 mg.L-1 (Myllyharju et al., 2009) 
Plants:   
Gsp (Panax ginseng C, medicinal peptide) 800.0 mg.L-1 (Yan, Chen and Li, 2003) 
Rice α-amylase (Amy 1A/3D) 340.0 mg.L-1 (Lee et al., 2003) 
Amaryllidaceae snowdrop agglutinin 80.0 mg.L-1 (Baumgartner et al., 2003) 
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Viruses:   
Measles virus nucleoprotein (MeN) 29% of total protein (Slibinskas et al., 2004) 
 
 
 
 
HPV type 16 L1 VLPs 13.8 g.mL-1 (Bazan et al., 2009) 
HPV type 16/18/33 L1 VLPs  (Coimbra et al., 2011) 
HPV type 58 L1 VLPs 20 mg.L-1 (Jiang et al., 2011) 
HPV type 16 L1 VLPs 104.8 μg.L-1 (Kotzé et al., 2011)  
HPV type 16/18  L1 VLPs 
 
9.5/6.4 mg.L-1 (Rao et al., 2011)  
 
 
 
HPV type 16 L1/L2 chimeric protein 1.43mg.L-1 (Smith et al., 2012)  
HPV type 16 L1 VLPs 5.35U.mL-1 (Zhao et al., 2015) 
Rotavirus VP2, VP4 VP6 and VP7 VLPs  (Zhang and Lou, 2011) 
Coxsackievirus A16 VLPs  (Feng et al., 2016) 
 Norovirus VLPs 
 
100 mg.L-1 
 
(Tomé-Amat et al., 2014) 
 Dengue virus type 1 glycoprotein VLPs 
 
 (Poddar et al., 2016) 
Dengue virus type 2 envelope  VLPs 
 
 (Mani et al., 2013) 
 Hepatitis B surface antigen VLPs 
 
 (Lünsdorf et al., 2011) 
 Tick-borne encephalitis virus VLPs 
 
 (Yun et al., 2014) 
 Heterocapsa circularisquama RNA virus VLPs 
 
2.5 g.L-1 
 
(Wu et al., 2012) 
  
 
 
 
 
  
Protein expressed Expression level Reference 
H. polymorpha   
Bacterial:   
β-Lactamase (E. coli)  (Ryan, et al., 1989) 
β-Galactosidase (E. coli)  (Brito et al., 1999) 
Fungal:   
Glucoamylase (Schwanniomyces) 1.4 g.L-1 (Gellissen et al., 1991) 
Glucose oxidase (Aspergillus) 2.25 g.L-1 (Hodgkins et al., 1993) 
Phytase (Aspergillus) 13.5 g.L-1 (Mayer et al., 1999) 
Plants:   
Seed storage protein  (Buckholz and Gleeson, 1991) 
Malate dehydrogenase (water melon)  (Faber et al., 1994) 
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Phytochrome (oat) 0.0013 g.L-1 (Mozley, Remberg and Gärtner, 1997) 
Viruses   
HPV type 16 L1 protein 0.72mg.L-1 (Smith et al., 2012)  
 HPV Type 52 L1 VLPs  (Liu et al., 2015) 
HPV Type 16 L1 protein 78.6 mg.L-1 (Li et al., 2009) 
Animals:   
Hirudin (Hirudo) >1 g.L-1 (Weydemann et al., 1995) 
Aprotinin (Bovine) 0.3 g.L-1 (Zurek et al., 1996) 
Green fluorescent protein (jellyfish)  (Amuel, Gellissen and Suckow, 2000) 
Human:   
Hepatitis B surface antigen  (Shen et al., 1989) 
Hemoglobin  (Gilbert et al., 1994) 
Human serum albumin 
 
0.46 g.L-1 
 
(Cox et al., 2000) 
 
 
Heat shock protein gp96 150mg.mL-1 (Li, et al., 2011) 
Hydroxylated gelatin/ mouse α1(I) collagen   (De Bruin et al., 2002) 
 
2. 1.1 Alcohol oxidase 
Methylotrophic yeasts share a compartmentalized methanol-metabolic pathway that harbours high 
abundance key enzymes, such as alcohol/methanol oxidase (AOX/MOX), formate dehydrogenase 
(FMD) and dihydroxyacetone synthase (DHAS) during growth on methanol (Fig. 2.1). Their 
synthesis is regulated at transcriptional level and gene expression is subjected to a carbon-source-
dependent repression/derepression/induction mechanism inherent of the specific promoter. These 
promoters are repressed, derepressed or induced in the presence of glucose, glycerol or methanol, 
respectively. Heterologous gene expression under the control of these promoters can be regulated by 
adding different carbon source to the growth medium (Gellissen et al., 2005). 
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Figure 2.1. Methanol metabolism pathway in methylotrophic yeasts. Enzymes: (1) alcohol oxidase, 
(2) catalase, (3) dihydroxyacetone synthase, (4) formaldehyde dehydrogenase, (5) formate 
dehydrogenase, (6) dihydroxyacetone kinase (Gellissen et al., 2005).  
Protein expression in H. polymorpha can also be induced by glycerol in the growth medium 
that derepresses the MOX promoter in the same way that methanol does. This added feature offers a 
safer alternative to using methanol to induce protein expression due to the dangers associated with 
the storage of large quantities of methanol (Hollenberg and Gellissen, 1997). 
The most noticable enzyme in the methanol-utilization pathway is AOX, which catalyzes the 
first step in this pathway. This enzyme is undetectable in cells cultured on media containing 
glucose, glycerol or ethanol. Protein synthesis is greatly enhanced and the protein can constitute 
levels up to 30% of the total soluble protein in cells fed with methanol at growth limiting rates in 
bioreactor cultures (Couderc and Baratti, 1980). Two genes in P. pastoris code for the AOX protein, 
AOX I and AOX II. The AOX I gene is responsible for 85% of the AOX activity, whereas AOX II 
provides the other 15% (Veenhuis, Van Dijken and Harder, 1983; Ellis, 1985). Therefore, it is not 
surprising that the AOX I gene has been isolated and the cloned version of the AOX I promoter is 
used to drive heterologous gene expression in transformation vectors (Tschopp et al., 1987). 
 
 
Stellenbosch University  https://scholar.sun.ac.za
 14 
2.1.2 Genotypes and phenotypes of P. pastoris and H. polymorpha 
Most of the P. pastoris host strains are auxotrophic, which allow for the selection of expression 
vectors containing the respective genes for complementation and serve as appropriate selectable 
marker gene upon transformation (Sreekrishna et al., 1997). Wild-type strain X-33 has both AOX 
genes fully functional and its phenotype is designated Mut+, methanol utilization plus. A derived 
Mut+ P. pastoris host strain, GS115, has a mutation in the histidinol dehydrogenase gene (genotype 
his4), which prevents them from synthesizing histidine (phenotype His-Mut+). Oxygen supply is a 
major concern in Mut+ cultures where high cell densities are obtained, since the bioreactor is unable 
to sustain the metabolic oxygen supply when air is used for sparging, thus requiring the enrichment 
of air feed with oxygen (Cos et al., 2006). More oxygen is required for the oxidation of methanol 
than for glycerol and therefore, considerable more heat is generated during methanol induction than 
during glycerol feeding. Rapid and efficient cooling is required as excessive heat in the culture 
vessel may affect the productivity and quality of the recombinant proteins (Jungo, Marison and von 
Stockar, 2007). Additionally, large scale production of this phenotype requires the storage of large 
quantities of methanol, which constitutes a potential fire hazard 
The parent P. pastoris KM71 strain has a mutation in the arginosuccinatelyase gene, which 
prevents the strain from growing in the absence of arginine. Wild-type ARG4 gene was used to 
disrupt the AOX I creating a genotype arg4 aoxI::ARG4 (Balamurugan, Reddy and Suryanarayana, 
2007) Since this strain must rely on the weaker AOX II gene for methanol metabolism, it grows 
slowly on this carbon source and produce low levels of biomass (Harder and Veenhuis, 1989); it 
therefore has the methanol utilization slow phenotype (MutSArg+) (Inan and Meagher, 2001). It 
requires less oxygen supply due to slower growth, which reduces the rate of heat generation, but 
also has less requirement for heat elimination. In order to increase cell density and process 
productivity, a multi-carbon substrate in addition to methanol is recommended. Mixed feeding 
occasionally resulted in enhanced protein expression (Katakura et al., 1998), while Brierley et al. 
(1990) reported lower productivity than when methanol was fed alone. Growth is therefore 
supplemented with alternative carbon sources such as sorbitol, mannitol, trehalose or alanine (Inan 
and Meagher, 2001; Sreekrishna et al., 1997). In addition, host strains with both AOX genes being 
disrupted, are unable to grow on methanol, and has the methanol utilizing minus phenotype (Mut-) 
(Cregg et al., 1989). 
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Of the three H. polymorpha parental strains, NCYC495 grows poorly in methanol-
containing media and therefore does not have the strong methanol pathway-derived promoters. This 
strain, previously called Hansenula angusta, was obtained from spoiled concentrated orange juice in 
Florida (Wickerham, 1951). However, this strain has been improved by crossing the original 
NCYC495 with CBS4732, giving rise to a methanol-utilizing strain, also called NCYC495 
(Titorenko et al., 1993). 
2.1.3 Multiple gene intergration versus single integration 
One of the preferred methods to generate genetically stable yeast transformants, is the integration of 
the expression cassette into the chromosome (genomic DNA) of the yeast (Sreekrishna et al., 1997). 
Integration into the chromosome occurs via homologous recombination when the yeast vector 
contains regions that are homologous to regions in the yeast genome. Integration happens by means 
of gene insertion from a single crossover point at either the AOXI/MOX promoter fragment, the 
aoxI::ARG4 gene or in the marker his4gene, or gene replacement mediated through double cross-
over events (Romanos, 1995) (Fig. 2.2, a-b). Transformants generated via gene replacement arise 
from a double-crossover event between the AOXI promoter and 3'AOXI region of the vector and the 
genome. Double crossover events result in the complete demolishing of the AOXI coding region, 
alias gene replacement (Cregg et al., 1985) (Fig. 2.2, c). These transformants are generally single 
copy transformants and are genetically more stable (Romanos, Scorer and Clare, 1992; Clare et al., 
1991). Insertion events at specific loci are more likely than replacement events, with frequencies 
between 50-80% of HIS+ transformants. Before integration, vector DNA is linearized with a 
restriction enzyme that cuts only once within the AOX1 promoter region or marker gene (e.g. HIS4). 
This linearized plasmid is then used to transform a specific auxotrophic mutant (Cregg et al., 1985). 
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Figure 2.2. Integration into the P. pastoris genome, either by (A, B) gene insertion or (C) gene 
replacement (Daly and Hearn, 2005). 
 
Yeast host strains containing multiple integrated copies of the expression cassette have been 
shown to yield more heterologous protein than single-copy strains (Clare et al., 1991; Thill et al., 
1990). Multiple integration at a single locus do occur spontaneously, but with a low frequency of 
between 1-10% of all selected His+ transformants. Various authors have reported on the proportional 
relationship between an increase in copy number and increase in heterologous protein production. 
Transformants containing up to four copies of the Heptitis B surface antigen gene (HbsAg) were 
A 
B 
C 
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found to increase the yield of HbsAg four-fold (Vassileva et al., 2001). Expression of the same 
protein in H. polymorpha correlated with the gene dosage of the intergrated DNA (Gellissen et al., 
1992). Similarly, a 10-fold increase in copy number of the β-galactosidase gene also resulted in a 
22-fold increase of the enzyme (Sunga and Cregg, 2004). Multi-copies of the inserted vector can be 
detected using dot-blot analysis, PCR, Southern blot analysis and differential hybridization. In 
contrast, P. pastoris transformants mostly consists of single-copy integrants (Balamurugan, Reddy 
and Suryanarayana, 2007).  
When hybridizing host DNA with the AOX1 promoter sequence, it should be possible to 
visualize two bands, one representing the endogenous AOX gene and the other representing the 
transformed and integrated vector. Theoretically, with every insertion of the gene into the genome, 
the intensity of the band representing the vector should increase due to an increase in the number of 
copies present (Klabunde et al., 2007). Another approach to construct multi-copy expression in P. 
pastoris, is to transform vectors harbouring multiple head-to-tail copies of an expression (Fig. 2.3). 
The advantage of this approach is that the precise number of expression cassettes is known as it can 
be determined via DNA sequencing (Brierley, 1998).  
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Figure 2.3. Map showing the integration of heterologous genes into the genome of P. pastoris. (A) 
Single copy integration versus (B) multiple copy integration (Li et al., 2007). 
 
In H. polymorpha, transformation vectors harbouring a HARSI (Hansenula ARSI) sequence 
as a replication signal can be randomly inserted into the genome resulting in recombinant strains 
harbouring multiple tandemly repeated copies of the expression cassette integrated into the target 
locus. The HARSI element allows autonomous replication with copy numbers as high as 40 
(Roggenkamp et al. 1986), 60 (Gellissen et al., 2005) and even 100 copies per cell (Hollenberg and 
Gellissen, 1997; Klabunde et al., 2007). Integration of these multiple copies into the H. polymorpha 
genome takes place via non-homologous recombination, which is different from P. pastoris where 
A 
B 
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recombination is homologous (Gellissen et al., 1992). These DNA integrations of the initially 
episomal vector is then present in a “head-to-tail” arrangement (Gellissen et al., 2005). It is possible 
to estimate the copy number in H. polymorpha by observing the colony sizes on selective agar 
plates. Larger colonies tend to have higher copy numbers when compared to smaller and medium-
sized colonies. Popov and co-workers (1997) showed when cells with more than one integrated 
vector and auxotrophic marker are grown under selective conditions, these cells are able to divide 
faster and thus form bigger colonies than cells containing only one copy of the vector. Colony size 
can thus be used as preliminary screening for varying copy numbers (Popov, Buztler and 
Bruggemann, 1997). 
On the contrary, very high copy numbers may have a negative effect on transcription and 
translation levels, reducing the yield of secreted proteins (Inan et al., 2006). A possible explanation 
may be that the increased copy number coding for an increased protein yield may block the 
secretory pathway (Wittrup et al., 1994). The unfolded protein response (UPR) is triggered in 
response to the accumulation of unfolded protein. In order to restore endoplasmic reticulum (ER) 
homeostasis, UPR activation upregulates a number of other genes, which ultimately leads to the 
transport of unfolded or misfolded proteins to the cytosol for proteasome degradation. Post-
translational folding within ER, membrane translocation, signal sequence processing and disulfide 
bond formation are all regarded as rate-limiting factors (Hohenblum et al., 2004). Overloading these 
post-translational processes could result in bottle-necks during protein expression. A common 
strategy to overcome such bottle-necks entails the overexpression of folding helper proteins or the 
transcriptional regulator, HAC1, of the UPR pathway genes. Unlike in S. cerevisiae, this HAC1 gene 
is constitutively expressed in P. pastoris, resulting in the high titers of proteins secreted in this 
organism (Guerfa et al., 2010). However, it has been reported that overexpression of folding helper 
proteins sometimes may either have no effect or reduce protein secretion (van der Heide et al., 
2002). When proteins are naturally expressed intracellularly, there is no stress on the secretory 
pathway and no negative effect on the UPR (Aw and Polizzi, 2013).  
The linear correlation between gene dosage and protein productivity is also strain dependent. 
The growth rate of Mut+ P. pastoris strains were significantly impaired when the gene copy number 
of porcine insulin precursor (PIP) exceeded 12 copies (Zhu et al., 2009). Cos et al. (2005) showed a 
similar effect was not observed in MutS strains where single copy and multiple copies of the 
Rhizopus oryzae lipase (ROL) gene had comparable effects on growth rates. 
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2.1.4 Intracellular versus extracellular protein expression 
Whether a recombinant protein is destined intra- or extracellularly, is depended on the presence of 
(native) secretion sequences. Where proteins need to be directed to the secretory pathway, a special 
secretion signal sequence is required. The most commonly used signal sequence is the S. cerevisiae 
alpha-mating factor pre-pro peptide (MFα1) (Cereghino and Cregg, 2000). This peptide comprises 
of a 19 amino acid signal pre-sequence followed by a 60 amino acid pro-sequence. The protein of 
interest is fused to the N-terminal pre-sequence, which directs the protein to the secretory pathway. 
An endopeptidase site separates the expressed protein from the pre-sequence, allowing the 
endoplasmic reticulum (ER) peptidase to cleave (Raemaekers et al., 1999). It is thought that the pro-
sequence play a determining role in transferring the protein from the ER to the Golgi compartments 
(Julius et al., 1984). During translation, the signal sequence and the pro-region are cleaved off by 
the peptidase and the yeast’s Kex2 protease, respectively. This results in the release of the mature 
protein into the culture supernatant (Raemaekers et al., 1999). 
Foreign secreted proteins can easily be isolated from the culture medium by removal of the 
yeast cells through centrifugation. An added advantage is that methylotrophic yeasts secrete very 
low levels of endogenous protein into the growth medium, which reduce the downstream 
purification process of secreted proteins (Barr, Hopkins and Sreekrishna, 1992). As a result, up to 
90% of the total extracellular protein in H. polymorpha cultures comprises of secreted heterologous 
protein (Van Dijk et al., 2000).  
Pichia pastoris, unlike prokaryotic expression systems, has the ability to perform many of 
the post-translational modifications usually performed in higher eukaryotes, such as correct folding, 
disulphide bond formation, O- and N- linked glycosylation and the processing of signal sequences. 
Due to its folding requirements, the option of secretion is usually reserved for foreign proteins that 
are normally secreted by their native hosts (Cereghino and Cregg, 2000). When a protein in its 
native form is not secreted and it is forced through the secretory pathway of the expression system, 
it may be altered by post-translational modifications, such as adding a secretion signal sequence, 
which may influence its functionality (Cereghino and Cregg, 2000). Moreover, folding and 
disulphide bond formation of certain recombinant proteins is often a slow, rate-limiting process 
(Hohenblum et al., 2004). It is more desirable to use MutS strains for expression of these proteins as 
the protein induction rate is slower, it allows for proper folding of the expressed protein and 
disulphide bond formation (Romanos, 1995). 
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Recombinant proteins expressed intracellularly represent less than 1% of the total 
intracellular proteins, and thus the purification of such proteins is more complicated and 
cumbersome than extracellular expressed proteins (Rees et al., 1999). Also, MutS strains are useful 
for the expression of intracellular proteins, because lower levels of alcohol oxidase inside the yeast 
cells allow a higher level of heterologous protein production (Romanos, 1995). 
Due to the reducing environment of the cytoplasm, prokaryotic systems such as E. coli have 
been generally unsuccessful in disulphide bond formation and glycosylation. Thus, foreign proteins 
are usually insoluble in E. coli, whereas P. pastoris has been used successfully to produce soluble 
proteins with multiple disulphide-bonds (White, Kempi and Komives, 1994). 
2.1.5 Scale-up of high cell density growth in bioreactor cultures 
Small-scale expressions performed in shake flasks are in general the first level of expressions to be 
employed in order to select the best producing transformant. Production of high levels of 
heterologous proteins during shake flask expression is difficult due to the limited volume and the 
inability to accurately control factors such as culture induction, oxygen transfer, pH and substrate 
utilization. Even at rotations of 200 per minute in baffled flasks, conditions offer limited aeration, 
resulting in protein levels about 10-fold lower compared to that obtained in bioreactors (Romanos, 
1995). 
P. pastoris strains are grown in bioreactor cultures using a three-stage process: a) a batch 
stage containing a repressing carbon source such as glycerol to accumulate biomass; b) the second 
fed-batch phase during which the culture is fed with glycerol at a growth-limiting rate to further 
maximise the biomass and to prepare (derepress) the cells for induction; and c) the third stage 
(induction) when the culture is adapting to and utilising methanol, and recombinant proteins are 
synthesised (Cereghino et al., 2002). Brierley et al. (1990a, 1990b) recommended a maximum 
glycerol concentrations of 6% as higher concentrations can inhibit cell growth (Sing et al., 2008). 
The first two phases are similar for both Mut+ and MutS phenotypes. The third phase, also known as 
the induction phase or methanol fed-batch phase, differs depending on yeast phenotype. Since the 
methanol growth rates are different between the between Mut+ and MutS phenotypes, the methanol 
consumption rates are also different. The Mut+ phenotype has a faster growth rate on methanol 
compared to the MutS yeast phenotype, which translates to a faster methanol consumption rate and a 
faster production rate of heterologous protein. 
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2.1.6 Induction with methanol 
Monitoring and control of methanol concentrations are crucial during the induction of recombinant 
proteins, because the productivity of the bioprocess is directly related to this parameter. Strains of P. 
pastoris can assimilate methanol, but they cannot tolerate high methanol concentrations. 
Formaldehyde and hydrogen peroxide (oxidized products of methanol by the alcohol oxidase) 
accumulate inside the cell and are toxic (Couderc and Baratti, 1980; Cregg and Madden, 1988; van 
der Klei, Bystrykh and Harder, 1990). This cytotoxic effect can reduce cell viability and the 
subsequent expression of recombinant proteins. Bioreactor cultures can yield up to 6 times more 
biomass and 3.5 times more expressed protein compared to shake flasks cultures (Zhang et al., 
2002). Optimal concentrations of 0.5-1.0% (2-3.65 g.L-1) methanol (Cunha et al., 2004; Schenk, 
Marison and von Stockar, 2007) are used in P. pastoris cultures to maximize protein production. 
Various studies contradict the accumulated methanol concentrations at which it is inhibitory to cell 
growth and can lead to decreased protein production (Romanos, 1995; Vassileva et al., 2001). 
Generally, methanol concentrations exceeding 3.65% in the culture medium have been reported to 
negatively affect cell growth (Zhang et al., 2000). However, an increase in methanol concentrations 
from 0.5 to 5% showed a 3-fold increase in the production of carboxypeptidase A2 in Mut+ 
transformants (Reverter et al., 1998). In the case of MutS strains, low levels of methanol may not be 
enough to initiate transcription (Cereghino and Cregg, 2000). Since MutS strains metabolize 
methanol poorly, the possible accumulation of excess methanol in the culture medium needs to be 
avoided. According to Invitrogen’s Pichia Fermentation Process Guidelines (Invitrogen Life 
Technologies, 2002), methanol concentrations more than 0.3% should be completely avoided in 
MutS strains. Transcription levels of the AOX1 promoter can be 3-5 times greater in cells that are fed 
with methanol at growth-limiting rates, compared to cells grown in excess methanol (Cereghino and 
Cregg, 2000). Therefore, it is important to determine the optimum methanol levels for each specific 
protein to be expressed. The lack of constant methanol supply in shake flasks is yet another limiting 
factor in these small-scale fermentations. Methanol metabolism requires oxygen and the expression 
of heterologous proteins is negatively affected by oxygen deprivation. Only bioreactors allow for the 
monitoring and control of all the parameters, such as pH, aeration and carbon source, 
simultaneously. 
Various methods exist for the monitoring of methanol levels in the culture media, either 
directly using gas chromatography, or high performance liquid chromatography (HPLC) for off-line 
analysis. Botht involve the processing of samples before analysis, which can be very costly and 
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running the risk of allowing the methanol to evaporate before determining the concentration 
(Schenk, Marison and von Stockar, 2007). On-line methanol sensors analyse the methanol 
concentrations in the bioreactor exhaust gas and adjust the feed rate accordingly (Potvin, Ahmad 
and Zhang, 2012), which may be essential for maintaining optimum levels of unmetabolized 
methanol. Alternatively, methanol levels can be controlled indirectly by the measurement and 
control of the dissolved oxygen (DO). Because the level of the DO in the culture is directly related 
to the rate of methanol consumption by the yeast, due to the highly oxidative nature of this process: 
An increase in DO levels therefore indicates that the rate of methanol accumulation has slowed 
down, typically due to insufficient methanol concentrations, requiring the (automatic) addition of 
more methanol (Li et al., 2007). Another strategy for controlling the methanol feeding rate is to 
adjust it manually to the specific growth rate of the yeast during the induction phase. 
2.1.7 Medium components 
Components for the Fermentation Basal Salts medium with PTM1 Trace Salts (Invitrogen Life 
Technologies, 2002) are listed in Table 2.2 and 2.3, respectively. Since the mineral medium 
components for fermentation (glycerol, methanol, biotin, salts and trace elements) are all 
economical and well-defined, P. pastoris is ideal for large-scale production of heterologous proteins 
but also safe for human use. The relatively low pH and the presence of methanol make this medium 
less likely to become contaminated by other microorganisms (Cereghino and Cregg, 2000). Despite 
the versatility of this medium, the most frequent problem is the precipitation of one or more of the 
salts at pH levels above 5. Upon closer investigation, our research group found that it was indeed 
the ferrous sulfatehepta-hydrate that precipitates at pH 5. As a result, the actual remaining salt 
concentration is difficult to assess and result in an unbalanced nutrient supply and the turbidity 
complicates the absorbance reading of the culture sample. Brady et al. (2001) showed that salt 
precipitation can be overcome by reducing the salt concentration to one-quarter of the original 
recipe (Invitrogen Life Technologies, 2002), without any negative effect on growth rate and biomass 
yield (Brady et al., 2001). Alternatively, Oehler et al. (1998) presented a medium in which the 
phosphoric acid and potassium hydroxide is replaced with 25.0 g sodium hexametaphosphate and 
9.0 g ammonium sulphate (Oehler, Lesnicki and Galleno, 1998). Ammonium hydroxide (28%) is 
added to control the pH at the desired level, but also act as a nitrogen source. 
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Table 2.2. Defined medium composition for P. pastoris and H. polymorpha fermentations. 
Component Quantity 
Phosphoric acid, 85%     26.7 ml 
Calcium sulphate  0.93 g 
Potassium sulfate  18.2 g 
Magnesium sulphate-7H2O  14.9 g 
Potassium hydroxide  4.13 g 
Glycerol   40.0 g 
Water to 1 liter 
 
Table 2.3. Defined PTM1 Trace Salt components for P. pastoris and H. polymorpha fermentations. 
Component Quantity 
Cupric sulfate-5H2O  6.0 g 
Sodium iodide     0.08 g 
Manganese sulfate-H2O   3.0 g 
Sodium molybdate-2H2O   0.2 g 
Boric Acid     0.02 g 
Cobalt chloride   0.5 g 
Zinc chloride  20.0 g 
Ferrous sulfate-7H2O 65.0 g 
Biotin     0.2 g 
Sulfuric acid       5.0 ml 
Water to 1 liter 
 
2.1.8 Temperature and pH 
Other important process parameters that affect the yield and activity of recombinant proteins, are 
culture temperature and pH. Higher temperature fermentations may result in the exposure of protein 
hydrophobic surfaces during peptide folding, which favour hydrophobic interactions and predispose 
proteins to aggregation. These aggregated proteins are more susceptible to intracellular proteolytic 
degradation (Lee, Choi and Yu, 1990). Lower growth temperatures result in reduced protein 
synthesis which allow proteins to fold properly. This can be advantageous to self-assembly proteins 
that could be seen as aggregated proteins by the yeast’s degradation system. Low-temperature 
expression reduces proteolytic degradation of secreted proteins and is suitable for aggregation-prone 
proteins, but the fermentation period is longer compare to higher fermentation temperatures (Li et 
al., 2007).  
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Controlling the medium pH during the fermentation process is critical for cell growth, 
protein formation and protein stability. It is recommended that P. pastoris is cultured at a pH of 5.0 
to 6.0 (Invitrogen Life Technologies, 2002). When the presence of inhibiting proteases are to be 
avoided, lowering the pH to 3.0 or below (Brierley, 1998). 
2.1.9 Dissolved oxygen control 
Methylotrophic yeast requires oxygen to metabolize glycerol and methanol. Sufficient oxygen 
supply is therefore indispesable for P. pastoris cell growth and heterologous protein expression 
(Harder and Veenhuis, 1989). As the cells metabolise the available carbon source, the oxygen is 
consumed and the dissolved oxygen (DO) will drop. Once the carbon source such as glycerol and 
methanol are depleted, the DO will rise rapidly and the methanol-feeding rate should be increased 
accordingly to maintain cell metabolism. Thus, methanol feeding is closely related to the DO level 
(Li et al., 2007).  
In the absence of a methanol sensor, the DO is a good indicator of cell growth, carbon 
availability and general state of the yeast culture. Methanol concentration is not given as a precise 
value but rather indicated by the DO levels. Therefore, the exact methanol level can probably be 
either under or exceeding the limiting value. A constant (DO) level of 30-35% is optimum for most 
P. pastoris fermentations (Li et al., 2007). Excessive high DO levels are cytotoxic and reduce cell 
viability (D’anjou and Daugulis, 2001). DO can be controlled using the agitation rate of the 
bioreactors’ impellers and aeration through air or oxygen (O2) sparging, while it is also very 
sensitive to the medium addition strategy. In addition, bioreactors also have metal baffles to 
improve aeration (Srivastava, 2008).  
Dissolved oxygen is sensed by a DO electrode and controlled by a cascade effect between 
agitation rate (200-1000 rpm) and aeration rate (1 volume of oxygen per volume of fermentation 
culture per minute, 1 vvm), which is maintained by the proportional (P) and integral (I) controller. 
Glycerol/methanol feeding is carried out in a fed-batch mode based on an open-loop control 
strategy, the DO stat method, also referred to as ‘demand-feed’. The feeding rate is adjusted 
according to a control algorithm that attempts to control the level of the dissolved oxygen in the 
bioreactor. This entails the controlled addition of glycerol/methanol depending on the DO level. As 
the yeast metabolises actively, glycerol/methanol becomes depleted and the DO level begins to rise. 
Once the DO >30%, the glycerol feed is switched on. In the presence of glycerol, the metabolic 
pathway becomes activated and the DO level begins to decrease. When the DO < 30%, the glycerol 
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feed is switched off. The speed of agitation increased and O2 supply is automatically supplied to the 
system after the agitation speed reached its maximum, causing the DO tension to increase again. 
Once the DO >30%, the glycerol is switched on again (Valero, 2013). 
Indirect methods such as DO levels in bioreactors can mask the actual reason why DO 
increases. Increased DO levels could be attributed to the lack of methanol in the bioreactor, but also 
when inhibitory methanol levels are reached in case of overfeeding. Subsequently, the culture will 
be inhibited, yeasts cells will die and the DO will increase. This can be incorrectly interpreted by the 
control system as a methanol “shortage” resulting in more feeding, and subsequent higher methanol 
accumulation in the bioreactor (Cos et al., 2006). Despite the fact that the DO stat is used widely, 
neither the methanol concentration nor the growth rate is kept constant by this system. Open loop 
systems are also easy to implement, but show no response to possible perturbations of the system. 
Heterologous protein production, particular in P. pastoris, is characterized by a complex and non-
linear dynamics, making this control strategy inadequate for precise methanol control (Cos et al., 
2006). 
2.1.10 Foam control 
Due to the high agitaion and aeration rate during yeast fermentation, together with the nature of the 
culture medium, foam is generated at the surface of the culture medium. Excess foam may cause 
denaturation of the secreted proteins, reduce the headspace in the bioreacter and even complicates 
gas exchange at the surface (Invitrogen Life Technologies, 2002). Hence, excess foam needs to be 
eliminated by adding a non-silicone reagent to the culture medium (Antifoam 204, SIGMA). 
2.1.11 Codon usage 
The production of heterologous proteins comprises many complex transcription and translation 
processes, which may exert stress on the host cells at different levels. Gene expression is regulated 
by transcription, as the level of the steady-state mRNA is indicative of the final yield of foreign 
protein. Introducing changes in the mRNA sequence may affect the overall stability of mRNA and 
result in degradation (Rai and Padh, 2001). Furthermore, translation efficiency is highly dependent 
on the preferred codon usage of the host organisms. Highly expressed genes show a strong bias 
towards a subset of codons. Rare codons may result in limited aminoacyl-tRNAs and increased 
mistranslation, followed by lower yields of the desired protein (Bennetzen and Hall, 1982). Pichia 
pastoris shows a preference for GC-rich codons. Due to its high AT content, the expression of HPV 
Stellenbosch University  https://scholar.sun.ac.za
 27 
L1 genes is negatively affected when expressed in this yeast (Kotzé et al., 2011; Li et al., 2003; 
Sinclair and Choy, 2002).  
2.1.12 Production of viral proteins in yeast 
The expression of structural proteins poses additional challenges to recombinant yeasts, some of 
which may have deleterious effects. In order to maintain their functionally-active conformation, 
structural proteins need to fold properly after translation within the lumen of the endoplasmic 
reticulum (ER). The structural folding programming is strongly contained in the primary 
polypeptide structure (Gething and Sambrook, 1992). Misfolded proteins can be retained in the ER, 
causing intracellular accumulation. This bottleneck might interfere with the secretion process of 
host proteins (Romanos, Scorer and Clare, 1992). Folding, disulphide bond formation (Hohenblum 
et al., 2004) and gene copy number (Clare et al., 1991) are all considered to be possible rate-
limiting steps in the secretion of foreign proteins from yeast cells. P. pastoris has been very 
successful in producing proteins that contain a high number of disulphide-bonds (White, Kempi and 
Komives, 1994). Inter-capsomeric disulfide bonds, formed between conserved cysteines, are crucial 
for virus-like particle (VLP) formation (Sapp et al., 1998). However, disulphide bond formation and 
glycosylation are not favoured when secreted proteins are expressed intracellularly. This can result 
in unstable and inactive products, followed by degradation (Rai and Padh, 2001). 
Increasing the copy number of the expression cassettes could have both positive and 
negative effects on recombinant protein expression (Thill et al., 1990). Rodriguez-Limas et al. 
(2011) showed that a single plasmid expressing three rotavirus genes had several advantages over 
three individual plasmids expressing separate rotavirus genes. Increased gene dosage can cause a 
significant metabolic stress on the host cell due to limited carbon and nitrogen resources, leading to 
reduced growth rate and gene expression (Rodríguez-Limas et al., 2011). 
In addition to correct folding, proper assembly and extracellular transport are required during 
multimeric protein complex formation. VLPs are good examples of monomeric proteins that self-
assemble into multimeric structures mimicing native virions. Viral VLPs comprise of different 
building blocks, representing either one monomer or combinations of various different monomers 
(Grgacic and Anderson, 2006). The efficiency of self-assembly of human papilloma VLPs can be 
sensitive to changes in even a single amino acid base (Kirnbauer et al., 1993). Human 
papillomavirus (HPV) L1 VLP formation, for example, requires inter-capsomeric hydrophobic 
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interactions; folding of the monomeric L1 proteins therefore needs to expose these hydrophobic 
areas (Chen et al., 2000). 
In case of rotavirus (RV), the minimum requirement for VLP formation is the co-expression 
of structural proteins VP2 and VP6. Since VP6 is present at higher quantities than VP2 in the viral 
particle, different kinetics apply for the synthesis of each structural protein. The production of 
appropriate amounts of each structural component is vital for efficient VLP production and avoiding 
accumulation of waste monomers (Vieira et al., 2005). Aggregation of monomeres/capsomeres 
competes with VLP formation and is a major cause of protein instability (Ding et al., 2010). Also, 
advances in VLP technology via in vitro manipulation of buffers have shown to increase the 
stability of VLP by improving native disulphide bond formation (Mach et al., 2006). 
2.2 Cervical cancer and current Human papillomavirus vaccines 
Cervical cancer is characterised by abnormal growth of cells in the cervix and have the ability to 
spread to other parts of the body. Early stages have no symptoms, therefore, regular screening is 
important to identify the condition. It is the fourth most common cancer in women worldwide after 
breast, colorectal and lung cancers (Ferlay et al., 2012), with the highest incidence in black females 
in developing countries, such as South Africa (Kay et al., 2003). Although South African women in 
the public sector are entitled to three free Papanicolaou (Pap) smears, at the age of 30, 40 and 50 
years, it is difficult to implement, especially in rural areas where access to health care is limited. 
This screening regime is predicted to reduce the risk of cervical cancer by 67% (Marcus, 2008). The 
lack of screening programmes resulted in higher incidence rates of cervical cancer in lower-resource 
countries of sub-Saharan Africa. Almost 70% of the global cervical cancer burden falls in 
developing countries (Ferlay et al., 2012) (Fig. 2.4). It has been reported that the incidence rate of 
cervical cancer in Zimbabwe is up to 14 times higher than in non-African countries (Marcus, 2008). 
Stellenbosch University  https://scholar.sun.ac.za
 29 
 
Figure 2.4. Geographic distribution of the world age-standardized incidence rate of cervical cancer 
worldwide in 2012 (Ferlay et al., 2012). Intensity of colour bar reflects incidence rate. 
Almost 100% of all invasive cervical cancers contain human papillomavirus (HPV) 
(Walboomers et al. 1999), identifying HPV type 16, 18 and a few others as major risk factors 
(Muñoz et al., 1992; Bosch et al., 1992). Even on home ground, Denny et al. (2014) reported 
evidence of HPV type 16 in more than 50% of cervical cancer biopsies from South African women 
with invasive cervical cancer (Denny et al., 2014). Other HPV types , such as HPV types 35 and 45 
are also now emerging and becoming amongst the most common types in sub-Saharan Africa 
(Clifford et al., 2005; Allan et al., 2008; Denny et al., 2014).  
The two HPV vaccines currently registered in South Africa are both VLP vaccines: Merck's 
Gardasil and GlaxoSmithKline's Cervarix. VLPs or pseudovirions are formed by the self-assembly 
of structural proteins L1 alone or the combination of L1 and L2, but lack any genetic material 
making them ideal immunogens ,without the risk of being infectious (Grgacic and Anderson, 2006). 
Gardasil comprises of HPV type 6, 11, 16 and 18 L1 recombinant proteins expressed in 
Saccharomyces cerevisiae (Shi et al., 2007). Cervarix consists of HPV type 16 and 18 L1 proteins 
made in the recombinant baculovirus expression system (Campo and Roden, 2010; Deschuyteneer 
et al., 2010). These two vaccines are targeted at the HPV types causing cervical cancer and have the 
potential to prevent this disease by 70%, but unfortunately these vaccines are very expensive 
(Marcus, 2008). In addition, the South African government extended its national vaccination 
programme in 2014 by administering the HPV vaccine to school girls between the age of 9 -12 years 
old in two doses, six months apart. This will escalate the cost of subsidised vaccinations 
dramatically, hence the quest for cheaper manufacturing costs. 
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2.2.1 Structure of the Human papillomavirus 
The virion (capsid) has a non-enveloped icosahedral structure, 55 nm in diameter, made up of 72 
pentameric capsomeres (Fig. 2.5). The HPV capsid consists of two proteins, the major structural L1 
protein and the minor one, L2. L2 is present at a ratio of 1 to every 30 L1 proteins (Kirnbauer et al., 
1993). HPV contains a viral genome of almost 8 000 bp of double-stranded circular DNA and is 
divided in three parts: two thirds code for early proteins E1 to E7, and the remainder for the 
structural proteins (Fig. 2.6) (Garcea and Chen, 2007). The L1 protein alone can self-assemble into 
either capsomeres (pentamers of L1) or VLPs (72 capsomeres) (Kirnbauer et al., 1992). The in vitro 
self-assembly process is accomodated by a combination of low pH and high salt concentrations (Liu 
et al., 2007; Mach et al., 2006). 
 
Figure 2.5. Atomic model of the HPV16 VLP, consisting of 72 pentamers with each pentamer 
containing 5 monomers (Zhao et al., 2012 ; Chen et al., 2000). 
 
Figure 2.6. Genome organization of Human papillomavirus type 16 (Shanmugasundaram and You, 
2017). 
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VLP formation requires inter-capsomeric interactions involving helics 2, 3 and 4 near the 
carboxy-terminus of each L1 monomer. These helices project laterally and outwards where helix 4 
from a L1 monomer with in a capsomer forms hydrophobic interactions with helices 3 and 4 from a 
L1 monomer of an adjacent capsomer. (Fig. 2.7) (Chen et al., 2000). Finnen et al. (2003) described 
a similar hydrophobic region near the carboxy terminus of L2 that specifically interacted with L1. 
The strong interaction indicates it as the principal domain responsible for anchoring L2 within the 
papillomavirus virion (Finnen et al., 2003). Yet, L2 is not necessary for VLP assembly. 
 
 
Figure 2.7. (A) Diagram showing the interactions amongst different pentamers.All subunits in the 
central pentamer are red; two monomers in each adjacent pentamer are shown in yellow and green, 
respectively. The helix 4 from each monomer projects laterally. (B) and interacts with helices 2 and 
3 of a monomer in an adjacent pentamer (Chen et al., 2000).  
2.2.2 HPV immunogenicity 
Thönes and Müller (2007) showed that different assembly forms of HPV type 16 L1, including 
capsomeres and VLPs, induce humoral and cellular immune responses after oral vaccination of 
mice (Thönes and Müller, 2007). Due to the amino acid sequence conservation of the L2 protein 
among different HPV types, L2 shows broad-spectrum cross-reactivity among different HPV 
genotypes and therefore great promise as a broadly neutralizing prophylactic vaccine (Yang et al., 
2003). The anti-L1 immune response, in turn, is more type-specific. Despite the cross-reactivity, the 
A 
B 
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titres of neutralizing antibody against L2 are rather low compared to those produced against L1 
(Roden et al., 2000). One option to overcome this problem is to include the L2-neutralizing epitope 
on the surfaces of VLPs, thus increasing the titers of neutralizing antibodies approximately 10-fold 
(Slupetzky et al., 2007). 
Gambhira et al. (2007) has found that antibodies raised against L2 also protect against low-
risk HPV types and cutaneous types, which makes it even more useful in a broadly-acting HPV 
vaccine. A region of L2 has been identified that shows the broadest cross-neutralizing activity. This 
domain, which is situated between amino acids 17 and 36, is recognized by a monoclonal antibody 
(RG-1) and is implicated in binding to a putative HPV secondary receptor (Palmer et al., 2009). 
A study done by Buck and co-workers (2008) has shown that the HPV capsid can 
accommodate up to 72 molecules of L2. This contradicts other studies where only 12 molecules of 
L2 are found within the viral capsid (Roden et al., 1996; Volpers et al., 1994; Finnen et al., 2003). 
These studies have implications for the development of broadly antigenic HPV VLP vaccines as the 
variability in the number of L2 proteins present within the particle may affect its immunogenicity. 
L1 and L2 have been revealed to interact with each other through strong hydrophobic interactions 
involving 44 amino acids at the carboxy terminus of L2. This region is very proline-rich, which is 
characteristic of protein-protein interactions and would allow L2 to bend in a way that would allow 
a short region to protrude from the L1 pentamer (Finnen et al., 2003; Slupetzky et al., 2007). The N-
terminal part of L2, which is recognized by neutralizing antibodies, extends into the external 
environment. Despite the broadly antigenic properties of L2, neutralizing antibodies mainly target 
L1 and it is thus the most important component of an HPV VLP vaccine (Kieback and Muller, 
2006). High titers of neutralizing antibodies are induced when L1 and L2 are co-expressed and VLP 
assembly takes place. Levels of antibodies are comparable to those elicited by L1 alone, however, 
the addition of L2 to VLPs is advantageous because it increases the VLP yield (Schiller and Lowy, 
1996; Wakabayashi et al., 2002). When expressing the structural proteins in an expression system 
for VLP production, it is important to keep in mind that codon usage in humans and the chosen 
expression system may differ greatly, which in turn may lead to reduced yields of VLPs. Codon 
optimization of the structural genes may ensure that expression takes place more efficiently and at 
high levels (Leder et al., 2001; Zhao et al., 2003). 
Up-regulation of the immune response is partly due to the role played by dendritic cells (DC) 
in capturing antigens and migrating to the lymphoid tissues where they initiate and modify 
Stellenbosch University  https://scholar.sun.ac.za
 33 
particular cellular immune responses. De Witte et al. (2007) investigated the interaction between 
HPV L1 VLPs and DCs because the activation of DCs by HPV L1 VLPs is critical in initiating a 
complete immune response. It was established that HPV L1 VLPs do interact with and activate 
DCs, which lead to up-regulation of immune co-stimulatory molecules as well as the production of 
cytokines IL-6, IL-8, IL-10 and IL-12 (De Witte et al., 2007). These results are important as 
previous studies have shown that incomplete activation of DCs results in the development of 
antigen-specific tolerance, rather than the activation of an immune response (Harper et al., 2006). 
Zhang and co-workers (2009) have shown that VLPs are able to induce B-cell proliferation and 
differentiation. B-cells form part of the lymphocyte population and play a central role in the 
humoral immune response. These immune cells are known to be activated by antigens with 
structured, repetitive configurations such as the capsids of most viruses, which lead to effective 
cross-linking with the B-cell surface. This in turn leads to the production of high-affinity antibodies 
that are extremely specific and long-lasting memory cells, which are advantageous when using VLP 
vaccines (Zhang et al., 2009). 
2.2.3 Expression of HPV L1, L2 or chimeric L1/L2 proteins 
HPV L1 VLPs have been produced in various expression systems, such as bacteria, e.g. E. coli 
(Chen et al., 2001) or Lactococcus lactis (Cortes-Perez et al., 2009), yeast such as S. cerevisiae 
(Woo et al., 2008), P. pastoris (Zhao et al., 2015; Bazan et al., 2009; Kotzé et al., 2011) and H. 
polymorpha (Li et al., 2009), baculovirus-infected insect cells (Le Cann et al., 1994), transgenic 
plants (Biemelt et al., 2003) and mammalian cells (McLean et al., 1990). L1/L2 VLP requires the 
co-expression of both L1 and L2, either as two separate genes on one plasmid or individual genes on 
separate plasmids. L1 and L2 VLPs have also been produced in human epithelial cells (Cianciarullo 
et al., 2010) and insect cells (Kirnbauer et al., 1993; Zhou et al., 1991). Co-expression of L1 and L2 
resulted in a four-fold increase in VLP yield (Kirnbauer et al., 1993). 
Furthermore, chimeric L1/L2 VLPs, comprising the L1 VLP displaying a common-
neutralizing L2 epitope in various regions of the L1 protein, have been expressed in insect cells 
(Varsani et al., 2003; McGrath et al., 2013) and more recently in the yeasts P. pastoris and H. 
polymorpha (Smith et al., 2012). One of these chimeric constructs was created by replacing the h4 
helix of the L1 protein with a 13-amino acid peptide from the L2 protein (Varsani et al., 2003). This 
construct was human codon-optimized and resulted in the formation of mainly capsomeres in insect 
cells, but the occasional T=7 VLPs (~50 nm in size) were seen (McGrath et al., 2013). Similarly, 
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formation of VLPs in the baculovirus system was prohibited when the h4 helix of L1 was replaced 
with human respiratory syncytial virus (RSV) epitopes, resulting in capsomeres (Murata et al., 
2009). The highest concentration of HPV-16 L1 protein obtained from various expression sytems, is 
reported to be in the P. pastoris KM strain (14.2 mg.L-1) (Bazan et al., 2009) and in H. polymorpha 
(78.6 mg.L-1) (Li et al., 2009), all obtained in shake-flasks experiments. 
2.3. Rotavirus infection and current vaccines 
Gastroenteritis, causing severe diarrhea, is one of the leading worldwide causes of illness and deaths 
in children under the age of five years (Parashar et al., 2006). Rotavirus (RV) infection accounts for 
one third of diarrhea-associated hospitalizations and more than 500 000 deaths annually (Parashar et 
al., 1998; WHO 2007). Approximately, 85% of those deaths occur in South Asia and sub-Saharan 
Africa (Parashar et al., 2009) (Fig. 2.8). There is no cure for gastroenteritis other than to treat the 
dehydration, and can therefore be especially harmful for infants and young children. Prevention with 
rotavirus vaccination is the best way to protect children from RV disease. Currently, there are two 
RV vaccines available in both the public and private sector: RotaTeq by Merck (Blue Bell, PA), 
given at three doses (2, 4 and 6 months) and Rotarix by GlaxoSmithKline Biologicals (Rixensart, 
Belgium), given at two doses (2 and 4 months). The latter vaccine is a live attenuated RV serotype 
G1P[8], the most globally common serotype, while Rotateq is produced through reassortment of 
VP7 proteins for serotypes G1-G4 strains and VP4 protein for the P[8] genotype (Gray, 2011).  
These two vaccines can prevent up to 34% and 96% of severe diarrhea in the developing 
world and developed world, respectively (Soares-Weiser et al., 2012).  Differences in vaccine 
efficacy highlights the importance of including emerging region-specific genotypes in future 
vaccines. However, both vaccines are still more expensive than most other childhood vaccines 
included in the WHO's Expanded Programme on Immunization (Madsen et al., 2012).  
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Figure 2.8. World map showing the rotavirus mortality in children younger than five by the end of 
2013. (World Health Organization, 2016) 
 
Due to the positive outcome of vaccine trials in South Africa (Madhi et al., 2010) and 
elsewhere (Gray, 2011), as well as funding opportunities (GAVI-Alliance), the rotavirus vaccine has 
been included in the South African Expanded Programme on Immunization (EPI). Despite being a 
highly cost-effective means of securing public health, future vaccination in low-income, high-
burden countries still have a large financial impact. Furthermore, current RV vaccines, constituted 
of live attenuated viruses, still have the risk of adverse effects, although these risks are considered to 
be very low. Recently, there has been an increase in the detection of RV strains other than the G1-
G4, resulting in current RV vaccines having a low efficacy in developing countries (Page et al., 
2009). Lower efficacy seen in developing countries might also be the result of poor nutrition, co-
infections with other enteric pathogens or co-administration with other live-attenuated oral vaccines 
such as oral poliovirus vaccines. Also, high concentrations anti-rotavirus antibodies in breast milk 
might neutralize live attenuated virus vaccines in a breast feeding community (Gray, 2011). 
Therefore, there is an urgent need to develop new vaccines with the intention to offer it at lower cost 
than the current approved vaccines.  
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2.3.1 Structure of rotaviruses 
Rotaviruses are unenveloped viruses with an icosahedral triple-layered capsid of 75 nm in diameter 
(Iturriza-Gomara, Kang and Gray 2004) (Fig. 2.9). They are members of the Reoviridae family and 
show a noticeable tropism for the intestinal epithelium. The capsid consists of three layers: (1) the 
outer capsid, composed of 180 VP4 and 780 VP7 proteins; (2) the inner capsid, composed of 780 
VP6 protein arranged in 260 trimers; and (3) the inner capsid composed of 120 nucleic acid 
proteins, VP2. These three layers are surrounding a core consisting of 11 distinct segments of 
double stranded (ds)RNA, which codes for two structural and six non-structural proteins (Parashar 
et al., 1998) (Fig. 2.10). Although VP6 and VP7 are present in equal quantities in the RV particles, 
VP6 provides the biggest molecular mass. Due to its high abundance, the majority of antibodies 
generated in an infected individual is directed against VP6. The VP6 protein is highly conserved 
with less than 13% amino acid divergence between any two mammalian group A rotavirus strains 
(Tang et al., 1997) 
 
 
Figure 2.9. Transmission electron micrograph of rotavirus particles (Centre for Disease control and 
Prevention, 2016).  
 
An intrinsic characteristic of VP6 is the oligomeric formation, in particular trimer structures, 
as seen from electron microscopic imaging (Gorziglia et al., 1985). Ready and Sabara (1987) 
reported that the formation of VLPs requires the co-expression of VP2, without which protein VP6 
alone can only form spherical or tubular aggregates (Ready and Sabara, 1987). Depending on the 
pH, ionic strength and divalent cation concentration (Ca2+ and Zn2+), VP6 trimers can spontaneously 
self-assemble into morphological subunits, such as spherical (at pH 4) or tubular multimeric 
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structures (at pH 5-9) (Lepault et al., 2001; Estes et al., 1987). Assembly of aggregates is also 
inhibited by high concentrations of divalent cations of 100 mM and more (Ready and Sabara, 1987). 
Contradictory to this, O’Brian et al. (2000) reported that VP6 can also form icosahedral or VLPs 
when expressed in plants, resembling the morphology of dually expressed VP2 and VP6 VLPs as 
observed in the insect cell-baculovirus expression system (O'Brian et al., 2000). 
 
 
Figure 2.10. Triple-layered structure of rotavirus showing the localization of the 6 different 
structural proteins (VP1,VP2,VP3,VP4,VP6, and VP7 (UNC, 2014). 
2.3.2 VP6 as a vaccine candidate 
Structural proteins VP4 and VP7, present in the outer layer of triple-layered particles, are the only 
proteins able to elicit neutralizing antibodies. Despite this, mouse model studies showed that triple-
layer particles provide the same protection as double-layered particles, indicating neutralizing 
antibodies are not required for protection (Svensson et al., 1987). Irrespective of how many 
chimeric VP6 protein dosages were administered, protection for up to 1 year against rotavirus 
shedding was obtained (Choi et al., 1999). Vaccination with VP6 via the oral, intranasal and 
intrarectal route was almost equally effective, suggesting the mucosal route is the preferred route to 
deliver antigens to the immune system (Choi et al., 2002; McNeal et al., 2007). VP6 is not only the 
most immunogenic protein, but due to its low divergence between different strains, the VP6 vaccine 
from any mammalian rotavirus may provide protection against all. 
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An alternative to VP6 vaccines is VLPs of different protein compositions. Co-expression of 
VP2 and VP6 results in the production of double-layered VLPs (2/6-VLP), whereas co-expression 
of VP2, VP6 and VP7, with or without VP4, results in the production of triple-layered VLPs (2/6/7-
VLP or 2/4/6/7-VLP) (Crawford et al., 1994; Labbé et al., 1991; Agnello et al. 2006). Studies done 
in mice confirmed that VLPs composed of VP2 and VP6 provided better protection when 
administered intrarectally compared to intranasally (Agnello et al., 2006), and intranasally better 
than orally (O’Neal et al., 1997). VLPs administered mucosally offer a promising, safe, non-
replicating vaccine alternative for rotavirus infection. Immunoglobulin A (IgA) levels correlate with 
protection from severe disease in humans (Jiang et al., 2010; Franco, Angel and Greenber, 2006; 
Offit, 2001), prevent primary infection in mice as well as resolve chronic infection in mice (Burns et 
al., 1996; S. Chen et al., 1997). Epitopes present on VP6 are also recognized by both cytotoxic T-
lymphocytes as well as T-helper cells, indicating a possible role for VP6 in stimulating a cell-
mediated immune response (Franco et al., 1994; Dharakul et al., 1991; Bruce et al., 1994). Despite 
the safety and stability of VLPs, commercialization of a VLP vaccine requires efficient quantities to 
minimise costs. 
In addition to its application as a vaccine candidate, VP6 has also been applied as a drug 
delivery tool (Redmond et al., 1991; Zhao et al., 2011). Frenchick et al. (1992) demonstrated that 
peptides coupled to VP6 spheres elicited a greater humoral response than the peptides alone, and 
that the spheres were not neutralized by anti-rotavirus antibodies (Redmond et al., 1991; Frenchick 
et al., 1992). Due to their natural tropism and non-replicative properties, RV VLPs are promising 
candidates to deliver anti-inflammatories to the intestine using the same mechanism used by RV to 
infect intestinal cells (Cortes-Perez et al., 2010). RV VLPs, especially VP6 multimeric structures, 
have been expressed in a variety of different heterologous systems. Mammalian cells (Gonzdlez and 
Affranchino, 1995), insect cell/baculovirus systems (IC-BVS) (Crawford et al., 1994; Bertolotti-
Ciarlet et al., 2003), prokaryote E. coli (Choi et al., 2004; Aijaz and Rao, 1996), the eukaryotic 
yeast S. cerevisiae (Rodríguez-Limas et al., 2011; Zhao et al., 2011), and more recently 
baculovirus-silkworm (Yao et al., 2012) have been explored. RV VLPs were also positively 
identified in the yeast P. pastoris after intracellular co-expression of VP2, VP4 VP6 and VP7 
(Zhang and Lou, 2011). No other attempt to express RV proteins in any other yeast strain have been 
reported ever since. 
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2.4 Burn wounds: treating with antimicrobial peptides and collagen 
The skin acts as a first line of defence for the human body and a protective barrier against the 
environment and its invasive microorganisms. Loss of the integrity of large portions of the skin as a 
result of a burn injury may lead to major disability or even death. It is estimated that more than a 
million burn injuries occur annually in Africa with almost 20% of hospital admissions that are due 
to burns. Three quarters of all deaths in patients with severe burns, covering more than 40% of the 
total body surface area (TBSA), are currently related to sepsis from burn wound infection or other 
related complications (Baker, Miller and Trunkey, 1979; Bang et al., 2002). 
In South Africa, thermal injuries are the most common external cause of death for children 
under the age of 4 years and the third most common cause under the age of 18 (Rode, Berg and 
Rogers, 2011). Over 80% of fatal burn injuries are said to occur in informal settlements where two-
thirds of the burns are due to dangerous and inappropriate energy sources (UNISA, 2016). Poverty, 
mass illiteracy, migration to urban areas with the development of slum areas and shanty towns are 
some of the factors that have led to an increase in burns during the past decade (Oluwasanmi, 1996).  
The skin is equipped with an array of immune mediators, capable of recruiting inflammatory 
cells to enable neutralization and clearance of foreign invaders from the site of infection. Significant 
thermal injuries induce a state of immunosuppression, such as neutrophil dysfunction (Grogan, 
1976), which predisposes burn patients to infectious complications and the emergence of 
antimicrobial drug-resistant microbes. Large amounts of necrotic tissue and cell debris present in 
the burn wound provides good culture medium for bacteria. Microbial invasion and subsequent 
doubling times of 20 minutes or less are often much more rapid than even the innate immune 
response, including the recruitment of neutrophils (Izadpanah and Gallo, 2005). Invading bacteria 
are powerful activators of the complement system, which in turn activate the neutrophils. Upon 
immune activation, neutrophil elastases are released and will hydrolyse proteins, such as those 
present in bacteria (Hasslen et al., 1992).  
2.4.1 Antimicrobial peptides (AMPs) 
Since the discovery of antimicrobial peptides (AMPs) during the early 1980’s (Steiner et al., 1981), 
they have been recognized as excellent candidates for novel therapeutic agents and complements 
conventional antibiotic therapy. Bacterial resistance against conventional antibiotics is becoming an 
increasing problem worldwide, but microbial resistance against AMPs is quite rare (Peschel and 
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Sahl, 2006). These small cationic, amphipathic peptides constitute the innate immune defence 
mechanism and are found in a wide range of eukaryotic organisms, including humans, plants and 
insects (Reddy, Yedery and Aranha, 2004; Rinaldi, 2002; Wegner, 1990; Zasloff, 2002). Based on 
their three-dimensional structure, AMPs are broadly classified into 5 groups: (i) α-helical; (ii) 
cysteine rich; (iii) β-sheet; (iv) AMPs rich in regular amino acids; and (v) AMPs with rare modified 
amino acids (Reddy, Yedery and Aranha, 2004).  
In humans, three different AMP families have been identified as part of the mammalian 
innate immune response: defensins, cathelicidins and histatins (Bals, 2000). AMPs are present in all 
human body areas exposed to microbes such as the skin and mucous membranes, and even some 
blood cell types including neutrophils, eosinophils and platelets. They are always produced as 
cocktails, either constitutively or induced by inflammation or injury, and act multifunctional 
(Wiesner and Vilcinskas, 2010). In addition to killing bacteria during wound healing, AMPs also 
stimulate the complex host repair mechanism during wound healing, comprising of cell proliferation 
and the migration of growth factors (Gallo et al., 1994). Neutrophil elastases, secreted by immune 
activated neutrophils, activate cathelicidins present in neutrophils (Scocchi et al., 1992). Cole et al. 
(2001) has reported that the inhibition of neutrophil elastases in porcine skin wounds prevents 
cathelicidin activation and impair clearance of bacteria during wound healing (Cole et al.. 2001). 
Cathelicidins are synthesized as pre-pro-peptides and characterized by the conserved amino-
terminal sequence of the pro-peptide, and a variable carboxy-terminal domain containing the 
antimicrobial activities (Zasloff, 2002). During activation, the cathelicidins pro-peptide must be 
proteolytically cleaved from the C-terminal peptide to unleash the microbicidal activity (Selsted et 
al., 1992) (Fig. 2.11). Based on amino acid sequences, mature cathelicidin peptides can be 
organized into three groups (Fig. 2.12): group I – linear; a-helical peptides without cysteines; group 
II – peptides with an even number of cysteines linked by disulphide bridges, eg. protegrin; and 
group III – peptides with an unusually high proportion of one or two amino acids (Bals and Wilson, 
2003). Protegrins, an AMP isolated from porcine leukocytes, are 18 amino acids long, rich in 
cysteines with two intramolecular disulphide bonds and β-sheet structures. Due to its ability to 
sustain increased concentrations of salt (Steiner et al., 1981), protegrin is used as a broad-spectrum 
antibiotic against both Gram-positive and Gram-negative bacteria. Another member of the 
cathelicidin family is indolicidin, a 13-residue peptide isolated from bovine neutrophils with an 
unusual high number of tryptophans. Because of its small size and potent antimicrobial activity 
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against Gram-positive and Gram-negative bacteria (Sharp et al., 1988), indolicidin has also been 
considered as a possible therapeutic agent 
 
Figure 2.11 Structure of the gene and peptide of LL-37 as a prototypical example for the α-helical 
human cathelicidin. The C terminus (3’ UTR) represents the antimicrobial part of the molecule. The 
gene is represented schematically with the following individual components: White box, 5’ 
untranslated region (5’UTR); grey box, signal sequence; black box, pro-sequence; shaded box, 
mature peptide; white box, 3’ UTR (Bals and Wilson, 2003). 
.  
 
Figure 2.12 Examples of the three basic types of AMPs. a) The α-helical human cathelicidin LL-37, 
b) the human β-defensin hBD-2 stabilised by three intramolecular disulfide bonds indicated in 
yellow and c) the tryptophan-rich bovine indolicidin (Wiesner and Vilcinskas, 2010). 
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2.4.2 Mode of action 
AMPs kill cells by disrupting the host’s membrane, inhibit the synthesis of cellular proteins, DNA 
and RNA, or interacting with certain intracellular targets (Bahar and Ren, 2013). In case other 
intracellular sites being are targeted, an initial contact between the host’s membrane and AMP is 
required for the antimicrobial activities of AMPs (He et al., 1996). Therefore, the main action 
involves their ability to cause cell membrane damage. This is done through the electrostatic 
interaction between the positively charged amino acid residue of the AMPs and the negatively 
charged host’s cell membrane. The hydrophobic part of AMPs assist to insert the AMP molecule 
into the host’s cell membrane (Madani et al., 2011). Several models have been proposed for how 
AMPs can insert into the cellular membrane leading to ion channels, transmembrane pores or 
extensive membrane rupture (Brogden, 2005). Three of the major models are described below (Fig. 
2.13): 
The carpet-like model. The peptides orientate themselves parallel to the cell membrane and 
cover a small area of the membrane. The AMPs form peptide-lipid aggregates and disrupts the lipid 
bilayer to form pores in the membrane (Chang et al., 2008). 
The Barrel-Stave model. The attached peptides insert themselves perpendicularly into the 
membrane bilayer so that the hydrophobic regions of the peptides align with the lipid core of the 
membrane and the hydrophilic regions form the interior of the pore (Rosado et al., 2008). 
The Toroidal model. This model differs from the Barrel-Stave model in that the attached 
peptides aggregate and cause the lipid monolayer to bend continuously through the pore. Thereby, 
the pores are lined with both the inserted AMPs and the lipid head groups (Yang et al., 2001). 
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Figure 2.13. Schematic representation of the three major models explaining how cationic 
amphipathic AMPs insert into lipid bilayers and lead to membrane disruption. Barrel-Stave model. 
AMP molecules insert themselves into the membrane perpendicularly. Carpet model. Small areas of 
the membrane are coated with AMP molecules with hydrophobic sides facing inward leaving pores 
behind in the membrane. The toroidal model resembles the Barrel-stave model, but AMPs are 
always in contact with phospholipid head groups of the membrane. Hydrophilic and lipophilic parts 
of the AMPs are indicated in light grey and black respectively (Wiesner and Vilcinskas, 2010). 
2.4.3 Collagen 
Collagen is the major component of wound connective tissue. An outstanding feature of collagen is 
their ability to self-assemble (Fessler, 1974). During the wound healing process, fibroblasts continue 
to generate collagen, which assemble into fibres, becomes cross-linked and are finally organized 
into bundles (Robson, Burns and Phillips 1994). Collagen consist of three polypeptide chains, 
known as alpha peptides, each possessing the conformation of a left-handed helix. Each polypeptide 
chain (procollagen) has a repetitive amino acid sequence of glycine-proline-X- or glycine-X-
hydroxyproline where “X” represents any amino acid. Three left-handed helixes are twisted around 
each other in a right handed triple helix. A prerequisite for triple helix formation is glycine (Gly) in 
every third position as the side chain of glycine, an H atom, is the only one that can fit into the 
crowded center of a three-stranded helix. That is also the reason why the rings of the proline (Pro) 
and hydroxyproline (Hyp) must point outward. This triple helical structure is referred to as 
tropocollagen and is stabilized by numerous hydrogen bonds between the Hyp and hydroxylysine 
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(Hyk) residues. Many tropocollagens aggregate together to form a fibril, and many fibrils then form 
a fibre (Fig. 2.14) (Campbell, 1995). 
 
 
Figure 2.14. Synthesis of collagen. Three polypeptides coil to form tropocollagen. Many 
tropocollagens then bind together to form a fibril, and many of these then form a fibre (Kruger et 
al., 2013) 
 
Different types of collagen occur in different places throughout the human body. Collagen 
type 1 is the most abundant collagen and is also synthesized in response to injury. This heterotrimer 
comprises two identical α1(I) chains and one α2(I) chains (Campbell, 1995) (Fig. 2.15).  
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Figure 2.15. Collagen type 1 consisting of 2 identical α1(I) chains and one α2(I) chain (National 
Center for Biotechnology Information, 2017). 
Collagen has been the major ingredient in a wide range of wound dressings and burn wound 
creams (Ruszczak and Schwartz, 1999). Previously, collagen was isolated from animals, but this 
process was quite expensive. Recombinant expression systems allowed for the production of large 
quantities of collagen at a fraction of the cost. Recombinant collagen has the advantage in that it 
does not elicit an immune response in humans as in the case of animal-derived collagen 
(Nokelainen et al., 2001). Significant effort has been made to express human collagen in 
recombinant systems, such as bacterial cells, yeast, insect cells and plants (Ruggiero et al., 2000; 
Myllyharju, 2009; An, Kaplan and Brodsky, 2014). However, the requirement for post-translational 
proline hydroxylation has been a major obstacle in achieving high production levels, as the 
responsible enzyme, prolyl 4-hydroxylase, is either insufficient or lacking. The 4-hydroxyproline 
residues are essential for the formation of stable triple helices and therefore, the recombinant 
collagen polypeptide chains produced in these systems will remain in the form of a non-triple-
helical, non-functional protein. Therefore, the co-expression of prolyl 4-hydroxylase together with 
the α1 and α2 chains of type I procollagen ensures the successful expression of human type I 
collagen in yeast (Nokelainen et al., 2001). 
Thermal trauma to the skin requires intensive treatment of the wounds involving expensive 
wound dressings (Olawoye, Osinupebi and Ayoade, 2013). In most cases of third-degree burns, skin 
grafting is necessary. Caring for burn injured patients can be a financial burden and may not be 
available to most people in developing countries. Therefore, there is a great need for alternative 
remedies THAT can aid in the effective treatment of burn wounds in developing countries. 
2.5 Concluding remarks 
Both viral proteins as well as collagen represent structural proteins with the ability to aggregate into 
higher order structures. HPV L1 protein alone and also RV VP6, with the addition of VP2, can self-
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assemble into VLPs (Kirnbauer et al., 1992; Gorziglia et al., 1985). The latter resembles the original 
viral capsid capable of mimicking an immune response similar to that against native viruses (Roy et 
al., 2008). Both HPV L1 and RV VP6 are highly immunogenic due to their abundant presence in the 
original VLP structure (Kirnbauer et al., 1993; Tang et al., 1997), which explainS their inclusion in 
current HPV and RV vaccines. High-yield expression systems are needed for the production of these 
protein subunits and methylotrophic yeasts qualify as highly efficient producers. Methylotrophic 
yeasts are established protein expression hosts that have rapid growth rates, use inexpenisve media 
and well-established fermentation technology. The expression of HPV16 L1 monomers in 
methylotrophic yeast systems has been limited to P. pastoris, mainly in shake-flask cultures. 
However, in our study the production was expanded to a human codon optimized chimeric HPV16 
L1/L2 protein, called SAF, in H. polymorha. As discussed, H. polymorpha is more thermo-tolerant, 
has faster high-yield fermentation and is ideal for the production of mammalian proteins such as 
collagen (Hollenberg and Gellissen, 1997).  
Although triple-layered rotavirus-like particles, consisting of VP2, VP6 and VP7 proteins, 
have succesfully been expressed in S. cerevisiae, the yields were very low. Expression of RV VP6 
was never explored in any other yeast, including the methylotrophic yeasts P. pastoris and H. 
polymorpha.  
Despite several attemps to express HPV L1 or RV VP6 proteins in methylotrophic yeasts, 
none of them yielded high enough concentrations to be cost-effective. These low yields prompted us 
to scale-up expression of these self-assembling proteins in the controlled environment of bioreactors 
in order to increase production levels. Scaled-up fermentations pose additional challenges as the 
yeasts were cultured on glycerol to increase biomass and protein production was induced using 
methanol. Depending on which P. pastoris strain was used, methanol feeding must be adjusted 
during feb-batch cultures to maintain optimum levels of methanol and prevent the toxic 
accumulation thereof. Very few studies address the impact of different feeding strategies on 
methylotrophic yeasts as well as the impact of different yeast strains on the production of HPV L1 
and RV VP6 monomers.  
High concentrations of these viral subunit proteins result in the self-assembly into VLPs. 
One of the objectives was to semi-purify the HPV16 SAF proteins and visualize any potential 
secondary structures using microscopy. SAF was previously expressed in a baculovirus recombinant 
Stellenbosch University  https://scholar.sun.ac.za
 47 
system. Despite the low expression levels, SAF proteins mostly assembled into capsomer and the 
occasional VLPs, 50 nm in size, have been seen (McGrath et al., 2013).  
Similarly, the three polypeptide strands (alpha peptides) of collagen are intertwined together 
into a right-handed triple helix (Hollenberg and Gellissen, 1997). The latter self-assembles to form a 
fibril that ultimately assembles in order to form a fibre. Various studies reported on the successful 
expression of collagen in P. pastoris before, but we have adapted the expression of a collagen α1(I) 
chain fused with an antimicrobial peptide, which can aid in burn wound dressings. This novel 
approach has never been explored in any expression system before.  
In the next chapters we report on the investigation of the methylotrophic yeasts P. pastoris 
and H. polymorpha for the expression of viral proteins, HPV SAF and RV VP6, as well as a novel 
collagen-antimicrobial fusion peptide.  
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Abstract 
Cervical cancer is ranked the fourth most common cancer in women worldwide. Despite two 
commercially available prophylactic vaccines, it is unaffordable for most women in developing 
countries. We compared the optimized expression of monomers of the unique HPV type 16 L1/L2 
chimeric protein (SAF) in two yeast strains of Pichia pastoris, KM71 (MutS) and GS115 (Mut+), 
with Hansenula polymorpha NCYC 495, to determine the preferred host in bioreactors. SAF was 
uniquely created by replacing the h4 helix of the HPV-16 capsid L1 protein with a L2 peptide. Two 
different methanol feeding strategies in fed-batch cultures of P. pastoris MutS were evaluated: a 
predetermined feed rate versus feeding based on the oxygen consumption by maintaining constant 
dissolved oxygen levels (DO stat). All cultures showed a significant increase in biomass when 
methanol was fed using the DO stat method. In P. pastoris, the SAF concentrations were higher in 
the MutS strains than in the Mut+ strains. Hansenula polymorpha produced the highest level of SAF 
at 132.10 mg.L-1 culture, while P. pastoris MutS only produced 23.61 mg.L-1. The H. polymorpha 
strain showed greater potential for the expression of HPV-16 L1/L2 chimeric proteins despite the 
track record of P. pastoris as a high-level producer of heterologous proteins. 
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Introduction  
Cervical cancer ranks as the fourth most frequent cancer among women in the World with an 
estimated 527 000 new cases diagnosed and 265 000 cervical cancer-related deaths in 2012 (Bruni 
et al., 2016b). In South Africa, cervical cancer is the second leading cause of female cancer and the 
most prevalent cancer in women between the ages of 15-44 years (Bruni et al., 2016a). Vaccination 
against HPV infection has proven to be most advantageous in the prevention of cervical cancer. 
Today, vaccinations performed using any one of the two commercial subunit-based HPV vaccines, 
Cervarix® or Gardasil®, provide almost 100% efficacy (White, 2014). Prior to 2014, the availability 
and subsequent dissemination of HPV vaccines in South Africa was constrained primarily due to the 
high costs associated with vaccination regimes in developing countries. HPV vaccination in the 
South Africa costs between USD 38-57 per dose, and with three doses needed to be effective, it is 
unaffordable for most women and place an enormous burden on developing countries’ economy 
(Minister Aaron Motsoaledi, 2015). In 2014, the South African National Department of Health 
implemented a school-based only HPV vaccination program (two-dose vaccination with Cervarix®) 
for girls 9 years and older in public schools (Richter et al., 2014; Richter, 2015). Despite these 
limited free vaccination programs, there is still a need for cheaper alternative vaccines. In addition, 
their effectiveness could also be hampered by the regional HPV type-specific prevalence. Human 
papilloma virus types 16 and 18 account for about 70% of all cervical cancers worldwide (Muñoz et 
al., 2004; Schiffman et al., 2007), whereas types 31, 33, 35, 45, 52 and 58 account for an additional 
20% (Clifford et al., 2006). Other HPV types are also emerging in Africa with type 35 becoming as 
prevalent as type 16 (Clifford et al., 2005; Allan et al., 2008). There is, therefore, an urgent need to 
develop local production capacity in the developing world for HPV vaccines targeted at future 
emerging types. 
Current HPV vaccines consist of VLPs that are morphologically indistinguishable from native 
virions. They are not infectious as they do not contain any genetic material and therefore serve as 
excellent vaccine candidates (Chackerian, 2007). Recombinant expression of the HPV type 16 
major capsid protein, L1, results in the spontaneous self-assembly of dimers, to which free L1 
monomers subsequently associate until a closed icosahedral VLP is formed that resembles native 
virions (Kirnbauer et al., 1992; Ding et al., 2010). Although the minor capsid protein, L2, is a 
prerequisite for infectious virions, it is not required for VLP formation (Fahey et al., 2009). HPV L1 
VLPs have been produced in various expression systems, such as bacteria, e.g. Escherichia coli 
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(Chen et al., 2001), yeast such as Saccharomyces cerevisiae (Woo et al., 2008), Pichia pastoris 
(Bazan et al., 2009; Coimbra et al., 2011; Jiang et al., 2011; Kotzé et al., 2011; Rao et al., 2011; 
Smith et al., 2012; Zhao et al., 2015), and Hansenula polymorpha (Li et al., 2009), baculovirus-
infected insect cells (Le Cann et al., 1994), transgenic plants (Biemelt et al., 2003), and mammalian 
cells (McLean et al., 1990). VLPs consisting of both L1 and L2 have been produced in human 
epithelial cells (Cianciarullo et al., 2010) and similarly bovine papillomavirus type 4 (BPV-4) VLPs 
in insect cells (Kirnbauer et al., 1996). Furthermore, VLPs of various chimeric L1/L2 permutations, 
such as the chimeric L1/L2 SAF protein, were expressed in insect cells (Varsani et al., 2003; 
McGrath et al., 2013) and more recently in the yeasts P. pastoris and H. polymorpha (Smith et al., 
2012). The chimeric SAF construct (~55 kDa) was created by replacing the h4 helix of the L1 
protein with a 13-amino acid peptide from the L2 protein, which is a common-neutralizing epitope 
for HPV-6 and HPV-16 (Kawana et al., 1998). Neutralizing antibodies, predominantly targeted 
against L1, play a preventative role in papilloma viral infections. Breitburd et al. (1995) determined 
that high levels of prophylactic antibodies are primarily elicited by L1, whereas L2 only evokes a 
low level of prophylaxis, yet the antibodies are more cross-neutralizing (Roden et al., 2000; Kawana 
et al., 2003; Rubio et al., 2009; Schiller et al., 2014). Replacing the h4 helix of L1 with the L2 
peptide in the SAF protein resulted in improved immunogenicity and cross-neutralization during 
mice immunization following successful capsomer formation in insect cells (Varsani et al., 2003; 
Rubio et al., 2009; McGrath et al., 2013).  
Although HPV structural proteins have been readily expressed in many platforms, 
methylotrophic yeasts are regarded as prime candidates for the production of pharmaceutical-based 
products. These yeasts are best known for having strong methanol-inducible promoters of their 
alcohol oxidase genes (AOX1 and AOX2) in P. pastoris (Cregg et al., 1989) and methanol oxidase 
gene (MOX) in H. polymorpha (Ledeboer et al., 1985). Strong promoters and well-established 
fermentation protocols using inexpensive defined media allow for the scale-up expression of 
recombinant proteins in these yeasts from shake-flasks to bioreactors. Transcription levels of the 
AOX1 promoter gene is 3-5 times greater and the oxidase protein can constitute up to 30% of the 
total soluble proteins when these yeasts are cultured at growth-limiting rates in bioreactors (Couderc 
et al., 1980; Higgins et al., 1998). In addition, methylotrophic yeasts secrete relatively low levels of 
endogenous proteins into the medium, resulting in less cumbersome purification of target proteins 
(Cereghino et al., 2000). Unlike bacterial expression systems, methylotrophic yeast has the ability to 
perform many of the post-translational modifications usually performed in higher eukaryotes, e.g. 
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correct folding, disulfide bond formation, O- and N-linked glycosylation, processing of signal 
sequences and certain types of lipid addition (Cereghino et al., 2000; Cereghino et al., 2002; 
Macauley-Patrick et al., 2005). VLP formation requires trimerization of the L1 proteins by disulfide 
bridges between conserved cysteins in the protein (Sapp et al., 1998).  
In this study, we combined the unique HPV type 16 L1/L2 chimeric SAF protein with high 
expression in methylotrophic yeasts. We evaluated the intracellular production of SAF monomers in 
both P. pastoris and H. polymorpha. First, we optimized the feeding strategy in P. pastoris_KM71 
(MutS) fed-batch cultures by supplying methanol either at a predetermined exponential rate or one 
based on the oxygen consumption of the microorganism. The ideal feeding strategy was then 
applied in 10 L bioreactors to compare the P. pastoris_GS115 (Mut+) strain with the P. 
pastoris_KM71 (MutS) strain. The preferred P. pastoris strain was then compared to H. polymorpha 
for SAF production. This study is one of a very few studies addressing different feeding strategies of 
methylotrophic yeasts, as well as comparing different yeast strains for the production of HPV16 L1 
viral proteins. This study is also the first to compare the production of the unique HPV16 L1/L2 
SAF chimeric protein in the yeasts P. pastoris and H. polymorpha in bioreactors, with higher 
production levels than reported previously in both systems. 
Materials and Methods 
Construction of plasmids, strains and yeast transformation 
The chimeric L1/L2 sequence, termed ChiΔF-L2, was kindly provided by Ed Rybicki (Molecular 
and Cell Biology Department, University of Cape Town). The h4 helix (corresponding to amino 
acid position 414-426) of the HPV16 L1 protein was replaced with amino acid 108-120 of the 
HPV16 L2 protein (McGrath et al., 2013; Varsani et al., 2003). The resulting ChiΔF-L2 gene 
(called SAF) sequence was codon-optimized for both yeasts and commercially synthesized by 
GeneArt (Invitrogen, Regensburg, Germany) as part of a plasmid, pGA15-ChiΔH-L2. Restriction 
enzymes BamHI and HindIII were used to directional subclone the ChiΔF-L2 gene into the H. 
polymorpha plasmid pHIPX4–HNBESX (leu2, kanR) (Gietl et al., 1994), and EcoRI and XhoI into 
the P. pastoris plasmid pBLHIS–IX (his4, ampR) (Cereghino et al., 2001). Escherichia coli DH5α 
cells were used as the host strain for propagation of recombinant DNA. Following transformation of 
competent E. coli cells, colonies were maintained on antibiotic-specific LB agar plates. Putative 
recombinant colonies were selected by PCR amplification using primers pHIPX4-F and pHIPX4-R 
(Smith et al., 2012) specific for plasmid pHIPX4–HNBESX, and primers 5’AOX and 3’AOX 
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(Invitrogen, California, USA) for plasmid pBLHIS–IX. Isolation of an amplicon of 1626 bp using 
agarose gel electrophoresis followed by nucleotide sequencing confirmed the presence of the SAF 
gene. Restriction enzyme digests, using the same enzymes as for cloning, were used to verify the 
presence of the SAF expression cassettes in the integration plasmids. Transformation of linearized 
plasmids into H. polymorpha NCYC 495 (Jan Kiel, University of Groningen, The Netherlands) and 
P. pastoris_KM71 (Invitrogen, California, USA) were carried out by electroporation as previously 
described by Smith et al. (2012). Putative recombinant yeast colonies were screened using yeast 
colony PCR and appropriate primers.  
Bioreactor fermentations 
Pre-cultures were prepared by inoculating a sub-cultured recombinant colony, previously confirmed 
by yeast colony PCR, from YPD (1% [g.L-1] yeast extract, 2% [g.L-1] tryptone, 2% [g.L-1] glucose) 
agar plates into buffered glycerol complex medium (BMGY; 10 g.L-1 yeast extract, 20 g.L-1 peptone, 
100 mM KH2PO4, pH 6.0, 13.4 g.L-1 YNB, 4 × 10-4 g.L-1 biotin, 10 g.L-1 glycerol) in baffled shake 
flasks. Following overnight incubation at 30°C for P. pastoris and 37°C for H. polymorpha at 250 
rpm, cultures were diluted to an optical density (A600) of 0.1 in fresh BMGY medium. Subsequently, 
these seed-cultures were again grown overnight at the same conditions to an A600 of between 2 and 
6, before diluting 10 times into fresh BMGY medium in bioreactors (New Brunswick Scientific, 
Edison, NJ). Initially 3 L bioreactors were used, but when different feeding strategies were accessed, 
fermentation volumes were increased to 10 L. Once methanol feeding was adjusted to accommodate 
the addition of micro volumes, the 1.3 L bioreactors were used to compare P. pastoris versus H. 
polymorpha cultures. 
Culture conditions for both yeasts were set up according the Invitrogen Pichia Fermentation 
protocol (California, USA), consisting of fermentation basalt salt medium, supplemented with 4% 
glycerol and 4.35 ml PTM1 trace salts.L-1 basalt salt medium. Culture conditions were conducted as 
follows: 30°C for P. pastoris and 37°C for H. polymorpha, pH 5.0 using 28% ammonium hydroxide 
(NH4OH) as a hydroxide donor and a nitrogen source, aeration rate of 1.0 volume of oxygen per 
volume of fermentation culture per minute (vvm) and dissolved oxygen (DO) of 30%. According to 
Li et al. (2007) most Pichia pastoris’ fermentations use a DO of 30-35%, but different proteins need 
different optimal levels. Since Invitrogen’s Pichia Fermentation Process Guidelines (Invitrogen Life 
Technologies, 2002) suggest a DO > 20%, we decided to use 30% as a constant to measure different 
culture variables such as different feeding strategies and different yeast strains. Dissolved oxygen 
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was sensed by a Mettler Toledo DO electrode (Ohio, USA) and controlled by a programmable 
cascade whereby the agitation range (200-1000 rpm) and aeration rate (1 vvm) were maintained by 
the proportional (P) and integral (I) controller. Upon glycerol depletion in the BMGY medium at the 
end of the glycerol batch phase (24 h post-inoculation), as indicated by a spike in the DO levels (DO 
> 30%), a 50% glycerol feed, supplemented with 12 ml PTM1 trace salts.L-1 was initiated. Glycerol 
feeding was carried out in a fed-batch mode based on the DO stat method, also referred to as 
‘demand-feed’, where glycerol addition was dictated by the DO concentration. As the yeast 
metabolises actively, glycerol becomes depleted and the DO concentration starts to increase. Once 
the DO > 30%, the glycerol feed is activated and the presence of glycerol in the medium lowers the 
DO concentration as the glycerol is metabolised. Conversely, when the DO < 30%, the glycerol feed 
is stopped. DO of 30% is maintained first by increased or decreased agitation, depending on the 
whether the DO is below or above 30%. If agitation has reached its maximum and cannot increase 
the DO further, aeration is supplemented with pure O2. Subsequently, the DO concentration 
increases and once it reaches > 30%, the glycerol feed is switched on again. Wet cell weights 
(WCW) of 180-220 g.L-1 indicated the end of the glycerol fed-batch phase. The glycerol feed was 
terminated and replaced with 100% methanol (48 h post-inoculation), supplemented with 12 ml 
PTM1 trace salts.L-1 of methanol. The same DO stat method was followed for six consecutive days 
or until the WCW started to decrease (see Appendix A). 
Alternatively, methanol feeding was administered using the predetermined controlled feed rate, 
as indicated by the Pichia Fermentation protocol (Invitrogen, California, USA): 1 mL.h-1.L-1 for the 
first 2 h, then increased gradually to 3 ml.h-1.L-1. This feeding strategy was compared with the DO 
stat method. 
During 10 L fermentations glycerol and methanol consumption was monitored by placing the 
reservoirs on a balance and changes in mass were recorded. However, during the 1.3 L and 3 L 
fermentations, volumes added to the bioreactors were so little that reservoirs were only weighed at 
the end of the fermentation to gain cumulative volumes added. For each fermentation variable, such 
as different P. pastoris strains, different methanol feeding strategies as well as P. pastoris versus H. 
polymorpha, comparative fermentations were carried out in triplicate. 
Analytical methods 
Cell growth 
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Five milliliter samples of the cultures were collected at the end of the glycerol batch (24 hours post-
inoculation) and glycerol fed-batch phase (48 hours post-inoculation), as well as every day during 
the methanol fed-batch phase (72, 96, 120, 144, 168 and 192 hours post-inoculation). Culture 
samples were monitored for cell growth using A600, WCW and dry cell weights (DCW). Three 1 ml 
culture aliquots were centrifuged at 14 000 rpm for 5 min, and used to determine the WCW. After 
drying the cell pellets overnight at 60°C dry heat, the DCW was determined. In addition, cumulative 
culture volumes, glycerol volumes, methanol volumes, and NH4OH were measured at each time 
point. The remainder of the collected samples were frozen as cell pellets at -80°C for the 
quantification of the expressed protein. 
Crude cell extracts 
Crude extracts were prepared from 60 mg of both P. pastoris and H. polymorpha cells, as 
previously described (Smith et al., 2012). Cell pellets were resuspended in 1.2 M sorbitol, 100 mM 
EDTA and 14 mM β-mercaptoethanol, followed by centrifugation at 13 000 rpm for 5 minutes. 
Following centrifugation, the supernatant was discarded and the cell pellets resuspended in 400 µl 
breaking buffer containing 50 mM NaH2PO4, pH 7.4, 1 mM EDTA, 5% v/v glycerol, Protease 
Inhibitor Cocktail (Sigma-Aldrich) at a concentration of 1 μl protease inhibitor cocktail for every 20 
mg wet weight cells, and equal volume of glass beads measured by displacement. Cells were 
subjected to 20 cycles of vigorous vortexing for 30 sec followed by incubation on ice for 30 sec. 
After the final cycle, 400 µl 2 × SDS PAGE loading dye (125 mM Tris-HCl, pH 6.8; 4% SDS; 20% 
glycerol; 0.01% bromophenol blue; 5 mM 2-mercaptoethanol) was added before incubating at 95°C 
for 5 min.  
Protein quantification 
Serial dilutions of the crude cell extracts were loaded onto a 10% polyacrylamide gel. Purified 
HPV16 L1 protein (50 kDa) in the form of virus-like particles (Deschuyteneer et al., 2010) was used 
as a standard for protein concentration determination during densitometry. Appropriate dilutions of 
the standard were loaded in parallel on the same gel to serve as a standard curve. Proteins were 
separated after which the proteins were transferred onto nitrocellulose membranes (BioTrace™ NT, 
PALL) using the Semi Phor blotting apparatus (Hoefer Scientific Instruments) at 43 mA per minigel 
for 75 minutes (Khyse-Andersen, 1984). According to Smith et al. (2012), membranes were blocked 
overnight in 5% g.L-1 skimmed milk powder (Sigma) in 1 × TBST (10mM Tris, pH 8.0, 125 mM 
NaCl, 0.1% v/v Tween 20). Subsequently, the membranes were incubated for 2 h in blocking 
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solution containing 15 ng.L-1 anti-HPV-16 L1 monoclonal antibody CAMVIR-1 (Santa Cruz 
Biotechnology, Dallas, Texas). After washing with 1×TBST, the membranes were incubated in 
blocking solution with 80 ng.mL-1 alkaline phosphatase conjugated goat anti-mouse IgG antibody 
(Santa Cruz Biotechnology, Dallas, Texas). Detection was carried out using NBT/BCIP detection 
reagents (Fermentas, ThermoFisher, Massachusetts, USA). The area and intensity of bands were 
quantified using the software ImageJ (Abramoff et al., 2004) using the methodology outlined by 
Miller (2007). To verify the mean protein quantity, SDS-PAGE followed by Western Blot analysis 
was performed in triplicate for each time point. 
Gas chromatography-flame ionization detector (GC-FID) 
 Fifty-milliliter culture fluid samples were taken daily post-induction and subjected to centrifugation 
to separate the supernatant fluid (SNF) from the yeast cells. One milliliter diethyl ether was used to 
extract 5 µl SNF with internal standard, 4-methyl-2-pentanol (100 µl of 0.5 mg.mL-1 soaking 
solution) in solution (12% alcohol spirit and 2.5 g.L-1 tartaric acid, pH 3.5), by placing the 
ether/SNF mixture in an ultrasonic bath for 5 minutes. The SNF/ether mixture was then centrifuged 
at 4000 rpm for 3 min, and the ether layer was removed. Any residual traces of water were removed 
by adding NaSO4. This diethyl ether extracts of culture samples were analysed for their methanol 
content using the Model 8610C gas chromatograph (SRI Instruments, USA), equipped with a 60 m 
DB-FFAP column (id 0.32 mm, 0.5 µm f.t), on-column injector and FID set to 200°C; H2 flow of 
30 mL.min-1 and air flow of 350 mL.min-1. The GC was also equipped with an internal air 
compressor and hydrogen generator. Nitrogen was used as carrier gas with pressure control and a 
flow set to 30 mL.min-1. Sample runs were performed through manual injections of 3 µL sample 
using a 5 µl Hamilton syringe. The syringe was thoroughly washed with ethyl acetate between 
injections to avoid cross-contamination. Each injection was repeated three times. A temperature 
gradient was implemented after injection with oven, column and injector temperatures all initially 
set at 33°C, held for 17 min and then elevated to 240°C, and held for a final 5 min. Peak Simple 
software version 2.8 (SRI Instruments, USA) was used for data analysis and GC control. 
Results 
Investigating different feeding strategies for P. pastoris MutS strains 
Initially, the different methanol feeding strategies for the expression of HPV-16 L1/L2 chimeric 
protein (ChiΔF-L2, termed SAF) in P. pastoris was investigated in 3 L bioreactors using the KM71 
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(MutS) strain. The glycerol fed-batch fermentations were carried out using the DO stat method to 
ensure aerobic conditions for biomass generation, followed by inducing heterologous gene 
expression by replacing glycerol with methanol. Sixty milligrams of yeast cells were collected at 24-
hour intervals starting 72 h post-inoculation, and analyzed by Western Blot and densitometry for 
SAF production. Both the SAF concentration and biomass in these P. pastoris cultures (DCW) 
decreased over time (Fig. 3.1A). Cumulative glycerol and methanol volumes, added to the 
bioreactor, were only measured at the end of each fermentation (Table 3.1). There was an increase 
in bioreactor volume at the end of all three fermentations. Residual methanol in the culture fluid 
was only measured on the last day of induction (192 hurs post-inoculation) and found to be less than 
0.045 g methanol per liter culture.  
 
Table 3.1 Changes in 3 L bioreactor volumes after glycerol and methanol addition in P. 
pastoris_KM71 (MutS) cultures using a predetermined methanol feeding rate. 
 
Reactor Starting 
volume (mL) 
Inoculum 
added (mL) 
Gly added 
(mL) 
MeOH added 
(mL) 
Cumulative 
samples taken 
(ml) 
Reactor End 
volume (mL) 
       Fermentation 1 1200 40 110 405 60 1650 
Fermentation 2  1200 40 115 410 60 1690 
Fermentation 3 1200 40 150 400 60 1710 
 
            
 
The same P. pastoris strain (KM71, MutS) was methanol-fed using the dissolved oxygen (DO) 
stat method where the yeast culture’s rate of oxygen consumption dictated the rate at which the 
carbon source was administered. This resulted in a 2- to 3-fold increase (p<0.005) in P. pastoris 
biomass during the course of methanol induction using the DO stat method, compared to a 
predetermined feed rate (average range: 91.12 - 108.94 g DCW.L-1 versus 57.51 - 36.54 g DCW.L-1) 
(Fig. 3.1B). Once the biomass in all the cultures reached a WCW of 180-220 g.L-1, the methanol 
feed was initiated; hence why DCW of all cultures was similar up until 48 hours post-inoculation. 
Due to the impact of different methanol feeding, the biomass started to divert from 48 hours 
onwards post-inoculation. 
Despite elevated levels of biomass compared to that observed during predetermined feeding, 
the biomass and SAF productivity did not increase significantly over time (Fig. 3.1C). Since P. 
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pastoris MutS strains, such as the KM71 strain, metabolize methanol at a much slower rate than the 
Mut+ strains, the constant level of biomass of P. pastoris_KM71 might be due to methanol toxicity. 
Adding methanol to the bioreactor occurred through an inlet in the roof of the vessel. In case of 
smaller culture volumes, the demand for methanol is lower and controlling the addition of micro 
volumes methanol is mechanically more challenging than in larger bioreactors. The methanol 
feeding strategy using the DO stat method could have resulted in overfeeding and subsequently into 
the accumulation of methanol. It is known that methanol concentrations higher than 3.65 g.L-1 in the 
culture broth can inhibit cell growth (Zhang et al., 2000b). 
If residual methanol levels were increasing, larger fermenter volumes, such as 10 L, could 
accommodate the dilution of excess methanol more efficiently. This urged us to investigate the 
expression of SAF in larger culture volumes such as 10 L bioreactors. 
 
Effect of the DO stat control strategy on biomass accumulation, methanol consumption and 
specific SAF production values of P. pastoris_GS115 (Mut+) versus P. pastoris_KM71 (MutS) 
strains in larger fermentation volumes 
The P. pastoris_GS115 (Mut+) strain containing the chimeric L1/L2 gene (SAF) was expressed in 
10 L cultures under similar controlled fermentation conditions than the P. pastoris_KM71 SAF 
strain. The DO stat method was used to administered methanol in both cultures. As expected, P. 
pastoris_GS115 (Mut+) had a faster growth rate than P. pastoris_KM71 (MutS). This was evident 
from the difference in biomass values from the start of culturing onwards (24 hour onwards post-
inoculation) (Fig. 3.2A). MutS and Mut+ reached maximum biomass densities of 246.37 and 334.46 
g. L-1 wet cell weight, respectively (75.50 g.L-1 and 118.40 g.L-1 dry cell weight). The methanol 
feeding rate in the DO stat cultures was 10% higher in P. pastoris_GS115 (Mut+) than in P. 
pastoris_KM71 (MutS) (Fig. 3.2B) resulting in 1.84 L cumulative methanol addition for GS115 
compared to 1.81 L for KM71. After initiating the methanol feed, the methanol consumption 
increased in both cultures (Fig. 3.2C). Gas chromatography was performed to determine if residual 
methanol was present in the cultures at toxic concentrations. Samples taken during methanol 
induction contained less than 0.045 g methanol per liter culture for both strains (data not shown). 
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Fig. 3.1 P. pastoris_KM71 (MutS) cultures induced at 72 h (3 days) post-inoculation using 
methanol. (A) Biomass (g P. pastoris DCW.L-1) and SAF concentration (mg SAF.L-1 P. pastoris) 
during a predetermined feed rate using the Invitrogen’s protocol. (B) Comparing biomass levels in 
response to different methanol feeding strategies: a predetermined   versus the DO stat feed rate 
which is related to the metabolic state of the culture. Increased biomass during DO stat feeding was 
significantly higher than during the predetermined feeding rate (p<0.05). (C) SAF concentration 
(mg SAF.L-1 P. pastoris), yield (P/X) (mg SAF.g-1 P. pastoris DCW) and biomass concentration (g P. 
pastoris DCW.L-1) during the DO stat feed rate for methanol induction in 3 L bioreactors. Each 
culturing was performed in triplicate to ensure reproducibility. Error bars represent standard 
deviations from the mean of triplicate samples. 
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Fig. 3.2 P. pastoris_GS115 (Mut+) versus P. pastoris_KM71 (MutS) cultures during the methanol 
induction phase, 72 h (3 days) post-inoculation, in 10 L reactor vessels. (A) Biomass dry cell weight 
concentrations. (B) Methanol feeding rates. (C) Cumulative methanol concentration consumed. 
Each culturing was performed in triplicate to ensure reproducibility. Error bars represent standard 
deviations from the mean of triplicate samples. 
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The SAF concentration, biomass concentration and SAF yield (YP/X) per biomass were significantly 
higher in P. pastoris_KM71 than in P. pastoris_GS115 (p<0.05) (Table 3.2). However, the SAF 
concentration was 2-fold higher in the 10 L cultures of P. pastoris_KM71 than in the 1.3 L-cultures 
(48.96 versus 23.61 mg.L-1) (Table 3.2, 3.3). These results confirmed that the P. pastoris_KM71 
strain was the preferred option to compare SAF the expression profiles with that of H. polymorpha.  
 
Table 3.2 Mean concentrations and yields of P. pastoris MutS versus Mut+ cultures in 10 L 
bioreactors 
 
 
Table 3.3 Mean productivity parameters of scaled-up fermentations (1.3 L) in bioreactors for the 
production of SAF in P. pastoris versus H. polymorpha cultures 
 
P. pastoris_ KM (MutS) H. polymorpha
0.20±0.01 0.61±0.07
Specific productivity (mg SAF.g DCW-1.h-1)* 2.33±0.3 6.78±1.5
YieldP/S (mg SAF.g
-1
 methanol) 0.10±0.07 0.32±0.16
YieldP/X (mg SAF.kg
-1
 DCW)* 257.87±74.59 1353.10±373.84
YieldX/S (g DCW.g
-1
 methanol) 0.18±0.01 0.35±0.12
SAF concentration(mg SAF.L-1 culture)* 23.61±11.78 132.10±35.94
*p <0.05
Volumetric productivity (mg SAF.L-1.h-1 )*
 
 
Expression of SAF in P. pastoris (MutS) related to H. polymorpha 
Another methylotrophic yeast strain, H. polymorpha NCYC 495, was investigated for the 
expression of SAF in 1.3 L bioreactors. Various factors, such as multimeric integrants and higher 
growth temperature (37-43°C), make this strain ideal for industrial applications (Gellissen et al., 
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2000; Gellissen, 2002). Methanol fed-batch fermentations were carried out using the DO stat 
method for 120 h. The addition of methanol was optimized using a modified inlet in the roof of the 
bioreactor to allow small volume increments and prevent the potential accumulation of excess 
methanol. The volumetric and specific productivity for each of these strains are shown in Table 3.3. 
H. polymorpha produced significantly higher levels of SAF proteins than P. pastoris_KM71 (MutS) 
(p<0.05). Although not significant, H. polymorpha produced more biomass per substrate methanol, 
but significantly higher SAF per biomass than P. pastoris. Both the specific and volumetric 
productivity rates of SAF were 3-fold higher in H. polymorpha than in P. pastoris_KM71 (MutS) 
(p<0.05). Since the methanol inlet in the KM71 bioreactor was modified, the methanol level was 
measured to verify the absence of residual methanol.  
Western Blot analysis showed the presence of bands representing proteins smaller than the SAF 
protein. This phenomenon is more evident in H. polymorpha cell extracts than in those from P. 
pastoris (Fig.3.3). Since both examples of H. polymorpha and P. pastoris had similar 
concentrations (13.01 mg.L-1 versus 18.80 mg.L-1, respectively), the smaller protein species evident 
in the H. polymorpha cultures were not due to a difference in the amount of protein loaded onto 
SDS-PAGE. 
 
Fig. 3.3 Western Blot analysis of SAF proteins (~55 kDa) expressed in (A) H. polymorpha and (B) 
P. pastoris. Crude cell lysates were prepared from 60 mg of yeast cells and aliquots of the lysates 
were loaded for quantification by densitometry. M: PageRuler™ Prestained Protein Ladder (Thermo 
Fisher Scientific, USA); Lane 1: 3 ng; lane 2: 7 ng; lane 3: 12 ng; lane 4: 20 ng HPV16 L1 (~50 
kDa); lane 6: 0.5µl; lane 7: 1 µl; lane 8: 2 µl; lane 9: 3 µl; lane 10: 5 µl SAF crude cell lysate. 
 
Statistical analysis 
The one-way analysis of variance (ANOVA) was used in combination with the Bonferroni post hoc 
test to determine any statistical differences amongst the means of the three recombinant systems in 
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terms of various expression parameters. Comparisons were also compiled between different feeding 
strategies. For all comparisons, p < 0.05 was considered statistically significant. 
Discussion 
Human papillomavirus infections are amongst the most threatening sexually transmitted diseases in 
the world as it is almost entirely associated with cervical cancer. A breakthrough in cervical cancer 
prevention is to vaccinate against HPV infection using prophylactic vaccines. Developing cheaper 
vaccines could reduce the cost associated with the prevention of this cancer in developing countries. 
This could be more feasible with the cost-effective expression of viral proteins. 
Previously our group compared the cytosolic expression of the same unique SAF protein in 
both P. pastoris_KM71 and H. polymorpha. Expression was only performed in shake flask cultures 
for 72 hours and yields were compared with the expression in peroxisomes of H. polymorpha. The 
levels of cytosolic SAF in P. pastoris was higher than those obtained in H. polymorpha. Directing 
the production to H. polymorpha peroxisomes resulted in very low expression of SAF (Smith et al., 
2012).  
In this study, we focused on the expression of the same SAF protein in both methylotrophic 
yeasts, but under controlled conditions in bioreactors. We first evaluated two different feeding 
strategies to optimize expression of HPV L1/L2 chimeric proteins in two P. pastoris strains, KM71 
(MutS) and GS115 (Mut+), by evaluating a predetermined feeding rate versus the DO stat method. 
Trinh and co-workers (2003) compared a predetermined exponential methanol feeding rate with two 
different methods based on the metabolism of the yeast P. pastoris_GS115 (Mut+); one method 
responded to the methanol consumption as measured by an on-line methanol sensor and the other 
method to the oxygen consumption. The predetermined exponential methanol feeding rate proved to 
be the most efficient at controlling the methanol feed rate as the specific production per biomass and 
per methanol was higher (Trinh et al., 2003). In another study, the predetermined feeding rate was 
also the preferred feeding method in P. pastoris MutS cultures (Kupcsulik et al., 2001). Minning et 
al. (2001) investigated different strategies for maintaining the methanol concentration of both P. 
pastoris_GS115 (Mut+) and KM17 (MutS) strains. One is based on the monitoring of methanol 
concentration with gas chromatography (GC) versus adjusting the feed rate according the DO 
concentration in the cultures (Minning et al., 2001). Their results showed that monitoring the 
methanol concentration by means of GC resulted in a 2.5-fold increase in productivity. They argued 
that the use of DO measurements to control methanol concentration was not optimum as methanol 
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was not measured directly, but rather indicated indirectly by the level of DO present. Therefore, the 
methanol concentration may not be maintained precisely and probably exceed the limiting value 
when the dissolved oxygen was increasing. This may pose a problem for methanol-sensitive strains 
such as P. pastoris_KM71. Slower growth rates of these P. pastoris strains can cause the methanol 
to accumulate in the bioreactor to toxic levels (Cregg et al., 1989), especially in smaller culture 
volumes where the lower flow rates of methanol addition are inherently more difficult to control 
accurately. In contrast, Kotzé et al. (2011) showed that DO controlled feeding produced both higher 
volumetric production of HPV type 16 L1 protein and biomass in P. pastoris Mut+ (X-33) 
cultivations compared to a predetermined feeding option. Our current results confirmed that the DO 
stat control was also the preferred feeding strategy for MutS cultures (Fig 3.1B). Since residual 
methanol was too low during the preferred feeding, the decrease in biomass and expressed SAF 
could not be attributed to methanol toxicity (Fig. 3.1A). Considering the increase in culture volume 
at the end of the fermentation period, it is evident that the decrease in SAF concentration was 
attributed to a dilution effect of the culture (Table 3.1). According to Chung (2000), the DO stat 
method is only applicable to cells growing under a single carbon source. In our study, methanol was 
the sole carbon source during the induction of the recombinant HPV L1/L2 chimeric proteins.  
Secondly, the effect of the DO stat methanol feeding on biomass, methanol consumption and 
SAF production was assessed in P. pastoris Mut+ versus MutS strains. Expression of recombinant 
proteins in methylotrophic yeast was induced in the presence of methanol, which also acts as a 
carbon source. Therefore, methanol concentration determines both the physiological condition of 
the cells as well as the production rate of recombinant proteins (Guarna et al., 1997). In addition to 
the wild-type P. pastoris strain (GS115, Mut+), which have both functional AOX genes, the KM71 
strain (MutS) has a defective AOX1 gene and relies solely on the AOX2 gene to produce AOX. The 
AOX2 is weaker and therefore produces lower levels of the oxidase, accounting for only 15% of the 
total AOX activity of the cell. In general, MutS strains have a slower growth rate and lower 
productivity than Mut+ strains (Romanos et al., 1992; Chiruvolu et al., 1997; Van den Burg et al., 
2001; Kim et al., 2009). Hence, it also consumes methanol at a slower rate (Cregg et al., 1988). 
Thus, the MutS strains require much less methanol for induction, making it advantageous for large-
scale fermentations where large quantities of methanol is considered a fire hazard (Krainer et al., 
2012). Slower growth rates are not only preferable for proteins where the folding is rate-limited to 
ensure correct folding, but also during the initial dimer formation in VLPs (Romanos, 1995; Ding et 
al., 2010). However, the slower growth rate of MutS strains can cause the methanol to accumulate in 
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the fermentation culture to levels that are toxic to the yeast cells (Cregg et al., 1989), especially in 
smaller culture volumes. Due to its higher metabolic rate, P. pastoris Mut+ strains result in higher 
productivity and faster accumulation of methanol oxidation by-products (formaldehyde and 
hydrogen peroxide) inside the cell (Hazeu et al., 1983; Brierley et al., 1990; Chiruvolu et al., 1997). 
Excess of these by-products can lead to cellular stress and ultimately to cell death (Couderc et al., 
1980; Cregg et al., 1988; Kern et al., 2007; Van der Klei et al., 1990; Zhang et al., 2000a). As the 
biomass increases, the methanol consumption rate also increases. Maintaining optimum methanol 
concentrations (preferably at 4 g.L-1) is critical during the successful product formation in P. 
pastoris fermentation as lower methanol levels also reduce the productivity by triggering the 
proteolytic degradation of the recombinant proteins (Kupcsulik et al., 2001).  
We have adopted a closed-loop proportional-integral (PI) controller to maintain a constant DO 
of 30%. Higher biomass concentration and methanol feeding rate in P. pastoris Mut+ cultures 
confirmed that P. pastoris Mut+ strains had faster growth rates, associated with a higher rate of 
methanol consumption, than P. pastoris MutS strains (Fig. 3.2A and B, respectively). However, the 
SAF protein concentration, biomass concentration and protein yield per biomass were almost double 
that of the Mut+ strain, making MutS strains attractive hosts for the production of recombinant 
proteins (Table 3.2). The methanol consumption rate differed by 10% between the two P. pastoris 
strains (Fig. 3.2C), demonstrated by the different cumulative volumes of methanol added to each 10 
L bioreactor (1.81 L versus 1.84 L for KM71 and GS115, respectively). Residual methanol levels of 
less than 0.045 g.L-1 were measured at the end of both cultures (data not shown), indicating the 
absence of methanol accumulation. Reduced biomass levels in MutS cultures could therefore not be 
attributed to accumulated methanol levels in the bioreactors. Several other studies support MutS 
strains to be superior in the production of some recombinant proteins (Pla et al., 2006; Orman et al., 
2009). Krainer et al. (2012) recently confirmed that both volumetric and specific productivities were 
higher for the MutS strain than the Mut+ strain. The substrate methanol in their MutS experiments 
was converted 7 times more efficiently into product than the Mut+ strain (Krainer et al., 2012).  
The expression of SAF was scaled up to 10 L bioreactors using the P. pastoris_KM71 (MutS) 
strain in parallel with the Mut+ P. pastoris_GS115 strain. Cultures can reach cell densities up to 150 
g DCW.L-1 in the controlled environment of a bioreactor (Cereghino et al., 1999; Cereghino et al., 
2000). The biomass yield of the MutS strain in 3 L bioreactor volumes was higher than that obtained 
in 10 L bioreactors. This phenomenon could be attributed to protein burden. Kafri et al. (2016) 
reported that protein overexpression can reduce growth rates. Highly abundant transcripts of the 
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recombinant protein compete for the limited resource of ribosomes present in the host, which is 
otherwise responsible for the translation of endogenous proteins. Both the SAF concentration as 
well as the SAF yield per biomass were higher in 10 L cultures. SAF concentrations were 2-fold 
higher in the 10 L cultures of P. pastoris_KM71 than in the 1.3 L-cultures, reaching a biomass 
concentration up to 75.50 and 118.40 g DCW.L-1 (for MutS and Mut+, respectively). The SAF yield 
per biomass (734.76 mg.kg-1 DCW) was almost 3 times more in 10 L P. pastoris_KM71 cultures 
than in 1.3 L cultures (257.87 mg.kg-1 DCW). Our results also showed that the larger 10 L 
fermentation volumes tolerated the addition of methanol with greater ease than in the smaller 
culture volumes. A possible reason for the lack of biomass increase in the 3 L fermenters (Fig. 3.2B, 
C) could be a result of methanol toxicity as methanol was added as droplets from an inlet in the lid 
of the bioreactor. These droplets were diluted more efficiently in larger cultures volumes than in the 
smaller volumes.  
The third objective of our study was to evaluate the expression of HPV type 16 L1/L2 chimeric 
proteins in P. pastoris_KM71 (MutS) versus H. polymorhpa in bioreactors. Previously our shake 
flask expressions showed P. pastoris_KM71 produced higher concentrations of SAF than H. 
polymorpha. Mack et al. (2009) compared the production of mammalian proteins in H. polymorpha 
with P. pastoris wild type X33 (Mut+) in shake flasks and found that P. pastoris yielded more than 
3-fold more protein than H. polymorpha. It could be that the amount of methanol added to batch 
cultures of H. polymorpha was inefficient to maintain maximum induction from the AOX promoter, 
compared to P. pastoris. This contradicts the results from our current study that showed H. 
polymorpha is superior in producing SAF proteins in bioreactors. As mentioned before, MutS strains 
have a slower growth rate and lower productivity than Mut+ strains. In this controlled environment, 
the slow growth rate of MutS strains, such as KM71, contributed to the lower yield obtained in P. 
pastoris cultures than in H. polymorpha. Again, no residual methanol was measured in this KM71 
culture. Therefore, the lower SAF yield in the KM71 culture was not attributed to methanol toxicity.  
Southern Blot analysis revealed that two or more copies of the SAF expression cassette were 
integrated into the genome of the H. polymorpha_NCYC 495 strain. The copy number of the SAF 
expression cassette could not be verified in the P. pastoris_KM71 strain using a similar method. In 
addition, a PCR protocol was used to distinguish between different copy numbers depending on the 
size of the amplicons. The P. pastoris_KM71 strain harbored only one copy of the SAF cassette 
(data not shown). However, Aw et al. (2013) demonstrated that higher copy number does not 
necessarily result in higher productivity. Li et al. (2009) reported the first case of HPV type 16 
Stellenbosch University  https://scholar.sun.ac.za
 84 
expression in H. polymorpha, only reaching levels of 78.6 mg.L-1 in shake-flasks. Our results 
showed the highest concentration of expressed SAF protein reported to date in both yeasts, i.e. 
23.61 mg.L-1 (48.96 mg.L-1 in 10 L) and 132.10 mg.L-1 for P. pastoris_KM71 and H. polymorpha, 
respectively. Previously, the highest concentration of HPV-16 L1 protein obtained from P. 
pastoris_KM71 in shake-flasks was 14.2 mg/L (Bazan et al., 2009). Although the yield of biomass 
or SAF production per methanol substrate was not significantly different between H. polymorpha 
and P. pastoris_KM71 (Table 3.3), H. These species are possibly degradation products of L1, since 
they were not seen in total extracts of P. pastoris that did not show expression of the recombinant 
protein. 5-fold.  
Our Western blot analysis revealed the presence of lower molecular weight protein species in 
the H. polymorpha crude cell lysates, but not in the P. pastoris KM71 crude cell lysates (Fig.3.3). 
Several other groups have seen this phenomenon after expressing HPV16 L1 in insect cells 
(Kirnbauer et al., 1992), yeast (Bazan et al., 2009; Jiang et al., 2011; Deschuyteneer et al., 2010) 
and bacteria (Aires et al., 2006; Kelsall and Kulski, 1995; Chen et al., 2001; Lai and Middelberg, 
2002; Zhang et al., 1998). The lower molecular weight proteins are most probably degradation 
products of the full-length L1 since they were not seen in total extracts of H. polymorpha before the 
induction of recombinant proteins (data not shown) (Bazan et al., 2009; Zhang et al., 1998). Smaller 
L1 fragments could also be formed due to premature termination of the L1 translation (Finnen et al., 
2003). The degradation of SAF proteins was more evident in H. polymorpha cultures performed at 
37°C than in P. pastoris cultures incubated at 30°C (Fig. 3.3A). Mack et al. (2009) also showed less 
degradation of the recombinant protein in the P. pastoris Mut+ strain than in H. polymorpha. It is 
known that yeast cells are stressed by various factors during methanol metabolism, including change 
of carbon source, heat and toxic by-products. Cells of H. polymorpha metabolizes methanol at a 
faster rate than the MutS strain of P. pastoris. The combination of enhanced methanol utilization 
and higher fermentation temperature at 37ºC could have contributed to the higher proteolytic action 
in H. polymorpha (Inan et al., 2006). Despite the observed degradation, H. polymorpha still 
produced higher yields of SAF per methanol substrate than P. pastoris as the degraded products 
were not quantified and added to the total recombinant protein yield. 
Several groups have produced HPV-16 L1 in yeast in small-scaled shake-flasks as well as up-
scaled bioreactors. Our study showed that the up-scale fermentation of P. pastoris and H. 
polymorpha in bioreactors provide substantial quantities of expressed protein. H. polymorpha 
proved to be an ideal system for the production of high yield recombinant proteins. The present data 
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also allowed us to investigate the DO stat method to control methanol feeding in both P. pastoris 
Mut+ as well as MutS cultures. Increased production of HPV type 16 chimeric L1 proteins, such as in 
H. polymorpha, hold promise in developing countries as it can lead to the manufacturing of cheaper 
HPV vaccines. 
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Future work 
Fermentations in bioreactor should be fitted with an on-line mentanol sensor. Measuring methanol 
concentrations, using GC-FID, during culturing is too time consuming and does not allow 
adjustments to be made to the system on time to prevent overfeeding. The initially screening of the 
optimum feeding method in P. pastoris MutS cultures must also include both the Mut+ and H. 
polymorpha strains. It could be that the optimum feeding strategy for the one strain is not 
necessarily the preferred feeding method for the other. Subsequently, each yeast strain with its own 
preferred feeding method must then be compared to verity the best producing yeast strain. 
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Chapter 4 
Semi-purification of the SAF protein and visualization of secondary structures 
 
Introduction 
The human papillomavirus capsid is a non-enveloped icosahedral shell consisting of two structural 
proteins, L1 and L2, which self-assemble in vivo into either capsomeres (pentamer = 5 L1 
monomers) or T=7 icosahedrons, (72 L1 pentamers = 360 L1 monomers) (Hagensee et al., 1994). In 
vivo, the L1 protein alone is capable to self assemble into capsid-like structures referred to as virus-
like particles (VLPs) (Kirnbauer et al., 1992). Capsomeres can self-assemble into VLPs in vitro by 
removing reducing agents, lowering the pH and increasing the ionic concentrations (Liu et al., 2007; 
Mach et al., 2006). 
When helix 4 of the HPV-16 L1 protein is either abolished (Bishop, Dasgupta and Chen 
2007; Murata et al., 2009; Schädlic et al., 2009) or replaced with a HPV-16 L2 epitope (McGrath et 
al., 2013; Varsani et al., 2003), the formation of higher-order structure, such as T=7 or T=1 
particles, is unexpected and capsomeres, 8-10 nm in diameter, or capsomer aggregates are most 
likely to form. If helices 2 and 3 are deleted, the formation of pentamers will be prohibited (Chen et 
al., 2001). Failing to assemble into bigger structures are mainly due to the lack of hydrophobic 
interaction between relevant helices (Chen et al., 2000). The chimeric SAF protein was constructed 
by replacing the h4 helix of the HPV-16 L1 protein with a 13-amino acid peptide from the L2 
protein. When expressed in insect cells, SAF proteins predominantly self-assembled into 
capsomeres (McGrath et al., 2013; Varsani et al., 2003). McGrath et al. (2013) reported the 
occasional presence of T=7 VLPs, 50 nm in diameter, during microscope analysis, but capsomeres 
were found most abundantly (McGrath et al., 2013). 
Capsomeres are much less immunogenic than VLPs (Thönes et al., 2008). Despite less 
immungenicity, immunization with capsomeres using various strategies including oral, intranasal 
and subcutaneous, have shown to still induce high titres of neutralizing antibodies and T-cell 
responses (Dell et al., 2006; Fligge et al., 2001; Ohlschlager et al., 2003; Rose et al., 1998; Thönes 
and Müller 2007; Yuan et al., 2001). Schädlic et al. (2009) demonstrated that certain capsomeres 
can even exhibit immunogenicity similar to that of VLPs. 
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Previously, the chimeric SAF protein was expressed in insect cells and their ability to 
assemble into high-order structures was assessed (Varsani et al., 2003; McGrath et al., 2013). Only 
McGrath et al. (2013) showed the occasional formation of VLPs using the SAF protein. However, 
in this study, the methylotrophic yeasts, P. pastoris and H. polymorpha, were employed to express 
the SAF protein intracellularly (Bredell et al., 2017, under review). Following expression, 
recombinant proteins were semi-purified from the yeast cell lysate and subjected to 
electronmicroscopy. Upon transmission electron microscopy (TEM), secondary structures of 25-
30nm in diameter were observed.  
Materials and Methods 
Crude cell extracts 
Crude extracts were prepared from both P. pastoris and H. polymorpha cells, as previously 
described (Chapter 3). Cell pellets were washed with 1.2 M sorbitol, 100 mM EDTA and 14 mM β-
mercaptoethanol, and resuspended in breaking buffer containing 50 mM NaH2PO4, pH 7.4, 1 mM 
EDTA, 5% v/v glycerol and Protease Inhibitor Cocktail (Sigma, 1 ml/20 mg wet weight cells). 
Equal volume of glass beads was added to the cell suspension and subjected to vigorous vortexing, 
followed by incubation on ice. This was repeated for 20 cycles and the lysates were cleared by 
centrifugation at 10 000 g for 10 min at 4°C.  
Positive identification of SAF expression in cell lysates 
An aliquot of clear cell lysate, mixed with an equal volume of 2 x loading dye (125 mM Tris-HCl, 
pH 6.8; 4% SDS; 20% glycerol; 0.01% bromophenol blue; 5 mM 2-mercaptoethanol), was heated at 
95°C for 5 min before loading onto a 10% polyacrylamide gel. Proteins were separated and then 
transferred onto nitrocellulose membranes (BioTrace™ NT, PALL) as previously described (Smith 
et al., 2012). Membranes were treated accordingly and incubated with an anti-HPV type 16 L1 
monoclonal antibody CAMVIR-1 (Santa Cruz Biotechnology, Dallas, Texas). Following detection 
using alkaline phosphatase-labelled antibodies and NBT/BCIP detection reagents (Fermentas, 
ThermoFisher, Massachusetts, USA), the presence of a 55 kDa protein specie indicated the 
expression of SAF and were selected for protein purification. Unless stated otherwise, all blots were 
treated with anti-HPV- type 16 L1 and alkaline phosphatase antibodies. One hundred grams of wet 
yeast cells were used to prepare yeast cell lysate for further L1 protein purification.  
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Ammonium sulphate precipitation 
SAF protein was recovered from the cleared lysates by ammonium sulphate (Sigma, USA) 
precipitation. Yeast cell lysates were adjusted to 20% saturated ammonium sulphate followed by 
stirring for 60 min at 4°C. Precipitated protein was pelleted at 13 000 x g for 20 min at 4°C. The 
protein pellets were resuspended in 50 µl distilled water (1 x PBS, pH 7.2 + 0.01% Tween 80) and 
the remaining supernatant was adjusted to a 10% increment in ammonium sulphate at 4°C, followed 
by stirring and centrifugation. The process was repeated until the lysates reached an ammonium 
sulphate concentration of 60% (Green and Hughes 1955). The resuspended pellets were subjected to 
SDS-PAGE analysis and Western blotting to verify the presence of SAF monomer proteins. 
After ammonium sulphate precipitation, the resuspended pellets were dialyzed against 1 x 
PBS (pH 7.2) + 0.01% Tween 80 buffer with two changes of buffer in 24 h and subjected to size-
exclusion chromatography. 
Size-exclusion chromatography 
Size-exclusion chromatography was performed with SephacrylTM S-1000 size column (GE 
Healthcare, US). The running buffer contains 10 mM sodium phosphate, pH 7.2, 150 mM NaCl, 
0.01% Tween 80. Fractions were collected from the column at 0.16 ml/min (fractions were taken 
every 5.8 min, total fraction volume of 928 µl) and their absorbance was measured at 280 nm with a 
spectrophotometer. Fractions were analysed by SDS-PAGE, and Western blotting. 
In addition, the nitrocellulose blots were also stained with Ponceau stain to verify the 
presence of any proteins bands on the blots. Membranes were incubated for one hour in staining 
solution (0.1% (g.L-1) Ponceau S (Sigma, USA) in 5% (v/v) acetic acid) with gentle agitation, 
followed by rinsing the membrane in distilled water until the background is clear. 
Cation-exchange chromatography  
The fractions containing the SAF monomer proteins were collected from the size-exclusion 
chromatography and equilibrated at 4°C with binding buffer containing 20 mM Tris, pH 6.5, 0.1 M 
NaCl, 0.1 mM EDTA, 5% glycerol and 15 mM DTT. The equilibrated fractions were loaded onto a 
CM Sepharose Fast Flow column (GE Healthcare, US). The column was washed with five column 
volumes of wash buffer containing 0.6 M NaCl. The SAF monomer proteins were eluted with 
elution buffer containing 1.1 M NaCl. 
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Sucrose gradient centrifugation 
As an alternative to chromatography, cleared yeast cell lysates were loaded onto a sucrose density 
gradient (50-70% g/L) in 1 x PBS, pH 7.2 and ultracentrifuged. The gradient is prepared by layering 
less dense sucrose solutions upon one another, starting with the 50% sucrose at the bottom of a 
polyallomer tube (Beckman, CA). The tubes were then centrifuged at 100 800 x g in a swinging 
bucket SW 50.1 type rotor (Beckman, CA) for 18 h at 4°C. Five hundred microliter fractions were 
collected through a fine piercing at the very bottom of the tube, and analysed by SDS-PAGE and 
Western blotting. Sucrose fractions containing the HPV type16 L1 protein were then dialysed 
against a disassembly buffer (PBS, pH 8.2, containing 0.166 M NaCl, 2 mM DTT and 2 mM 
EDTA, with 0.01% Tween 80), followed by a reassembly buffer (PBS, pH 7.0, containing 0.5 M 
NaCl) with 4 changes of buffer at 4°C.  
Electron microscopy 
Carbon coated copper grids were glow discharged using the Glow Discharge Unit to render the 
carbon surface hydrophilic. Samples were adsorbed to the grids for 5 min. Grids were washed twice 
in distilled water and negatively stained with 2% uranyl acetate for 1 min. Grids were blotted on 
filter paper to remove excess liquid and air-dried prior viewing. Alternatively, carbon coated grids 
were treated with the HPV type 16-conformation-specific antibody H16:V5 (donated by Ed Rybicki, 
University of Cape Town) at a 1:1000 dilution for 10 min. These antibodies captured only L1 
pentamers and other higher-order aggregates including VLPs onto the grids (Christensen et al., 
1996; Varsani et al., 2003]. Unbound antibody was first washed off by floating the grids on PBS 
droplets for 1 min before the samples were absorbed to the grids, washed with water and negatively 
stained. Air-dried grids were viewed and micrographs taken using a transmission electron 
microscope (Zeiss 912 Omega Cryo Eftem, USA) at 50 000 times magnification. 
Results 
Effect of different percentage ammonium sulphate on SAF precipitation 
Following different percentage ammonium sulphate precipitation, protein pellets were analysed 
using SDS-PAGE and Western blotting. Blots revealed a prominent band correspondig to the 
correct-size (55 kDa) HPV16 SAF monomers. Faint lower and higher molecular weight protein 
species were also detected. The lower bands corresponded to degradation products and the higher 
bands represent possible oligomers. 
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Initially, ammonium sulphate was added add 20%, then 30%, 40%, 50% and 60% to 
precipitate the SAF monomer proteins. When the highest concentration SAF proteins was recovered 
at 40% and 50% (Fig 4.1 A), smaller increments of 5% were subsequently investigated and showed 
that 45% precipitated most of the SAF proteins (Fig 4.1B). 
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Figure 4.1. Western blots of precipitated SAF monomer proteins using different ammonium 
sulphate percentages. (A) M: PageRuler™ Prestained Protein Ladder (Thermo Fisher Scientific, 
USA); lane 1: 20%; lane 2: 30%; lane 3: 40%; lane 4: 50%; lane 5: 60% ammonium sulphate, (B) 
M: Protein Ladder; lane 1: 45%; lane 2: 50%; lane 3: 40% ammonium sulphate. 
 
Size-exclusion chromatography 
After the 40% ammonium sulphate precipitation, the resuspended protein pellet was dialyzed before 
it was loaded onto a SephacrylTM S-1000 size column. All the fractions were examined at 280 nm 
(Fig. 4.2) and analysed by SDS-PAGE and Western blotting for the presence of SAF monomer 
proteins (Fig. 4.3A, B). Ponceau S-stained SDS-PAGE analysis indicated the presence of proteins 
only in fractions 10-21 with HPV16 SAF confirmed in all 12 fractions. However, only fractions 14-
20, showing the absence of degradation products, were pooled and subjected for further purification 
using cation exchange chromatography. 
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Figure 4.2. Size-exclusion chromatography curve indicating 55 intervals when fractions were taken.  
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Figure 4.3. Size-exclusion chromatography fractions separated by SDS-PAGE followed by Western 
blotting. (A) Western blots showing all extracted proteins using Ponceau S staining. M: 
PageRuler™ Prestained Protein Ladder (Thermo Fisher Scientific, USA); lane 1-9: fractions 5-13; 
lane 10-18: fractions 14-22. (B) Western blots showing only HPV-16 L1 proteins using anti-HPV-
16 L1monoclonal and alkaline phosphatase-labelled antibodies. M: PageRuler™ Prestained Protein 
Ladder; lane 1-9: fractions 5-13; lane 10-17: fractions 14-22.  
Cation-exchange chromatography 
Fractions 14-20 from the size-exclusion chromatography (Fig 4.2) were pooled, equilibrated and 
fractionated using cation-exchange chromatography (Fig 4.4). The SAF monomer proteins were 
eluted with 1.1 mM NaCl and cation chromatography fractions 1-12 were analysed by SDS-PAGE, 
followed by Western blotting (Fig 4.5A, B). The SAF protein (~55 kDa) was successfully eluted in 
fractions 1-8 (Fig. 4.5A). 
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Figure 4.4. Cation-exchange chromatography curve indicating 12 intervals when fractions were 
taken.  
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Figure 4.5. (A) Western blot result of cation-exclusion chromatography fractions separated by SDS-
PAGE. M: PageRuler™ Prestained Protein Ladder (Thermo Fisher Scientific, USA); lane 1-8; 
fractions 1-8, (B) lane 9-12; fractions 9-12. 
Sucrose gradient centrifugation 
As an alternative strategy, cleared yeast cell lysates were also loaded onto a sucrose density gradient 
(50-70% g/L) and ultracentrifuged. After centrifugation, the sucrose gradient separated in different 
phases (Fig 4.6A). Five hundred microliter fractions were collected through a piercing at the bottom 
of the tube, and analysed by SDS-PAGE and Western blotting (Fig 4.6B). The highest recovery of 
HPV16 SAF was from fractions representing 65%, 60% and 55% sucrose. 
 
Figure 4.6. Isolation of HPV SAF chimeric monomeric proteins. (A) Yeast cell lysate loaded onto a 
50-70% sucrose density gradient and ultracentrifuged. (B) Sucrose gradient fractions separated by 
SDS-PAGE followed by Western blotting. M: PageRuler™ Prestained Protein Ladder (Thermo 
Fisher Scientific, USA); lane 1: pellet, lane 2: 70% sucrose, lane 3: 65% sucrose, lane 4: 60% 
sucrose, lane 5: 55% sucrose, lane 6: 50% sucrose.  
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In order to dilute the sucrose content in the sucrose gradient centrifuged samples, fractions 5 
and 6 were dialyzed against distilled water for 4 hours. In addition, the cation-exchange 
chromatography fractions 1-8 were pooled and concentrated using dialysis tubing and PEG 35000. 
Both the concentrated cation-exchange chromatography sample and sucrose samples were used to 
prepare carbon grids for transmission electron microscopy. 
Self-assembly of purified SAF monomer proteins 
Semi-purified SAF monomer proteins self-assembled into recognizable secondary structures. It is 
evident from the frequency distribution chart that SAF proteins assembly mostly into capsomeres 
(~10 nm in diameter) with a lower frequency of other higher-ordered structures. The lowest 
frequency was T=1 VLPs (30 nm in diameter) (Fig. 4.7 A, B).  
 
 
Figure 4.7. Analysis of the HPV16 L1/L2 (SAF) chimeric protein. A) TEM analysis. T=1 VLPs (25-
30nm in diameter) are indicated by arrows against a background of smaller particles. A 100 nm bar 
for reference is located in the lower right corner of the picture. B) Diameter distribution of particles 
shown by frequency histogram. 
Discussion 
HPV L1 VLPs have been produced in various expression systems, such as bacteria, e.g. Escherichia 
coli (Chen et al., 2001; Li et al., 1997), Lactococcus lactis (Cortes-Perez et al., 2009) and 
A B 
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Lactobacillus casei (Aires et al., 2006), yeast such as S. cerevisiae (Woo et al., 2008), P. pastoris 
(Liu et al., 2007; Bazan et al., 2009; Kotzé et al., 2011; Zhao et al., 2015) and H. polymorpha (Li et 
al., 2009), baculovirus-infected insect cells (Kirnbauer et al., 1992; Le Cann et al., 1994), 
transgenic plants (Biemelt et al., 2003), and mammalian cells (McLean et al., 1990). Other studies 
have also reported on the production of VLPs consisting of both structural HPV proteins, L1 and 
L2, in human epithelial cells (Cianciarullo et al., 2010) and insect cells (Kirnbauer et al., 1993; 
Zhou et al., 1991). In all of these expression systems, HPV type L1 assembled into relatively regular 
T=7 VLPs consisting of 72 pentamers. With the exception of expression in E. coli, smaller T=1 
VLPs, consisting of 12 L1 pentamers (60 L1 monomers) and about 30-40 nm in diameter, have been 
observed but only when 10 or more amino acids have been removed from the amino-terminus of L1 
(Chen et al., 2001). 
In this study, a chimeric protein was constructed by replacing the h4 helix of the HPV-16 L1 
protein with a 13-amino acid peptide from the HPV-16 L2 protein, followed by the expression in 
methylotrophic yeasts P. pastoris and H. polymorpha. Electron microscopy (EM) showed that the 
chimeric L1/L2 protein (SAF) retained the ability to aggregate mainly into capsomeres (10 nm in 
diameter) and the occasional T=1 VLPs (25-30 nm in diameter) (Fig. 4.7 A, B). These secondary 
structures were present in samples from both the chromatography and sucrose gradient 
centrifugation. Bishop et al. (2007) reported the presence of the helix 4 near the C-terminus of HPV 
L1 as a prerequisite for the assembly of both T1 and T7 virus-like particles. Their helix 4 deletion 
mutants oligomerize into only capsomeres (Bishop, Dasgupta and Chen, 2007). Although other 
studies showed successful VLP formation following the expression of intact HPV-16 L1 proteins in 
P. pastoris (Liu et al., 2007; Bazan et al., 2009; Kotzé et al., 2011; Zhao et al., 2015), we did not 
include the expression of intact HPV-16 L1 in our study. Therefore, one cannot assume that the low 
frequency of T=1 VLPs and the absence of T=7 VLPs was attributed to the displacement of the 
helix 4. Although HPV-16 L1 had been expressed in H. polymorpha, no secondary structures were 
observed (Li et al., 2009). 
Analysis of EM also showed low frequencies of VLPs smaller than T=1 (20 nm in diameter) 
as well as particles smaller than capsomeres (5 nm in diameter). This could possibly be incomplete 
capsomeres or VLPs. Despite low yields of VLPs, our EM preparations did not inadequately 
assemble into amorphous aggregates. 
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Although our study did not investigate the immunogenicity of these secondary structures, 
Schädlic et al. (2009) showed that the humoral immunity elicited by T=1 VLPs was comparable to 
those elicited by T=7 VLPs (Schädlic et al., 2009). Capsomeres were also highly immunogenic and 
capable of eliciting strong neutralizing antibody responses against both LI and L2 epitopes, but the 
responses were 20- to 40-fold lower than those by VLPs (Fligge et al., 2001; Rose et al., 1998; 
Thönes et al., 2008). Schädlic et al. (2009) hypothesized that the lower antibody titers induced by 
capsomeres were the results of their smaller particle size compare to VLPs. Capsomeres have also 
provided protection against viral challenges in the canine oral papillomavirus model (Rose et al., 
1994; Yuan et al., 2001). Despite their lower immunogenicity, capsomeres still offer great potential 
in future vaccine preparations. Chimeric SAF proteins displaying L2 epitopes offer simultaneously 
high titres of L1 specific neutralizing antibodies as well as cross-neutralizing antibodies against L2 
(Varsani et al., 2003; Rubio et al., 2009; McGrath et al., 2013). In addition to HPV L2 epitopes, L1 
monomers bearing other heterologous epitopes within the helix 4 region can self-assemble into 
capsomeres that elicit antibody response specific against such non-HPV encoded epitopes. Thus, the 
HPV L1 helix 4 site can function as a novel antigen carrier within the L1 pentamer and thereby 
serve as a potential vaccine platform. 
Although HPV type 16 L1 has been expressed in H. polymorpha before (Li et al., 2009; 
(Liu, Yang and Yao, 2014), our study is the first report showing the formation of T=1 VLPs in this 
methylotrophic yeast. Previously, Liu et al. (2015) showed the formation of T=7 VLPs when HPV 
type 52 L1 was expressed in H. polymorpha.  
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Abstract 
During this study, we successfully expressed a codon-optimized gene for rotavirus VP6 protein 
intracellularly in two methylotrophic yeasts, Pichia pastoris and Hansenula polymorpha, during 
methanol induction. Expressions were performed in shake flasks and subsequently scaled-up to 1.3 
L bioreactors. The yields obtained in the yeasts were compared with that observed in E. coli. 
Despite producing the lowest biomass levels of all the expression systems in shake flasks, the 
highest VP6 concentration was obtained with E. coli. In shake flasks, P. pastoris yielded higher 
volumetric levels of VP6 than H. polymorpha, but specific production of VP6 was similar in both 
yeasts. In the controlled environment of bioreactors, yeast strains attained typical high cell densities, 
but also increased VP6 production compared to all shake flask cultures. Unlike in shake flask 
expressions, H. polymorpha outperformed both P. pastoris as well as E. coli during bioreactor 
cultivation. In all three VP6 systems, the VP6 production was growth-associated. In contrast to yeast 
expressions, bacterially expressed VP6 protein was found to be insoluble upon analysis. This is the 
first report of VP6 expressed in methylotrophic yeast and holds the promise for the inexpensive 
production of VP6 as a possible vaccine candidate or drug delivery mechanism.  
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Introduction 
Gastroenteritis, resulting in severe diarrhea, is one of the leading causes of illness and deaths in 
children under the age of five years worldwide (Parashar, Bresee and Glass, 2003). Rotavirus (RV) 
infection accounts for one third of diarrhea-associated hospitalizations and more than 500 000 
deaths annually in developing countries (Parashar et al., 1998; World Health Organization, 2007). 
More than half of those deaths occur in developing sub-Saharan Africa (World Health Organization, 
2007). A rotavirus vaccine has been included in the South African Expanded Programme on 
Immunization (EPI) due to the positive outcome of vaccine trials in South Africa (Madhi et al., 
2010) and elsewhere (Gray, 2011). Despite being highly effective, future vaccination in low income, 
high-burden countries may have a large financial impact. In addition, these countries also show 
lower vaccine efficacy than in high- and middle-income countries. This could be due to various 
factors, including the emergence of viral variants other than the vaccine strains. Booster doses may 
improve the rotavirus vaccine performance (Program for Appropriate Technology in Health: PATH, 
2015). Therefore, there is a large demand for cheaper RV vaccine alternatives.  
Rotavirus particles are icosahedral composed of three concentric protein layers: the inner 
layer, containing VP2 as the scaffold arranged as dimers, together with VP1 and VP3; the 
intermediate layer forming the inner capsid consists of 780 VP6 protein molecules arranged in 260 
trimers, and the surface layer consisting of VP7 with VP4 spikes (Desselberger et al., 2009; Mena et 
al., 2006). VP6 is the most abundant protein in the particle and contributes the greatest molecular 
mass (Parashar et al., 1998). This protein is highly immunogenic (Svensson et al., 1987; Estes and 
Cohen, 1989) and contains conserved cross-reacting epitopes (Tang et al., 1997), making VP6 an 
attractive candidate for a potential RV vaccine (Estes and Cohen, 1989). Whether antibodies 
directed against VP6 are neutralizing the virus, remains controversial. While there are some studies 
showing that anti-VP6 antibodies do not induce passive protection in mice (Coste et al., 2001), 
others reported they were able to reduce viral shedding in mice challenged with RV (Burns et al., 
1996; Corthésy et al., 2006; Schwartz-cornil et al., 2002). Furthermore, a murine VP6 DNA vaccine 
(Herrmann et al., 2012; Chen et al., 1997) as well as the Escherichia coli (E. coli) expressed 
chimeric protein (Choi et al., 1999; Choi et al., 2000) induced protective immunity in mice, 
suggesting VP6 is a promising antigen in vaccine design.  
Trimerization and assembly of VP6 into different structural conformations are intrinsic 
properties of this 45 kDa protein (Estes et al., 1987). Depending on the pH, ionic strength and 
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divalent cation concentration, VP6 alone can self-assemble into either spherical or tubular 
multimeric structures (Lepault et al., 2001). Although irregular, VP6 can form closed particles by 
itself (Mathieu et al., 2001). In addition to rods, it can also form icosahedral or virus-like particles 
(VLPs) when expressed in plants, resembling the morphology of dually expressed VP2 and VP6 
VLPs, as observed in the insect cell-baculovirus expression system (O’Brien et al., 2000). 
In addition to its application as vaccine candidate, VP6 VLPs have also been applied as drug 
delivery tool (Redmond et al., 1991; Zhao et al., 2011). Frenchick et al. (1992) demonstrated that 
peptides coupled to VP6 spheres elicited a greater humoral response than the peptides alone, and 
that the spheres were not neutralized by anti-rotavirus antibodies (Redmond et al., 1991; Frenchick 
et al., 1992). RV VP6 multimeric structures have been expressed in a variety of different 
heterologous systems: mammalian cells (Gonzalez and Affranchino, 1995), insect cell/baculovirus 
systems (IC-BVS) (Crawford et al., 1994; Bertolotti-Ciarlet et al., 2003), the prokaryote E. coli 
(Choi et al., 2004; Zhao et al., 2011) the eukaryotic yeast Saccharomyces cerevisiae (Rodríguez-
Limas et al., 2011), and baculovirus-silkworm (Yao et al., 2012). More recently, the methylotrophic 
yeast Pichia pastoris (P. pastoris) has been investigated for the intracellular co-expression of VP2, 
VP4 VP6 and VP7 and subsequent VLP formation (Zhang and Lou, 2011). 
Due to the inability of E. coli to effectively express complex eukaryotic proteins and the cost 
associated with mammalian and insect cell lines, yeast became the preferred alternative for VLP 
production because of the ease of manipulation, scalability and lower production cost  (Federico, 
2010). Methylotrophic yeasts, such as P. pastoris and Hansenula polymorpha (H. polymorpha), 
possess several advantages as the ideal expression system: (i) expression of recombinant proteins is 
under a tightly regulated and highly productive promoters (AOX1/AOX2) in P. pastoris (Cregg et 
al., 2000) and MOX in H. polymorpha (Gellissen, 2000); (ii) they can attain high-cell densities of 
150 g L-1 dry cell weight in bioreactors (Cereghino and Cregg 1999); (iii) relatively low levels of 
endogenous protein are secreted into the medium (Cereghino and Cregg, 2000); and (iv) these yeasts 
tend not to hyperglycosylate recombinant proteins (Sudbery, 1996), rendering them less allergenic 
and more suitable as pharmaceuticals. Hansenula polymorpha is more thermotolerant than P. 
pastoris (37°C versus 30°C), which enables faster high-yield fermentation (Hollenberg and 
Gellissen, 1997).  
Growing P. pastoris and H. polymorpha in bioreactors at high biomass yields can produce 
copious amounts of heterologous protein, due to the increased transcription efficiency from the 
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AOX1 and MOX promoters (Cereghino and Cregg, 2000). Bulk biomass was obtained with fed-
batch feeding of both glycerol and methanol as carbon source in fermentor cultures. Methanol 
metabolism requires oxygen. The expression of foreign proteins is negatively affected by oxygen 
depletion. Bioreactors provide a controlled environment to monitor and adjust oxygen levels in the 
culture medium. 
During this study, we set out to establish the capacity of P. pastoris and H. polymorpha to 
produce the VP6 protein and to compare the levels to that produced in E. coli. Expression of VP6 
was performed in shake flasks as well as in 1.3 L bioreactors. High VP6 concentration is important 
for the production of multimeric structures as higher concentrations are prone to assemble more 
efficiently both in vitro and in vivo (Pattenden et al., 2005). The recombinant VP6 protein obtained 
following expression in E. coli BL21 (DE3), was used as a baseline reference. The VP6 amino acid 
sequence used during this work was derived from an emerging South African RV strain, G9P[6] (N. 
Page, personal communication), making this VP6 protein suitable to boost local vaccine efficacy. 
To our knowledge, this is the first report of RV VP6 expression levels in methylotrophic yeasts P. 
pastoris and H. polymorpha. 
Materials and methods 
Strains and maintenance media 
E. coli DH5α strain was used as host to maintain and amplify synthesized plasmids as well as 
expression vectors for both yeasts. The E. coli DH5α parental strain and transformants were grown 
at 37°C on Luria Bertani (LB) agar plates (0.5% [g.L-1] yeast extract, 1% [g.L-1] tryptone, 1% [g.L-1] 
NaCl and 1.5% [g.L-1] agar) containing either 50 µg.mL-1 ampicilin or 100 µg.mL-1 kanamycin, 
depending on the plasmid used. Bacteria were grown in LB culture medium (0.5% [g.L-1] yeast 
extract, 1% [g.L-1] tryptone, 1% [g.L-1] NaCl) and all plasmid preparations for cloning, 
transformation and sequencing were performed using cetyltrimethyl ammonium bromide (CTAB) 
(Del Sal et al., 1988). The P. pastoris_GS115 strains were obtained from Invitrogen (Life 
Technologies) and the H. polymorpha NCYC 495 strain from Jan Kiel, University of Groningen, 
The Netherlands. Both yeast species were cultured on YPD (1% [g.L-1] yeast extract, 2% [g.L-1] 
tryptone, 1% [g.L-1] glucose) agar plates; P. pastoris was incubated at 30°C and H. polymorpha at 
37°C. The E. coli BL21 (DE3) strain was used as bacterial expression strain and cultured on LB 
agar plates, selective for ampicilin resistance. 
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Construction of expression cassettes 
The RV VP6 sequence used in this work was derived from a prevalent South African RV strain, 
G9P[6] (N. Page, personal communication). All DNA manipulations were performed as outlined by 
Sambrook et al. (1989). The rotavirus VP6 gene was double-codon-optimized for both P. pastoris 
and H. polymorpha, and synthesized (GeneArt, Regensburg, Germany). The commercial codon-
optimized VP6 genes were closely examined for preferred codon usage in both yeasts to further 
reduce the usage of rare codons. This was done using an adaptation of the codon bias index for each 
of the two yeasts from Sharp et al. (1988). The pHIPX4-HNBESX plasmid (leu2, kanR) (Gietl et al., 
1994) was used as the backbone for the construction of all plasmids transformed into the H. 
polymorpha genome and the pBLHIS-IX plasmid (his4, ampR) (Cereghino et al., 2001) for the 
construction of all plasmids transformed into the P. pastoris genome. Appropriate restriction sites 
flanking the VP6 gene were incorporated during synthesis to enable directional sub-cloning into the 
relevant shuttle vectors: BamHI and HindIII were used for cloning into pHIP4X-HNBESX, and 
EcoRI and XhoI into pBLHIS-IX, resulting in pHIP4X-VP6 and pBLHIS-VP6, respectively. This 
allowed cloning of the VP6 gene down-stream of the P. pastoris and H. polymorpha methanol-
induced promoters, AOX and MOX, respectively. Shuttle vectors were sequenced using primers 
pHIPX4-F and pHIPX4-R (for pHIP4X-HNBESX) (Smith et al., 2012) and 5’AOX and 3’AOX (for 
pBLHIS-IX) from Invitrogen (Life Technologies) to verify an open reading frame of the VP6 gene. 
For E. coli expression, the pProEx™ HTc vector was selected to clone VP6. The 
commercial E. coli codon-optimized VP6 gene was further optimized using Sharp and co-workers’ 
codon bias index replacing rare codons in the VP6 gene with codons commonly used by E. coli 
(Sharp et al., 1988). To sub-clone the optimized VP6 gene into pProEx™ HTc, the pGA15-VP6 
plasmid was linearized with NdeI and pProEx™ HTc was linearized with HindIII in parallel. 
Following digestion for 2 h at 37°C, Klenow enzyme was added to both digestions and incubated for 
another 1 h to generate blunt ends. The DNA from both digestions was recovered by precipitation 
and the linear pGA15-VP6 and pProEx™ HTc were again digested with XhoI and SalI, respectively. 
The VP6 gene was subsequently ligated into the pProEx™ HTc plasmid using T4 DNA ligase 
resulting in the expression plasmid pProEx-VP6c. The pProEx-VP6c vector was sequenced using 
commercial primers to verify an open reading frame of the VP6 gene. All the enzymes used for 
cloning were provided by Fermentas (Thermo Scientific, Inqaba Biotec). Glycerol stocks of all 
desired clones were prepared for storage purposes. 
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Bacterial transformation 
One tube of chemically prepared competent E. coli DH5α cells per transformation was thawed on 
ice. Once thawed, the ligation mix (10 µl) was added to BL21 (DE3) cells and the cell-DNA 
mixture was incubated on ice for 30 min followed by heat shock treatment at 42°C for 90 s. To 
allow the cells to recover, 1 ml of LB medium was added and incubated while shaking at 37°C for 1 
h. The transformation was then plated in various dilutions onto selective LB agar plates and 
incubated overnight (o/n) at 37°C.  
Yeast transformation 
Transformation into H. polymorpha NCYC495 was carried out by electroporation according to 
Faber et al. (1994). Prior to electroporation, plasmids were linearized by digestion with StuI, 
precipitated and complete digestion verified using agarose gel electrophoresis. Linear DNA (0.005-
1.0 μg) was added to 60 μl of cell suspension and transferred to a pre-chilled 2 mm electroporation 
cuvette. For transformation, the cell suspension was pulsed approximately 10 ms with a field 
strength of 1.5 kV, 200 Ω and 25 μF using a Bio-Rad GenePulser®II. Following transformation, 
yeast cells were plated onto yeast nitrogen base (YNB) selective plates (0.17% [g.L-1] YNB, 0.25% 
[g.L-1] ammonium sulphate [(NH4)2SO4], 0.5% [g.L-1] glucose) followed by incubation at 37°C for 
3 to 10 days. Transformation of plasmids into the P. pastoris_KM71 genome was carried out by 
electroporation according to Becker and Guarenthe (1991). Plasmids were linearized by digestion 
with SacI, precipitated and complete digestion verified using agarose gel electrophoresis. The 
electro-competent cells (40-50 μl) were mixed with 0.005-1.0 μg of linear pBLHIS-VP6 plasmid 
DNA in a 2 mm electroporation cuvette. The cells were pulsed for 10 ms with a field strength of 1.5 
kV, 200 Ω and 25 μF using a Bio-Rad GenePulser®II. Following electroporation, the cells were 
plated onto double strength YNB plates supplemented with 0.5% [g.L-1] (NH4)2SO4, 1% [g.L-1] 
glucose and incubated at 30°C for 3-10 days. 
PCR confirmation of positive recombinants 
Recombinant colonies large enough for colony PCR as well as subsequent inoculation for storage 
purposes were selected. Each yeast colony was transferred to a 10 μl solution containing 2.5 mg.mL-
1 Zymolyase enzyme solution (ICN Biomedicals), 1.2 M Sorbitol and 0.1 M sodium phosphate 
buffer, pH 7.4, and the colony suspension incubated at 37°C for a minimum of 15 min. The PCRs 
were performed in a total volume of 20 μl, containing 0.5 μM of each primer, 0.05 U Taq DNA 
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Polymerase (NEB), 2 μl 10x ThermoPol buffer (NEB), 1.5 mM MgCl2 and 1 μl colony mix as DNA 
template. Primers 5’AOX1 and 3’ AOX1 (Invitrogen) were used for screening P. pastoris 
transformants and pHIPX_F and pHIPX_R (Smith et al., 2012) for H. polymorpha. The PCR 
conditions were: one cycle at 95 °C for 5 min, followed by 35 cycles at 95 °C, for 10 s, 50 °C (55 
°C for P. pastoris) for 40 s, and 72 °C for 1 min 30 s, and a final elongation step at 72°C for 4 min.  
Bacterial recombinants were screened using restriction enzyme analysis following 
inoculation from selective plates. Correct band patterns following agarose gel electrophoresis, 
verified the presence of VP6 in plasmid pProEx™ HTc. 
Gene expressions and growth conditions in shake flasks 
The H. polymorpha colonies were cultured in 25 ml mineral medium (Van Dijken, Otto and Harder, 
1976). Each recombinant selected was inoculated into three separate shake flasks with mineral 
media containing vitamin solution (Van Zutphen et al., 2008) and 5 mg ml-1 glucose, and incubated 
overnight at 37°C with shaking at 200 rpm. The following morning, the culture was diluted to an 
A600 of 0.1 and grown to the mid-exponential growth phase. This was repeated until the doubling 
time of wild-type is almost 1 h (Van Zutphen et al., 2008). As a negative control, wild type H. 
polymorpha NCYC495 containing only the pHIP4X-HNBESX plasmid was included. After pre-
culturing, mid-exponential cells were diluted into minimal medium containing 0.5% [v/v] methanol 
to an A600 of 0.1 so as to induce expression. Samples for protein extraction were taken at 24 h, 48 h 
and 72 h. 
Culturing and induction of protein expression in P. pastoris_GS115 cultures was according 
to the protocol described in the Pichia Expression kit (Invitrogen). Briefly, the recombinant strains 
were cultured, in triplicate, in 20 ml buffered glycerol-complex medium (BMGY: 1% [v/v] glycerol, 
1% [g.L-1] yeast extract, 2% [g.L-1] peptone, 100 mM potassium phosphate, pH 6, 1.34% [g.L-1] 
yeast nitrogen base and 4 x 10-5% biotin) to generate biomass. When sufficient biomass had been 
obtained, 75 ml buffered methanol-complex medium (BMMY: 0.5% methanol, 1% yeast extract, 
2% peptone, 100 mM potassium phosphate, pH 6, 1.34% yeast nitrogen base and 4 x 10-5% biotin) 
in 500 ml baffled flasks covered with only a cotton wool plug to encourage O2 diffusion was used 
for induction purposes. Cultures were incubated at 30°C while shaking at 200 rpm for both biomass 
generation and induction. Methanol (0.5% [v/v]) was added every 24 h to maintain induction. As a 
negative control, wild type P. pastoris_GS115 containing only the pBLHIS-IX plasmid was 
included. Samples for protein extraction were taken at 24 h, 48 h and 72 h.  
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Single colonies of recombinant BL21 (DE3) cells were cultured o/n at 37°C and agitation in 
5 ml LB broth with 50 µg ml-1 ampicilin. The following day, cultures were diluted 1/100 in 200 ml 
LB and grown until an A600 of 0.5–1.0, followed by the addition of isopropyl β-D-thiogalactosidase 
(IPTG) to a final concentration of 0.6 mM to induce expression. Alternatively, recombinant BL21 
(DE3) cells were also cultured in 120 ml phosphate/citric acid buffer, pH 6.3, used for E. coli high 
cell-density fermentation (Korz et al., 1995). The medium consist of 0.1 M KH2PO4, 30 mM 
(NH4)2HPO4 and 9 mM citric acid, supplemented with 3% glucose, 10 M MgSO4, 1x trace metal 
solution, 15 μM Thiamine solution and 100 μg ml-1 ampicilin. Once the A600 reached 0.6, 1 mM 
IPTG is added to initiate protein production. 
Yeast fermentation cultures  
All fermentations were conducted in 1.3 L New Brunswick Bioreactors. Pre-cultures were prepared 
by inoculating a streak of colonies from YPD (1% [g.L-1] yeast extract, 2% [g.L-1] tryptone, 2% 
[g.L-1] glucose) agar plates into 0.04 L of buffered glycerol complex medium (BMGY; 1% yeast 
extract, 2% peptone, 100 mM potassium phosphate pH 6.0, 1.34% YNB, 4 x 10-5% biotin, 1% 
glycerol) in baffled shake flasks. Pre-cultures were incubated overnight at either 30°C (for P. 
pastoris) or 37°C (for H. polymorpha) at 200 rpm. Cultures were then diluted to an A600 of 0.1 in an 
equal amount of fresh BMGY medium and subsequently cultured overnight at the same conditions 
to an A600=2-6. This culture was used to inoculate 0.36 L of fermentation medium in the bioreactor 
to obtain a starting A600 = 0.2-0.6. 
Both P. pastoris and H. polymorpha strains were grown in triplicate in fermentation basalt 
salt medium, supplemented with 4% [v/v] glycerol and 4.35 ml PTM1 trace salts/L medium, 
according to the Pichia Fermentation protocol (Invitrogen Life Technologies, 2002). Culture 
conditions were maintained as follows: 30°C for P. pastoris and 37°C for H. polymorpha, pH 5.O 
with 28% ammonium hydroxide (NH4OH) aeration rate of 1.0 volume of oxygen per volume of 
fermentation culture per minute (vvm) air and dissolved oxygen (DO) = 30%. DO is sensed by the 
DO electrode and controlled by a cascade effect between agitation rate (200-1000 rpm) and aeration 
rate (1 vvm), which is maintained by the proportional (P) and integral (I) controller. Once the 
glycerol is depleted from the glycerol batch phase (Day 1, 24 hrs post-inoculation), as indicated by a 
spike in the DO levels, a 50% [v/v] glycerol feed supplemented with 12 ml PTM1 trace salts L-1, is 
initiated (Day 2, 48 hrs post-inoculation). Glycerol feeding was carried out in a fed-batch mode 
based on the DO stat method, also referred to as ‘demand-feed’. This entails the controlled addition 
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of glycerol depending on the DO tension. As the yeast metabolized actively, glycerol became 
depleted and the DO tension began to rise. Once the DO > 30%, the glycerol feed was switched on. 
In the presence of glycerol, the metabolic pathway became activated and the DO began to decrease. 
When the DO dropped below 30%, the glycerol feed was switched off. The DO levels were restored 
to 30% by a mixture of agitation cascade and oxygen supplementation. As the DO increased beyond 
30%, the glycerol feed switched on again. A cellular yield of 180-220 g L-1 wet cell weight (WCW) 
indicated the end of the glycerol fed-batch phase. The glycerol feed was terminated and replaced 
with 100% [v/v] methanol (Day 3, 72 hrs post inoculation; Day 1 induction), supplemented with 12 
ml PTM1 trace salts L-1, to start the methanol fed-batch phase and proceeded for 5 consecutive days 
or until the WCW started to decrease. Methanol feeding in P. pastoris and H. polymorpha cultures 
was controlled similarly using the DO stat method. 
Bacterial fermentation cultures  
A single colony of E. coli was inoculated in triplicate in three 12 ml LB medium with 50 µg ml-1 
ampicilin in a 50 ml tube and incubated overnight at 200 rpm and 37°C. Two of the cultures were 
spun for 10 min at 4000 rpm, their supernatant was discarded and the pellets were resuspended in 
the remaining culture. This culture was used to inoculate 630 ml 1x phosphate/citric buffer (0.1 M 
KH2PO4, 0.03 M (NH4)2HPO4, 0.009 M citric acid), supplemented with 3% [v/v] glucose, 0.01 M 
MgSO4, 1x trace metal solution, 0.015 mM Thiamine and 50 µg ml-1 ampicilin, in a 1.3-L 
bioreactor. Except for a pH of 6.8 and fermentation temperature of 37°C, the culturing conditions 
were identical to that of yeast. 
The end of the batch phase was indicated by an increase in the DO levels (24 hours post-
inoculation), followed by the start of the fed-batch phase. The 70% [v/v] glucose feed, enriched 
with 0.16 M MgSO4, 1x trace metal solution, 0.14 mM Thiamine and 50 µg ml-1 ampicilin, lasted 
for 8 hours. Towards the end of the fed-batch phase (32 hours post-inoculation), the culturing 
temperature was lowered to 20°C and protein expression was induced by the addition of 3 ml 320 
mg ml-1 yeast extract and a final IPTG concentration of 0.8 mM. 
Crude protein extractions and SDS-PAGE 
After 72 h of growth, triplicate yeast samples of 1 ml were taken to determine the wet cell weight 
(WCW) and dry cell weight (DCW) of each expression. DCW was determined by drying the WCW 
pellets at 60°C for 3 days or until no more weight loss was noted. In addition, 60 mg WCW from 
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each yeast culture was weighed for crude cell extracts. Cells were lysed and total protein was 
extracted and prepared for SDS PAGE gel electrophoresis as previously described by Smith et al. 
(2012). The first bacterial sample was taken within one hour after IPTG induction, and then hourly 
for 6 hours. Due to the low biomass obtained in bacterial expressions, only 6 mg and 10 mg from 
shake flask and bioreactor expressions, respectively, were used to prepare protein extracts. The 
bacterial WCW was resuspended in 2x SDS PAGE gel electrophoresis buffer (4% SDS, 10% [v/v] 
β-mercaptoethanol, 20% [v/v] glycerol, 0.002% [g.L-1] bromophenol blue and 0.1 M Tris-HCl, pH 
6.8) and boiled for 5 min. When the solubility of the VP6 protein was determined, 2 ml of bacterial 
culture was collected and centrifuged to isolate the bacterial cells. The cells were resuspended in 
suspension buffer (1 × PBS, pH 8.0, 100 mM NaCl, 0.2% [v/v] Triton X-100, 1 mM PMSF) 
followed by the addition of 1.5 mg [g.L-1] lysozyme and incubated at room temperature for 20 min. 
Centrifugation at 10000 x g for 10 min at 4°C yielded two phases, of which the upper soluble phase 
was aspirated and saved for further use. The bottom phase was washed twice in 500 µl milli-Q 
water and the pellet resuspended in solubilization buffer (20 mM phosphate buffer, pH 8.0, 300 mM 
NaCl, 2% [v/v] SDS, 2 mM DTT, 1% [v/v] Triton X-100). After centrifugation for 10 min at 
maximum, the supernatant containing the insoluble protein fraction was aspirated and kept for 
further analysis (Drummond, 2011). Prior to SDS PAGE electrophoresis, equal volume of 2x SDS 
PAGE electrophoresis buffer was added to the soluble and insoluble fractions followed by boiling 
for 5 min.  
SDS-polyacrylamide gel electrophoresis for western blot and densitometric analysis was 
performed as described previously (Smith et al., 2012). Where bacterial proteins were analyzed to 
determine the solubility of the proteins, the acrylamide gels were stained with Coomassie Brilliant 
blue for 1 h followed by destaining with 50% [v/v] methanol and 10% [v/v] acetic acid until no 
more background was visible. For quantification purposes, VP6 from a crude lysate of recombinant 
SF9 cells at a predetermined concentration were used as a reference protein (provided by Albie van 
Dyk, North West University).  
Western blot analysis 
Proteins separated on acrylamide gels were transferred to nitrocellulose membranes (BioTrace™ 
NT, PALL) by electro-blotting using the Semi-Phor blotting apparatus (Hoefer Scientific 
Instruments) at 50 mA per minigel for 80 min (Khyse-Andersen, 1984). The membranes were 
blocked overnight at room temperature with 5% skim milk (Sigma) in 1x TBST (10 mM Tris-HCl, 
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pH 8.0, 150 mM NaCl and 0.05% [v/v] Tween-20) with gentle agitation. The following day, the 
membranes were probed with mouse anti-rotavirus VP6 antibodies (Cat no. 227144, US Biological, 
Massachusetts) diluted 1:5000 for 2 h, followed by another 2 h incubation with alkaline 
phosphatase-conjugated goat anti-mouse antibodies (Santa Cruz Biotechnology) diluted (1:5000). 
After each antibody incubation, membranes were washed three times for 5 min at room temperature 
in 1x TBST with gentle agitation. Prior to detection, membranes were equilibrated in 1 x detection 
buffer (0.1 M Tris-HCl, 0.1 M NaCl, 0.01 M MgCl2, pH 9.5) for 5 min. Detection was carried out 
for 10 min using 1-step nitrobluetetrazolium (NBT) and 5-bromo-4-chloro-3-indolylphosphate 
(BCIP) (Fermentas). 
Quantitative western blot 
The same quantity of cells (60 mg of yeast cells, 6 mg of bacterial cells) were collected from every 
time point to ensure we do not introduce any bias with regards to VP6 protein present as a factor of 
the sampling. Equal volumes of cell lysate from every time point were loaded and immuno-detected 
using VP6 antibodies. Each blot was visualized for the gradual increase and decrease in VP6 band 
intensity over time. In case any irregular intensity was noted during the course of induction, the 
extraction was repeated. Once VP6 proteins were positively identified during Western Blot analysis, 
the protein yield from each time point in each culture was quantified in triplicate using 
densitometry. VP6 proteins expressed in SF9 cells were used as a reference for the determination of 
protein concentrations. Dilutions of the VP6 reference were analyzed in parallel with dilutions of 
yeast-expressed VP6 on the same SDS-acrylamide gel and nitrocellulose membrane. The amount of 
protein was normalized by comparing to known concentrations of SF9-expressed VP6. A Canon 
Canoscan LIDE 100 scanner was used to scan the nitrocellulose membranes at 300 dpi on grayscale. 
The area and intensity of protein species were quantified by densitometry analysis (Abramoff, 
Magalhães and Ram, 2004) as outlined in http://www.lukemiller.org/journal/2007/08/quantifying-
western-blots-without.html. Shake flask expressions were performed in triplicate and each shake 
flask expression was quantified in triplicate. A simple T-test was performed to determine the 
significance between the protein yields in P. pastoris versus H. polymorpha and p values of less 
than 0.05 were considered significant. 
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Results and Discussion 
VP6 shake flask expressions 
Recombinant E. coli BL21 (DE3) strains harboring the pProEx-VP6c plasmid were cultured 
and expression of the VP6 protein was monitored after induction with IPTG. A time course 
experiment was performed to monitor when VP6 production occurred, sampling hourly after 
induction for a period of 6 h. Production was noticed 1 hour after induction and peaked at 3-4 hours 
after induction, in both LB medium (not shown) and Fermentation medium (Figure 5.1A). After 
that, protein concentrations stayed relative constant with little decrease.  
Once successful production of VP6 using E. coli BL21 (DE3) was observed, we determined 
the extent of VP6 protein solubility. E. coli BL21 (DE3) cells were lysed in an aqueous buffer to 
separate the soluble from the insoluble proteins. SDS PAGE analysis revealed that no induction 
occurred prior to the addition of IPTG (Figure 5.1B, lanes 2 and 3), but production of the VP6 
protein followed after the addition of IPTG (Figure 5.1B, lane 7). However, all of the VP6 protein 
produced by E. coli BL21 (DE3) was insoluble (Figure 5.1B, lane 4).  
Equal volumes of cell lysate, representing equal biomasses, from every time point were 
loaded to verify successful extraction of VP6 (Figure 5.2A). Various dilutions of the SF9 crude 
lysate containing the recombinant expressed VP6 reference protein were separated on SDS-PAGE 
gels and Western blots were performed to determine the optimal range for use as a standard curve 
(Figures 5.2B, C). The VP6 reference was subsequently loaded together with samples of crude 
lysate each time quantification was performed. Analysis of the Western blots involved plotting the 
concentrations of VP6 (ng) reference against the area under the profile plot for each band as 
assigned by ImageJ and the equation of the resulting standard curve was used to calculate the 
respective concentration of VP6 protein (ng µl-1) visible on the blot. Protein samples were diluted to 
ensure that the area under the profile plot of each sample fell within the range determined by the 
standard curve. 
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Fig. 5.1. VP6 expressed in E. coli BL21 (DE3). (A) Time course analysis of VP6 expressed in 
triplicate, cultured in high-cell density medium. Lane M: Pageruler™ (Thermo scientific); lane 1, 2 
and 3: culture1, 2 and 3;1 h, 2 h, 3 h, 4 h, 5 h and 6 hours post-induction of VP6, respectively. (B) 
SDS PAGE analysis of the soluble and insoluble fractions of VP6. Lane 1: Pageruler™ (Thermo 
scientific); Lane 2: Uninduced insoluble fraction; Lane 3: Uninduced soluble fraction; Lane 4: 
Induced insoluble fraction; Lane 5: Induced soluble fraction; Lane 6: blank; Lane 7: Total protein 
fraction.  
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 Fig. 5.2. Western blot of VP6 expressed in shake-flasks for quantification by densitometry. (A) 
Expressed by recombinant P. pastoris_GS115. Lane 1, PagerulerTM (Thermo scientific); Lane 2, 
(uninduced), Equal volume yeast cell lysate before methanol induction; Lane 3-7, Equal volumes 
yeast cell lysates from day 1 to 5 post methanol induction. (B) Expressed by recombinant E. coli 
BL21 (DE3). Lane 1, Pageruler™ (Thermo scientific); lane 2, 80ng; lane 3, 160ng; lane 4, 320ng; 
lane 5, 480ng; Lane 6, 640 ng of VP6 reference; lane 7, 2.0 µl; lane 8, 3.0 µl; lane 9, 4.0µl; lane 10, 
5.0µl; of E. coli VP6 crude cell lysate. (C) Expressed by recombinant P. pastoris_GS115. Lane 1, 
Pageruler™ (Thermo scientific); lane 2, 72ng; lane 3, 144ng; lane 4, 288ng; lane 5, 433ng; Lane 6, 
578 ng of VP6 reference; lane 7, 0.5 µl; lane 8, 1.0 µl; lane 9, 2.0µl; lane 10, 3.0µl; of P. pastoris 
VP6 crude cell lysate. 
Both volumetric and specific productivity of each of the production platforms evaluated in 
shake flasks are shown in Table 1. In both instances, E. coli significantly outperformed the two 
yeasts platforms in both growth media. E. coli showed the highest volumetric levels at an average of 
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97.60 mg VP6.L-1.h-1 in LB broth and 36.58 mg.L-1.h-1 in Fermentation medium. Analysis of the 
specific production revealed that E. coli produced an average 139.43 g VP6.kg-1DCW.h-1 in LB 
media and 34.53 g.kg-1.h-1 in Fermentation medium. In yeast, the average specific production was 
very much similar with H. polymorpha and P. pastoris yielding 0.174 g.kg-1DCW.h-1 and 0.185 
g.kg-1.h-1, respectively. The average volumetric VP6 productivity attained by H. polymorpha was 
the lowest at 0.37 mg.L-1.h-1, whereas P. pastoris produced almost five times more at an average of 
1.688 mg.L-1.h-1. Comparing the VP6 concentration in yeasts, P. pastoris had an almost five times 
higher VP6 concentration than H. polymorpha (121.563 mg.L-1 versus 26.630 mg.L-1). Since the 
different strains were cultured in different volumes, the amount of biomass produced in each 
expression system was normalized for the same volume (Table 5.1). The yeast strains produced the 
highest biomass, 2.13 g.L-1 and 9.14 g.L-1 for H. polymorpha and P. pastoris, respectively, 
compared to E. coli, 0.700 g.L-1 and 1.400 g.L-1, with the lowest specific VP6 yield. Using both 
types of culture media, E. coli showed the highest VP6 yield (Yp/x) per unit biomass (Table 5.1). 
Scaled-up VP6 quantification in bioreactors 
All three expression systems were evaluated in terms of their productivity in bioreactors. The latter 
provided a controlled environment for optimum expression of recombinant proteins. The bacterial 
strain, using only Fermentation medium, outperformed the two yeast systems with a volumetric 
productivity of 93.91 mg.L-1.h-1 compared to 12.91 mg.L-1.h-1 and 26.48 mg.L-1.h-1 for P. pastoris 
and H. polymorpha, respectively (Table 5.1). Comparing specific productivity levels, E. coli had the 
highest with 3.36 g.kg-1.h-1 compared to 0.09 g.kg-1.h-1 (P. pastoris) and 0.293 g.kg-1.h-1 (H. 
polymorpha). Volumetric productivity of all three expression systems and the specific productivity 
of only H. polymorpha were higher in bioreactors than in shake flasks. Fermentation in bioreactors 
resulted in higher concentrations of biomass for all three expressions compared to that obtained in 
shake flasks: 27.933 g.L-1 DCW (E. coli), 90.58 g.L-1 DCW (H. polymorpha) and 151.12 g.L-1 
DCW (P. pastoris). H. polymorpha’s biomass increased more than 45 times in bioreactors, whereas 
the biomass in P. pastoris and E. coli increased up to 20 times. Unlike in shake flasks, the lowest 
biomass concentration in bioreactors did not result in the highest VP6 concentrations. E. coli 
produced double the VP6 yield per unit biomass of P. pastoris (0.017 gVP6.g DCW-1 versus 0.009 g 
VP6.g DCW-1), and H. polymorpha double the VP6 yield of E. coli (0.037 g VP6.g DCW-1 versus 
0.017 g VP6.g DCW-1) (Table 5.1). 
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Although rotavirus infection affects the developing world to a larger extent, it remains a 
high-cost global threat (Desselberger et al., 2009; Parashar, Bresee and Glass, 2003) that has been 
prioritized as a target for vaccine development (Ward et al., 2008). Unresolved safety concerns 
regarding living rotavirus vaccines have shifted the focus towards non-living vaccines as next 
generation candidates (Ward et al., 2008). Despite the fact that VP6 is not considered the primary 
antigen for protective immunity, studies have shown that this highly immunogenic protein does 
provide protection even though the mechanism is not fully understood (Corthésy et al., 2006). 
Therefore, VP6 is an ideal candidate to be used as a booster to the current vaccine regime in high 
burden countries. Recently, the expression of VP2/4/6/7 VLP’s was reported in P. pastoris, but not 
in H. polymorpha. Very few literature exists regarding VP6 production in E. coli reporting low 
yields (Choi et al., 2004; Zhao et al., 2011). This urged us to include E. coli thereby establishing the 
production potential of this well-exploited expression system and use the yield as a reference for 
comparison to that found in methylotrophic yeast. 
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Table 5.1. Different parameters of shake flask cultures as well as scaled-up fermentations in bioreactors for VP6 producing strains. 
Parameter
E coli                                      
LB media                                
( 0.2L)
E coli                       
Fermentation media                    
(0.12L)
H polymorpha              
Mineral media                
(0.025L)
P pastoris             
BMGY/BMMY               
(0.075L)
E coli                         
Fermentation media           
(0.725L)
H polymorpha              
Mineral media                                  
(0.784L)
P pastoris             
BMGY/BMMY                   
(0.883L)
OD600 4.300 3.210 4.290 14.600 63.967 453.167 391.833
VP6 (mg/L) 292.799 186.931 26.630 121.563 469.572 3350.717 1432.830
Biomass (g/L) 0.700 1.400 2.130 9.140 27.933 90.577 151.123
#Yp/x (g VP6/g DCW) 0.418 0.105 0.013 0.013 0.017 0.037 0.009
Total volume MeOH (ml) added ­ ­ 0.0004 0.001 ­ 293.333 572.000
*Yp/s (g VP6/g MeOH)* ­ ­ 2.242 10.233 ­ 0.0114 0.0029
Volumetric productivity (mg/L.h-1) 97.600 36.575 0.370 1.688 93.914 26.480 12.905
Specific productivity (g/kg.h-1) 139.428 34.527 0.174 0.185 3.362 0.293 0.085
# Yield =  mass VP6 product produced per mass dry cell weight
*Yield = mass VP6 product produced per mass carbon source (methanol)
Shake flask expressions Up-scaled fermentation in 1.3L bioreactors
 
 
 
 
125 
Stellenbosch University  https://scholar.sun.ac.za
126 
 
Despite less biomass, the VP6 concentrations produced by E. coli in shake flasks using 
both LB and Fermentation medium were higher than that obtained in yeast. This is also evident 
in the higher mass VP6 per mass dry cell weight (Yp/x) obtained in E. coli compared to yeast. LB 
medium support cell density of E. coli up to an OD600 of 10. This was evident as high biomass 
and VP6 concentrations were obtained in LB shake flask cultures (Table 5.1) with an average 
A600 = 4.30 compare to 3.21 in more complex Fermentation medium (Table 5.1). Common 
growth medium such as LB cannot sustain high density cell growth in bioreactors with an OD600 
exceeding 50; hence the reason why complex medium was used for high cell density 
fermentation. The latter is buffered by phosphates and organic salts, keeping the pH neutral for 
optimal protein expression (Expression Technologies Inc. 2003).  
The huge difference in VP6 yield between shake flasks and controlled reactor E. coli 
cultures (Table 5.1), can be attributed to the different absorbance at which IPTG induction was 
initiated. High cell-density fermentation of E. coli entailed a batch phase during which the 
culture increased in biomass. The end of this phase was indicated by a sharp increase in DO as 
glucose levels started to drop. Biomass was further increased with the addition of glucose during 
an 8-hour fed-batch phase followed by IPTG induction at an average biomass of 23.456 g 
DCW.L-1 (OD = 45.861). Bioreactor fermentations allowed constant growth conditions such as 
set temperature and DO levels as well as the fixed rate of glucose supplementation as carbon 
source. In contrast, the DO levels in shake-flask cultures was not maintained constant, glucose 
levels were not supplemented and induction was started only at an average biomass of 0.700 g 
DCW.L-1 (OD = 0.748). 
We monitored the stability of VP6 protein production following induction in E. coli. 
Ernst and Stroup (1988) expressed VP6 in E. coli using the JM10 strain and showed VP6 protein 
production peaked during the initial 3 h after induction with IPTG, followed by a sharp decline in 
VP6 protein until nothing was visible after 7 h. We noted a similar trend for the first 4 h, 
followed by a steady decline in VP6 yield (Figure 5.2A). The final VP6 concentrations produced 
in E. coli BL21 (DE3) culture were the highest ever reported for any culture volume, yielding an 
average concentration of 469.57 mg L-1 in bioreactors, volumetric production of 97.60 mg L-1 h-1 
and specific production of 139.43 g kg-1 h-1 DCW in shake flasks (Table 5.1). Choi et al. (2004) 
produced 2 mg L-1 and 20 mg L-1, using a codon-optimized VP6 in E. coli BL21 (DE3) and 
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Rosetta (DE3) placI, respectively. Similar levels of 20 mg L-1 were reported by Zhao et al. (2011) 
using E. coli BL21 (DE3) while we produced up to 292.799 mg VP6 per liter culture (Table 5.2). 
One possible explanation for this discrepancy in yield is the difference in biomass between our E. 
coli expressions and theirs. Although not very clear from the literature, it seems that induction 
with IPTG was started at a much lower OD (0.500 as opposed to 0.748 in our study) and 
maintained for an OD of 1.500 compared to 4.300 in this study. 
Table 5.2. Rotavirus VP6 concentrations obtained in other studies compared to current study. 
Authors
BL21 strain Rosetta strain
Choi et al.  2004 2 20
Zhao et al.  2011 20 -
This study 293 -
VP6 levels (mg.L-1) obtained in E. coli
 
Upon investigating the solubility of the VP6 produced by E. coli, we found that all the 
protein was insoluble (Figure 5.1B). This was in agreement with the findings documented by 
Aijaz and Rao (1996), where they described that the VP6 they produced in E. coli BL21 (DE3) 
formed inclusion bodies immediately following synthesis. The insoluble nature of VP6 in E. coli 
is likely due to the native trimetric conformation assumed by the protein (Mathieu et al., 2001), 
which might prove too difficult for E. coli to process. Despite the many advantages of 
heterologous expression in E. coli, the major disadvantage is the accumulation of partially folded 
or misfolded proteins during over-expression. Protein folding is a challenge in the highly 
reductive environment of the bacterial cytosol, where protein translation occur at a fast rate 
(Lorimer 1996). During over-expression of recombinant proteins in E. coli, folding modulators 
are required for large multi-domain proteins. The inability to interact with these modulators or to 
perform several eukaryotic post-translational modifications, result in the assembly of these 
insoluble proteins in inclusion bodies (Baneyx and Mujacic 2004).  
Inclusion bodies are classified as either amorphous aggregates or may contain ordered 
structural segments of cross-β structures (Sawaya et al., 2007). The latter resembles amyloid 
structures, which are associated with pathological disorders such as Alzheimer and Parkinson 
disease. Aggregation occurs when the intramolecular hydrophobic surfaces of the structural 
subunits of a partially folded protein interact with the intermolecular surface of neighboring 
subunits. This results in the exposure of hydrophobic areas, which are hidden in the native form 
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of the protein. These exposed hydrophobic areas have a very strong tendency for aggregation 
(Fink, 1998). The fact that the expressed VP6 protein was recovered from the insoluble part of 
the bacterial cell lysate, indicated that the protein was also trapped in inclusion bodies or amyloid 
structures. The rotavirus VP6 protein has a distinct β-barrel domain (Mathieu et al., 2001) that 
predisposed for amyloid formation. Zhao et. al. (2011) reported the successful in vitro 
renaturation of VP6 followed by self-assembly into VLP’s. They showed that VP6 can be 
prepared in large scale from E. coli, their inclusion bodies were solubilized and the VP6 was 
retrieved, refolded and self-assembled into VLP’s (Zhao et al., 2011). 
However, recovering recombinant proteins from inclusion bodies entails a couple of 
cumbersome steps. Firstly, bacterial cells are lysed and inclusion bodies are separated from cell 
lysates by low-speed centrifugation. The latter step also sediments cell wall and outer membrane 
components, which are then subsequently removed by various detergent washes. Recombinant 
proteins are solubilized and folded into native and biological active proteins. Refolded proteins 
are separated by SDS-PAGE and the VP6 band is cut from the gel; VP6 is removed from the gel 
band by dialysis and concentrated. Alternatively, the unfolded protein can be further purified by 
gel filtration. Refolding recombinant proteins from inclusion bodies can be challenging and 
yields of correctly folded proteins can be low (Lilie, Schwarz and Rudolp, 1998). In contrast to 
soluble intracellular VP6 proteins, host cells are lysed and the supernatant is subjected to 
ammonium sulphate precipitation. After clarification, the preparation is loaded onto a size-
exclusion chromatography column followed by anion ion-exchange chromatography (Kar and 
Roy, 2003). 
The successful production of VP6 as part of a VLP in S. cerevisiae (Rodríguez-Limas et 
al., 2011), prompted us to investigate the potential of P. pastoris and H. polymorpha to produce 
VP6 in shake flasks. The concentration of VP6, produced in shake flasks, in P. pastoris (121.56 
mg L-1) was much higher than that observed in H. polymorpha (26.63 mg L-1) (Table 5.1). Both 
the yeast strains reached higher cell concentrations than E. coli, but produced VP6 at 
significantly lower concentrations. VP6 products were formed along with the growth of the 
microbial cells after induction with either IPTG or methanol, depending on the expression system 
(Figure 5.3). Product concentration is almost directly proportional to biomass in all three 
expression systems. There appears to be a notable trend in both our hands and that of other 
researchers when comparing the production potential between H. polymorpha and P. pastoris in 
shake-flask cultures using the same protein. In a previous study expressing human 
Stellenbosch University  https://scholar.sun.ac.za
 129 
papillomavirus (HPV) in shake flasks, we showed twice as much production of the target protein 
in P. pastoris (Smith et al., 2012). In another study, Mack et al. (2009) also compared the two 
platforms by expressing two mammalian proteins, showing that P. pastoris produced 
significantly more than H. polymorpha in both cases. Though only a hand-full of direct 
comparisons have been made between the two systems to date, it does appear as though P. 
pastoris outperforms H. polymorpha in shake-flask cultures. To obtain a true reflection in 
production potential and efficiency we determined the specific production of the two systems to 
dateand observed that there was no significant difference in the ability of H. polymorpha (0.17 g 
kg-1 DCW h-1) and P. pastoris (0.19 g kg-1 DCW h-1) to produce VP6 (Table 5.1). According to 
the methodology of Van Dijken, Otto and Harder (1976), culture volumes for H. polymorpha 
shake flask expressions (0.025 L) are three times less than the culture volumes for P. pastoris 
(0.075 L). Due to the nature of this expression, H. polymorpha yields more than 4-times lower 
cell concentration, measured in dry weight. Larger culturing volumes also explain the higher 
volumetric productivity observed for P. pastoris in shake flasks as expression last for the same 
duration in both yeast systems. 
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Fig. 5.3. Growth kinetics of E. coli, H. polymorpha and P. Pastoris. Bacterial cells were sampled every hour for 6 hours and yeast cells every 24 h for 5-6 days for biomass 
concentration (lower panel). Simultaneously, cell samples were lysed and rotavirus VP6 concentrations were determined (upper level) by Western blot analysis. 
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The true potential of the two yeast platforms was investigated with bioreactor studies. 
Recombinant protein expression in bioreactor cultures of methylotrophic yeasts is usually 
done using a three-stage process (Schenk et al., 2007). The first is the batch phase with an 
unlimited repressing carbon source such as glycerol, followed by the fed-batch phase, when 
the carbon source is limited. During these first two phases, the biomass is increased. During 
the third phase, the yeasts cells are induced using methanol to express the protein. Due to the 
increased transcription efficiency from the AOX1 promoter in fermentation cultures, the level 
of transcription can be up to 3-5 times greater in cells fed with methanol at growth-limiting 
rates compared to cells grown in excess methanol (Cereghino and Cregg, 2000). This 
phenomenon is evident in the increased biomass and VP6 concentrations of the bioreactor 
cultures compared to that of shake flasks (Table 5.1). The scaled up VP6 production in 
bioreactors was driven by the increase in cell growth of the host. Except for H. polymorpha 
which is marginally higher, the VP6 yield obtained per unit biomass in the rest of the scaled-
up expressions is less than that obtained in shake flasks expression. Expressing rotavirus VP6 
proteins in a controlled environment such as bioreactors, increased the volumetric 
productivity for all expression systems, but decreased specific productivity, except for H. 
polymorpha. In contrast to what has been observed thus far in shake flasks, H. polymorpha 
produced the highest VP6 concentration and the highest VP6 yield per unit biomass, of the 
three microbial systems compared. Between the two yeast systems, H. polymorpha also 
showed higher volumetric as well as specific productivity than P. pastoris. The production 
levels obtained with the yeasts under bioreactor conditions were significantly larger than 
obtained with E. coli in either shake flasks or bioreactors. 
 Since methanol is used to induce the production process, the amount of methanol 
used plays an important role in determining the expression platform of choice. The P. 
pastoris GS115 strain has a methanol utilization plus phenotype (Mut+), which is known to 
utilize more methanol for protein induction than the other Pichia phenotypes (Veenhuis et al., 
1983). Our studies showed that P. pastoris used almost double the amount of methanol than 
H. polymorpha to induce expression, contributing to an Yx/s value = 0.0114 compared to an 
Yx/s value = 0.0029 in P. pastoris in bioreactors (Table 5.1). Therefore, H. polymorpha is 
more methanol-effective in producing large-scale rotavirus VP6 than P. pastoris.   
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Conclusion 
Although E. coli is still one of the most widely used hosts for the production of heterologous 
proteins, protein products are often deposited in inclusion bodies that complicates 
downstream purification. Despite higher yields of VP6 in E. coli shake flask expressions, all 
the expressed protein was found to be insoluble and possibly linked to amyloid formation. 
Intermediate structures during amyloid formation might be cytotoxic when administered to 
eukaryotes and poses an additional threat in cases where insoluble inclusion bodies were used 
for any human purposes. Scaled-up fermentation of H. polymorpha proved to be most 
effective in expressing high concentrations rotavirus VP6 protein (Figure 3), outperforming 
both E. coli and P. pastoris bioreactor cultures. It is encouraging as it opens the possibility for 
inexpensive production of VP6 as a potential antigen and subsequent vaccine candidate. This 
could include VP6 alone, used as a carrier protein (Zhao et al., 2011) or in combination with 
the three remaining rotavirus structural proteins as Rodríguez-Limas and co-workers (2011) 
showed in S. cerevisiae. 
Future work 
Future work will need to incorporate the expression of VP2 as well, in H. polymorpha. Both 
genes will preferably be cloned into a single plasmid since multiple plasmids can pose a 
methabolic burden on the yeast and result in lower recombinant yields (Rodríguez-Limas, et 
al., 2011).  
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
 133 
References 
Aijaz S and Rao CD. Comparative sequence analysis and expression in E. coli of the 
subgroup I-specific antigen VP6 from a G2 serotype human rotavirus IS2. Currt Sci 
1996;71:456-64. 
Abramoff M, Magalhães P and Ram S. Image processing with ImageJ. Biophotonics Int 
2004;11:36–42. 
Baneyx F and Mujacic M. Recombinant protein folding and misfolding in Escherichia coli. 
Nat Biotechnol 2004;22:1399–408. 
Becker DM and Guarente L. High-efficiency transformation of yeast by electroporation. 
Methods Enzymol 1991;194: 182-7. 
Bertolotti-Ciarlet A, Ciarlet M, Crawford S et al. Immunogenicity and protective efficacy of 
rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and 
administered intramuscularly, intranasally, or orally to mice. Vaccine 2003;21:3885–900. 
Burns J, Siadat-Pajouh M, Krishnaney A et al. Protective effect of Rotavirus VP6-specific 
IgA monoclonal antibodies that lack neutralizing activity. Science 1996;272:104–7. 
Cereghino G and Cregg J. Applications of yeast in biotechnology: protein production and 
genetic analysis. Curr Opin Biotechnol 1999;10:422–7. 
Cereghino GL, Cereghino JL, Sunga A et al. New selectable marker/auxotrophic host strain 
combinations formolecular genetic manipulation of Pichia pastoris. Gene 
2001;263:159–69. 
Cereghino JL and Cregg J. Heterologous protein expression in the methylotrophic yeast 
Pichia pastoris. FEMS Microbiol Rev 2000;24:45–66. 
Chen S, Fynan E, Robinsons H et al. Protective immunity induced by rotavirus DNA 
vaccines. Vaccine 1997;15:899–902. 
Choi A, Basu M, Mcneal M et al. Antibody-independent protection against rotavirus infection 
of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein 
antibody-independent protection against rotavirus infection of mice stimulated by 
intranasal immunization with chime. J Virol 1999;73:7574–81. 
Choi A, Basu M, McNeal M et al. Functional mapping of protective domains and epitopes in 
the rotavirus VP6 protein. J Virol 2000;74:11574–80. 
Stellenbosch University  https://scholar.sun.ac.za
 134 
Choi A-C, Basu M, McNeal M et al. Intranasal administration of an Escherichia coli-
expressed codon-optimized rotavirus VP6 protein induces protection in mice. Protein 
Express Purif 2004;38:205–16. 
Corthésy B, Benureau Y, Perrier C et al. Rotavirus anti-VP6 secretory immunoglobulin A 
contributes to protection via intracellular neutralization but not via immune exclusion. J 
Virol 2006;80:10692–9. 
Coste A, Cohen J, Reinhardt M et al. Nasal immunisation with Salmonella typhimurium 
producing rotavirus VP2 and VP6 antigens stimulates specific antibody response in 
serum and milk but fails to protect offspring. Vaccine 2001;19:4167–74. 
Crawford S, Labbe M, Cohen J et al. characterization of virus-like particles produced by the 
expression of rotavirus capsid proteins in insect cells. J Virol 1994;68:5945–52. 
Cregg JM, Cereghino JL, Shi J et al. Recombinant protein expression in Pichia pastoris. Mol 
Biotechnol 2000;16:23–52. 
Del Sal G, Manfioletti G and Schneider C. A one-tube plasmid DNA mini-preparation 
suitable for sequencing. Nucleic Acids Res 1988;16:9878. 
Desselberger U, Manktelow E, Li W et al. Rotaviruses and rotavirus vaccines. Br Med Bull 
2009;90:37–51. 
Drummond D. Protocols. 2011, DOI: http://drummondlab.org/protocols/index.html.(4 
January 2009, date last accessed). 
Estes M and Cohen J. Rotavirus Gene Structure and Function. Microbiol Rev 1989;53:410–
49. 
Estes M, Crawford S, Penaranda M et al. Synthesis and immunogenicity of the rotavirus 
major capsid antigen using a baculovirus expression system. J Virol 1987;61:1488–94. 
Expression Technologies Inc. 2003. http://www.exptec.com/ (4 January 2009, date last 
accessed). 
Faber K, Haima P, Harder W et al. Highly efficient electrotransformation of the yeast 
Hansenula polymorpha. Curr Genet 1994;25:305–10. 
Federico M. Virus-like particles show promise as candidates for new vaccine strategies. 
Future Virol 2010;5:371–4. 
Fink A. Protein aggregation: Folding aggregates, inclusion bodies and amyloid. Fold Des 
1998;3:R9–23. 
Stellenbosch University  https://scholar.sun.ac.za
 135 
Frenchick P, Sabara M, Ready K et al. Biochemical and immunological characterization of a 
novel peptide carrier system using rotavirus VP6 particles. Vaccine 1992;10:783–91. 
Gellissen G. Heterologous protein production in methylotrophic yeasts. Appl Microbiol 
Biotechnol 2000;54:741–50. 
Gietl C, Faber K, Van Der Klei I et al. Mutational analysis of the N-terminal topogenic signal 
of watermelon glyoxysomal malate dehydrogenase using the heterologous host 
Hansenula polymorpha. Proc Natl Acad Sci USA 1994;91:3151–5. 
Gonzalez S and Affranchino J. Assembly of double-layered virus-like particles in mammalian 
cells by coexpression of human rotavirus VP2 and VP6. J Gen Virol 1995;76:2357–60. 
Gray J. Rotavirus vaccines: safety, efficacy and public health impact. J Intern Med 
2011;270:206–14. 
Herrmann J, Chen S, Fynan E et al. Protection against rotavirus infections by DNA 
vaccination. J Infect Dis 2012;174 (Suppl 1):S93-7. 
Hollenberg CP and Gellissen G. Production of recombinant proteins by methylotrophic 
yeasts. Curr Opin Biotechnol 1997;8:554–60. 
Invitrogen Life Technologies.Pichia Fermentation Process Guidelines. 2002. 
Korz DJ, Rinas U, Hellmuth K et al. Simple fed-batch technique for high cell density 
cultivation of Escherichia coli. J Biotechnol 1995;39:59–65. 
Lepault J, Petitpas I, Erk I et al. Structural polymorphism of the major capsid protein of 
rotavirus. EMBO J 2001;20:1498–507. 
Lilie H, Schwarz E and Rudolp R. Advances in refolding of proteins produced in E. coli. 
Curr Opin Biotechnol 1998;9:497–501. 
Lorimer G. A quantitative assessment of the role of the chaperonin proteins in protein folding 
in vivo. FASEB J 1996;10:5-9. 
Madhi S, Cunliffe N, Stel D et al. Effect of human rotavirus vaccine on severe diarrhea in 
African infants. N Engl J Med 2010;362:289–98. 
Mathieu M, Petitpas I, Navaza J et al. Atomic structure of the major capsid protein of 
rotavirus: implications for the architecture of the virion. EMBO J 2001;20:1485–97. 
Mena J, Ramirez O and Palomares L. Intracellular distribution of rotavirus structural proteins 
and virus-like particles expressed in the insect cell-baculovirus system. J Biotechnol 
2006;122:443–52. 
O’Brien G, Bryant C, Voogd C et al. Rotavirus VP6 expressed by PVX vectors in Nicotiana 
benthamiana coats PVX rods and also assembles into viruslike particles. Virology 
2000;270:444–53. 
Stellenbosch University  https://scholar.sun.ac.za
 136 
Parashar U, Bresee J, Gentsch J et al. Rotavirus. Emerg Infect Dis 1998;4:561–70. 
Parashar U, Bresee J and Glass R. The global burden of diarrhoeal disease in children. B 
World Health Organ 2003;81:236. 
Parashar U, Hummelman E, Bresee J et al. Global illness and deaths caused by rotavirus 
disease in children. Emerg Infect Dis 2003;9:565–72. 
Pattenden L, Middelberg A, Niebert M et al. Towards the preparative and large-scale 
precision manufacture of virus-like particles. Trends Biotechnol 2005;23:523–9. 
Program for Appropriate Technology in Health (PATH). PATH’s work in vaccine 
development: evaluation of current rotavirus vaccines. Vaccine Development Global 
Program. 2010 [online] http://sites.path.org/vaccinedevelopment/diarrhea-rotavirus-
shigella-etec/evaluation-of-current-rotavirus-vaccines/ [2016, 4 January] 
Redmond M, Ohmann H, Hughes H et al. Rotavirus particles function as immunological 
carriers for the delivery of peptides from infectious agents and endogenous proteins. Mol 
Immunol 1991;28:269–78. 
Rodríguez-Limas W, Tyo K, Nielsen J et al. Molecular and process design for rotavirus-like 
particle production in Saccharomyces cerevisiae. Microb Cell Fact 2011;10:33. doi: 
10.1186/1475-2859-10-33. 
Sambrook J, Fritschi EF and Maniatis T. Molecular cloning: a laboratory manual. Cold 
Spring Harbor Laboratory Press, New York. 1989. 
Sawaya M, Sambashivan S, Nelson R et al. Atomic structures of amyloid cross-β spines 
reveal varied steric zippers. Nature 2007;447:453–7. 
Schenk J, Marison I and Stockar U. A simple method to monitor and control methanol 
feeding of Pichia pastoris fermentations using mid-IR spectroscopy. J Biotechnol 
2007;128:344–53. 
Schwartz-cornil I, Benureau Y, Greenberg H et al. Heterologous protection induced by the 
inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins 
heterologous protection induced by the inner capsid proteins of rotavirus requires 
transcytosis of mucosal immunoglobulins. 2002,76:8110-7. 
Sharp P, Cowe E, Higgins D et al. Codon usage patterns in Escherichia coli, Bacillus subtilis, 
Saccharomyces cerevisiae, Schizosaccharomyces pombe, Drosophila melanogaster and 
Homo sapiens; a review of the considerable within-species diversity. Nucleic Acids Res 
1988;16:8207–11. 
Stellenbosch University  https://scholar.sun.ac.za
 137 
Smith JJ, Burke A, Bredell H et al. Comparing cytosolic expression to peroxisomal targeting 
of the chimeric L1 / L2 ( ChiΔH-L2 ) gene from human papillomavirus type 16 in the 
methylotrophic yeasts Pichia pastoris and Hansenula polymorpha. Yeast 2012:385–93. 
Sudbery PE. The expression of recombinant proteins in yeasts. Curr Opin Biotechnol 
1996;7:517–24. 
Svensson L, Sheshberadaran H, Vesikari T et al. Immune response to rotavirus polypeptides 
after vaccination with heterologous rotavirus vaccines (RIT 4237, RRV-1). J Gen Virol 
1987;68 ( Pt 7):1993–9. 
Tang B, Gilbert J, Matsui S et al. Comparison of the rotavirus gene 6 from different species 
by sequence analysis and localization of subgroup-specific epitopes using site-directed 
mutagenesis. Virology 1997;237:89–96. 
Van Dijken JP, Otto R and Harder W. Growth of Hansenula polymorpha in a methanol 
limited chemostat. Arch Microbiol 1976;111:137–44. 
Van Zutphen T, Van der Klei I and Kiel JAKW. Pexophagy in Hansenula polymorpha. In: 
Klionsky DJ (ed.). Methods in Enzymology. 451st edn, Vol 451. San Diego, CA: 
Academic Press–Elsevier, 2008, 197–215. 
Veenhuis M, Van Dijken J and Harder W. The significance of peroxisomes in the metabolism 
of one-carbon compounds in yeasts. Adv Microb Physiol 1983;24:1–82. 
Ward R, Mcneal M, Steele A. Why does the world need another rotavirus vaccine? Ther Clin 
Risk Manag 2008;4:49–63. 
World Health Organization. Rotavirus vaccines. Wkly Epidemiol Rec 2007;82:285-95. 
Yao L,Wang S, Su S et al. Construction of a baculovirus-silkworm multigene expression 
system and its application on producing virus-like particles. PLoS One 2012;7: e32510.  
Zhang Q and Lou J-R. Preparation and identification of recombinant Pichia pastoris for 
expression of rotavirus-like particles. Chinese J Biol 2011;24:818–23. 
Zhao Q, Chen W, Chen Y et al. Self-assembled virus-like particles from rotavirus structural 
protein VP6 for targeted drug delivery. Bioconjugate Chem 2011;22:346–52. 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
 138 
Chapter 6 
Expression of a novel collagen-antimicrobial peptide fusion protein in yeast 
 
 
 
 
 
 
 
 
 
 
 
 
 
In collaboration with Prof Marina Rautenbach, Department Biochemistry, Stellenbosch 
University 
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Introduction 
Due to poor living conditions throughout Africa, large families are forced to live in confined 
spaces. Using candles, kerosene lamps and open fires as light and energy sources, the 
incidence of burn wounds are increasing. The rate of burn related child deaths is seven times 
higher in developing countries than in developed countries (World Health Organization, 
2016). Patients with serious burn wounds need to be hospitalized immediately and treated 
with specialised sterilising wound dressings to minimize morbidity and mortality due to 
infection. Commercialized sterilising wound dressings are very costly and are therefore not 
readily available to people in developing countries. In addition, bacteria that infect burn 
wounds can become resistant against conventional antibiotics found in the wound dressings. 
Therefore, there is a great demand for alternative wound dressings that would be more 
affordable with a low probability to induce bacterial resistance. 
Antimicrobial peptides (AMPs) are possible candidates to replace antibiotics in the 
treatment of burn wounds. AMPs are small peptides that form part of the natural immunity of 
most living organisms. They have antimicrobial activity against various bacteria, viruses, 
fungi and parasites with virtually no resistance (Peschel and Sahl, 2006). The group of 
antimicrobial peptides, namely cathelicidins, are synthesized as pre(signal)-pro-peptides in 
neutrophils. The carboxy-terminal domain represents the antimicrobial active peptide. Once 
the neutrophils are activated, the pro(signal)-peptide must be removed from the C-terminal 
peptide to unleash the microbicidal activity (Bals and Wilson, 2003) (see Fig. 6.1). 
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Figure 6. 1. Structure of the gene and peptide of LL-37/hCAP-18 as a prototypical example 
for the cathelicidin family. The C terminus represents the part with antimicrobial activity. The 
gene is represented schematically with the following individual components: White box, 5¢ 
untranslated region (5’ UTR); grey box, signal sequence; black box, pro- sequence; shaded 
box, mature peptide; white box, 3’ UTR (Bals and Wilson, 2003). 
 
Apart from curbing the initial infection, the healing of the wound needs to be as rapid 
as possible to limit the exposure of open wounds to bacteria and fungi. Collagen enhances 
wound healing and therefore has been widely used in the management of severe burn wounds 
(Ruszczak and Schwartz, 1999). Previously, collagens were thought to function only as 
structural support, but it is now evident that its mode of action entails the following: 1) 
collagen signals and increases fibroblast production; 2) it has a hydrophilic property that 
encourages fibroblast infiltration to the wound and enhances the deposition of oriented, 
organized collagen fibers; 3) it assists in the uptake of fibronectin; 4) it helps to preserve cells 
such as leukocytes, macrophages, fibroblasts, and epithelial cells; and 5) it helps to maintain 
the chemical and thermostatic microenvironment of the wound (Doillon and Silver, 1986; 
Doillon et al., 1988; Doillon et al., 1984; Burton, Etherington and Peachey, 1978; Palmieri, 
1992). Animal derived collagen, the most abundant protein in mammals, can be used for this 
application, but can cause allergies or an immune response in humans (Nokelainen et al., 
2001). Isolating sufficient quantities from animal tissue is also not feasible.  
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An efficient large-scale system for the production of both human α1 (type 1) collagen 
(collagen found in most connective tissue) and selected AMPs would have a valuable medical 
application in burn wound treatment. Yeasts can grow rapidly on inexpensive media to high 
cell densities, and can be modulated to secrete modified recombinant proteins of interest. The 
authors hypothesize that a cost-effective method would be to express AMPs linked to 
collagen via an amino acid sequence containing an enzymatic cleavage site, as fusion proteins 
in yeast such as Pichia pastoris and Hansenula polymorpha. Once it is expressed, the 
recombinant protein can be purified and applied in wound dressings. The collagen part of the 
fusion protein will associate with the collagen in the wound in such a way that it exposes the 
cleavage site. Enzymes in the wound, as part of the natural immune response, will cut the 
linker sequence and release the AMPs. The latter targets bacteria in the wound and also helps 
with wound healing. 
Material and Methods 
Design of a fusion collagen-AMP cassette 
The human collagen alpha-1(I) chain sequence (Accession number XP_005257115) was used 
as template to select a suitable candidate for the collagen part of the recombinant fusion 
protein. The collagen part was then linked to one of the cathelicidin peptides, protegrin, via a 
linker sequence containing a cleavage site(s) for the neutrophil elastases present in the burn 
wound.  
Cloning and expression of the collagen-protegrin cassette 
The codon-optimised collagen-protegrin gene was sub-cloned from the commercial bacterial 
cloning vector into pBLHIS–IX (his4, ampR) (Cereghino et al., 2001) and pHIPX4–HNBESX 
(leu2, kanR) (Gietl et al., 1994), integration-expression plasmids of P. pastoris and H. 
polymorpha, respectively. Both cloning vectors without the collagen-protegrin insert were 
transformed into the respective yeast hosts to verify the expression of the fusion protein in 
positive cultures. In addition, yeast cells were also transformed with only ligase buffer 
(without any vector DNA) to verify the absence of any endogenous proteins with similar 
molecular weight secreted in the yeast cultures. All these cultures served as negative controls. 
To mediate extracellular secretion of the collagen-protegrin protein, the collagen-protegrin 
cassette was cloned downstream of the α-factor secretion signal of Saccharomyces cerevisiae. 
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Cloning and transformation of H. polymorpha NCYC 495 (Jan Kiel, University of 
Groningen, The Netherlands) and P. pastoris_KM71 (Invitrogen, Carlsbad, CA, United 
States) genomes were carried out as previously described by Smith et al. (2012). After growth 
on selected agar plates, several colonies were screened according the PCR protocol of the 
Pichia Expression Kit (Invitrogen, Carlsbad, CA, United States) for P. pastoris 
transformants. Alternatively, the pHIPX4-F and pHIPX4-R primers were used for H. 
polymorpha transformants (Smith et al., 2012). Positive yeast transformants were cultured in 
shake-flasks and expression was initiated by the methanol inducible promoters AOX1 and 
MOX in P. pastoris and H. polymorpha, respectively. Transformants expressing well in shake 
flasks were up-scaled to express in bioreactors as per fermentation protocols previously 
described (Bredell et al., 2016; Bredell et al., 2017, under review). Expression was monitored 
at regular intervals to determine optimal time post-induction to harvest the expressed protein.  
Analytical methods 
Supernatant extracts 
Supernatant fluid (SNF) samples of positive yeast cultures were collected prior to induction 
and daily during induction. Bigger unwanted proteins present in the supernatant fluids were 
precipitated using one of the following techniques: i) SNF was heated to 80ºC, centrifuged at 
15000 × g for 10 min, and SNF freeze dried; or ii) 100% acetonitrile (ACN) was diluted to 
50% using SNF, centrifuged at 15000 × g for 10 min at 4ºC, and SNF freeze dried.  
Detection of collagen-protegrin fusion proteins using tricine-sodium dodecyl sulphate 
(SDS)-polyacrylamide gel electrophoresis (PAGE) and Silver staining  
Freeze dried samples were analysed for the presence of the collagen-protegrin fusion protein 
using tricine-SDS-PAGE under denaturing conditions (Schägger, 2006). Gels were stained 
using Silver stain (O’Connell and Stults, 1997) and the correct-sized polypeptide construct 
was verified using an appropriate protein marker. 
Detection of collagen-protegrin fusion protein using Liquid Chromatography-Mass 
Spectrometry (LC-MS)  
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Freeze dried SNF samples were reconstituted in 50% ACN and subjected to LC-MS 
(Stellenbosch University, Central Analytical Facility) to provide highly accurate molecular 
weight information on the fusion molecules.  
Detection of antimicrobial activity against Micrococcus luteus  
To verify the antimicrobial activity of the released protegrin, Gram-positive bacteria 
Micrococcus luteus were plated onto LB agar plates. Supernatant extracts, either untreated or 
treated with commercial elastase, were spotted onto the agar plates and incubated at the 
appropriate temperature of the bacterial strain. Once the elastases have cut the protegrin from 
the rest of the fusion protein, it will become activated and acted upon the M. luteus. 
Antimicrobial activity was detected as zones of growth inhibition on the carpet of yellow 
bacterial growth.  
Nano-liquid chromatography-mass spectrometry (nano-LC-MS) of tricine-SDS PAGE gel 
bands 
Treated SNF samples were loaded onto a tricine-SDS PAGE gel. After electrophoresis, the 
correct-sized band (~8 kDa) was cut out from the acrylamide gel using a clean scalpel. The 
acrylamide gel piece were treated with trypsin following the Trypsin Digest Protocol for MS 
Sample Preparation (http://www.sun.ac.za/caf/Trypsin Digest Protocol for MS Sample 
Preparation). Dried peptides were dissolved in 5% ACN in 0.1% formic acid and 10 µl 
injections were made for nano-LC-MS using a Thermo Scientific EASY-nLC II connected to 
a LTQ Orbitrap Velos mass spectrometer (Stellenbosch University, Central Analytical 
Facilities, Proteomics lab). Thermo Proteome Discoverer 1.3 (Thermo Scientific, Bremen, 
Germany) was used to identify proteins via an automated database searching all tandem 
spectra against the sequence of the fusion protein provided. Proteins were positively 
identified when at least 2 tryptic peptides match the provided sequence, a Mascot/Sequest 
score of more than p>0.05, as determined by Proteome Discoverer 1.3 (Stellenbosch 
University, Central Analytical Facilities, Proteomics lab). 
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Results 
Screening for positive transformants 
Following transformation, several colonies were screened for the correct size insert (625 base 
pairs). Only H. polymorpha had positive transformants (Fig. 6.2).  
 
Fig. 6.2. Agarose gel showing PCR products of H. polymorpha transformed colonies. M: 
lambda DNA, digested using Pst1, Lane 1-3, 5-15: 625 bp PCR product of positive 
transformed colonies; Lane 4: No PCR product, negative transformed colony; Lane 16: 
Negative control; Lane 17: Positive control. 
Designing and construction of the collagen-protegrin fusion gene 
One of the main obstacles in expressing collagen was solubility as the protein is naturally 
very hydrophobic (Shoulders and Raines, 2009). The collagen part needed to be long enough 
for efficient attachment to the existing collagen matrix in the wound. Excessively long 
fragments will aggregate into inclusion bodies of the yeast and complicate downstream 
purification of the recombinant proteins. In addition to neutrophil elastases, contaminating 
microbial pathogens in the wound also secrete various proteases, which are capable of 
cleaving the linker region and releasing the protegrin.  
In order to find a suitable collagen candidate, it has to have the following criteria: 1) 
long enough to attach to existing collagen; 2) contain polar amino acids to ensure solubility; 
3) high frequency of the repetitive amino acid sequence of glycine-proline-X or glycine-X-
hydroxyproline where “X” represents any amino acid to ensure a right handed triple helix 
formation; and low frequency of elastase cleavage sites (*A/G/V). The human collagen alpha-
1(I) chain sequence (Accession number XP_005257115) (National Center for Biotechnology 
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Information, 2017a) was used as template to find suitable candidate collagen sequences. Each 
of the 12 possible candidates (Fig. 6.2, highlight in yellow) was assessed for the different 
criteria mentioned above. Candidate sequence 2 was chosen since it was significantly long 
(40 aa), has minimum elastase cleavage sites (2), has the most abundant helix turns (13) and 
contained polar amino acids.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3. The human collagen alpha-1(I) chain sequence (Accession number 
XP_005257115) (National Center for Biotechnology Information, 2017) used as template to 
identify 12 possible collagen candidate sequences, marked 1-12 (yellow highlight), in the 
collagen-antimicrobial peptide fusion protein. 
 
The amino acid sequence of mature protegrin (PG-1) is 
RGGRLCYCRRRFCVCVGRG (Accession no. AAB27599.1) (National Center for 
Biotechnology Information, 2017b) (Fig 6.3). Using the pro-PG-1 as a template (Fig. 6.3), a 
linker sequence of 11 amino acids containing the tetrapeptide EVQSV at the end of the pro-
PG-1, was added to the N-terminus of the mature protegrin. This 11-aa sequence served as a 
MFSFVDLRLL LLLAATALLT HGQEEGQVEG QDEDIPPITC VQNGLRYHDR DVWKPEPCRI  
CVCDNGKVLC DDVICDETKN CPGAEVPEGE CCPVCPDGSE SPTDQETTGV EGPKGDTGPR  
GPRGPAGPPG RDGIPGQPGL PGPPGPPGPP GPPGLGGNFA PQLSYGYDEK STGGISVPGP 1. 
MGPSGPRGLP GPPGAPGPQG FQGPPGEPGE PGASGPMGPR GPPGPPGKNG DDGEAGKPGR 2. 
PGERGPPGPQ GARGLPGTAG LPGMKGHRGF SGLDGAKGDA GPAGPKGEPG SPGENGAPGQ  
MGPRGLPGER GRPGAPGPAG ARGNDGATGA AGPPGPTGPA GPPGFPGAVG AKGEAGPQGP 3. 
RGSEGPQGVR GEPGPPGPAG AAGPAGNPGA DGQPGAKGAN GAPGIAGAPG FPGARGPSGP 4. 
QGPGGPPGPK GNSGEPGAPG SKGDTGAKGE PGPVGVQGPP GPAGEEGKRG ARGEPGPTGL  
PGPPGERGGP GSRGFPGADG VAGPKGPAGE RGSPGPAGPK GSPGEAGRPG EAGLPGAKGL  
TGSPGSPGPD GKTGPPGPAG QDGRPGPPGP PGARGQAGVM GFPGPKGAAG EPGKAGERGV  
PGPPGAVGPA GKDGEAGAQG PPGPAGPAGE RGEQGPAGSP GFQGLPGPAG PPGEAGKPGE 5. 
QGVPGDLGAP GPSGARGERG FPGERGVQGP PGPAGPRGAN GAPGNDGAKG DAGAPGAPGS  
QGAPGLQGMP GERGAAGLPG PKGDRGDAGP KGADGSPGKD GVRGLTGPIG PPGPAGAPGD  
KGESGPSGPA GPTGARGAPG DRGEPGPPGP AGFAGPPGAD GQPGAKGEPG DAGAKGDAGP 6. 
PGPAGPAGPP GPIGNVGAPG AKGARGSAGP PGATGFPGAA GRVGPPGPSG NAGPPGPPGP 7. 
AGKEGGKGPR GETGPAGRPG EVGPPGPPGP AGEKGSPGAD GPAGAPGTPG PQGIAGQRGV 
VGLPGQRGER GFPGLPGPSG EPGKQGPSGA SGERGPPGPM GPPGLAGPPG ESGREGAPGA 8. 
EGSPGRDGSP GAKGDRGETG PAGPPGAPGA PGAPGPVGPA GKSGDRGETG PAGPAGPVGP 9. 10. 
VGARGPAGPQ GPRGDKGETG EQGDRGIKGH RGFSGLQGPP GPPGSPGEQG PSGASGPAGP 11. 
RGPPGSAGAP GKDGLNGLPG PIGPPGPRGR TGDAGPVGPP GPPGPPGPPG PPSAGFDFSF 12. 
LPQPPQEKAH DGGRYYRADD ANVVRDRDLE VDTTLKSLSQ QIENIRSPEG SRKNPARTCR  
DLKMCHSDWK SGEYWIDPNQ GCNLDAIKVF CNMETGETCV YPTQPSVAQK NWYISKNPKD  
KRHVWFGESM TDGFQFEYGG QGSDPADVAI QLTFLRLMST EASQNITYHC KNSVAYMDQQ  
TGNLKKALLL QGSNEIEIRA EGNSRFTYSV TVDGCTSHTG AWGKTVIEYK TTKTSRLPII 
DVAPLDVGAP DQEFGFDVGP VCFL 
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linker between the collagen and protegrin with the tetrapeptide EVQSV as one of the 
preferred cleavage site for elastases (Fig. 6.4A). Also, the valine in the elastase cleavage site 
should preferably be preceded by an amino acid with a β-turn, and followed by a small amino 
acid to ensure the exposure of the valine for elastase cleavage. The complete collagen-
protegrin construct (Fig.6.4B) was commercially codon-optimized and synthesized to ensure 
optimal expression by both H. polymorpha and P. pastoris. The commercial codon-optimized 
gene was further optimized using Sharp and co-workers’ codon bias index replacing rare 
codons in the gene with codons commonly used by both yeasts (Sharp et al. 1988).  
 
 
 
 
 
 
 
 
 
Figure 6.4. Comparison of different cathelicidin antimicrobial peptides and their pre- and pro-
sequences. The tetrapeptide EVQSV of protegrin (PG-1), indicated in a red box, is the 
preferred cleavage site for elastases (Bals and Wilson, 2003). 
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A 
 
B 
 
Figure 6.5. Collagen-protegrin peptide design (A) Schematic presentation of the novel 
approach. i) Amino acid sequence of the pro-sequence and mature peptide, protegrin. Original 
cleavage site of neutrophil elastases to release the active mature peptide is indicated. ii) 
Amino acid sequence of the mature protegrin (19 aa) with 11-aa linker sequence attached to 
the N terminal-end. Possible cleavage sites for elastases are indicated. iii) Attachment of the 
40 amino acid-collagen sequence to the N terminal-end of the linker. iv) Attatchment of the 
α-factor secretion signal sequence from Saccharomyces cerevisiae to the N terminal-end of 
the collagen to allow for extracellular secretion of the collagen-protegrin peptide. (B) 
Nucleotide - and amino acid sequence of the complete collagen-protegrin construct. Kex2 
signal cleavage site indicated as red arrow ( ). 
 
Stellenbosch University  https://scholar.sun.ac.za
 148 
Detection of putative collagen-protegrin fusion protein using tricine-SDS-PAGE and LC-
MS 
Suprnatant fluid from PCR-positive cultureSupernatant samples were first treated with either 
80ºC heat or ACN to precipitate any unwanted large proteins present in the culture fluid. 
After centrifugation, SNF samples were freeze dried and resuspended in 2 x loading dye 
(Bredell et al., 2016) before loading onto a tricine-SDS-PAGE gel. The theoretical molecular 
weight (MW) of the putative fusion protein is 7,23 kDa. There was only one protein specie 
visible on the SDS-PAGE of shake-flask SNF which correspond to a MW of <10 kDa (Fig. 
6.6 A, Lane 1-3). The protein specie was absent in cultures transformed with vectors without 
the fusion insert (Fig. 6.6 A, Lane 4-6). Similarly, the protein specie was also absent in 
cultures transformed without any vector DNA (Fig. 6.6 A, Lane 7). Supernatant fluid from 
bioreactor cultures also showed the presence of protein species larger than 10 kDa on silver-
stained SDS-PAGE. 
 
Figure 6.6. Silver stained tricine-SDS-PAGE gels showing the presence of protein species in 
the SNF of H. polymorpha cultures. (A) Supernatant fluid of positive shake-flask cultures 
expressing the putative fusion protein (indicated with arrow) (Lane 1-3: 1 µl, 5 µl, 10 µl). 
Supernatant fluid of shake-flask cultures transformed with vectors without the fusion insert 
(Lane 4-6: 1 µl, 5 µl, 10 µl). Supernatant fluid of shake-flask cultures transformed without 
any vector DNA (Lane 7). (B) Supernatant fluid of 1.3 L bioreactor cultures expressing the 
putative fusion protein (indicated with arrow) as well as other protein species >10 kDa (Lane 
1-5: day 1-5 post-inoculation). No proteins were expressed during the glycerol fed-batch stage 
(Lane 6). Kaleidoscope™ Prestained Protein standard (BIO-RAD, CA, USA) was used as 
marker. 
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The reconstituted SNF in 50% ACN was subjected to LC-MS for protein 
identiﬁcation and characterization. Theoretically, the average molecular mass of the fusion 
protein is 7 234.13 Da and the collagen and protegrin part of the fusion protein is 5 034.46 
and 2 217.68 Da, respectively. The LC-MS spectrum revealed the presence of a dominant 
species of 7 608.23 Da (Fig. 6.7).  
 
 
Figure 6.7. Chromatogram of the LC-MS showing the molecular weight of peptides present in 
the culture of positive transformed Hansenula polymorpha cultures. According to their 
masses, neither of the peptides present resembled the putative fusion protein, nor the collagen 
or protegrin part.  
 
Detection of antimicrobial activity against Micrococcus luteus 
Supernatant fluids from both positive transformed H. polymorpha cultures as well as negative 
control cultures were spotted onto agar plates covered with M. luteus bacteria. Antimicrobial 
activity, seen as growth inhibition zones, was detected for both positive and negative cultures. 
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Extracts treated with 80ºC heat showed bigger inhibition zones than those treated with 50% 
ACN (Fig. 6.8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.8. An agar plate covered with M. luteus showing growth inhibition zones. a) SNF 
from positive transformed yeast culture treated with 50% ACN and elastase, b) SNF from 
positive transformed yeast culture treated with 50% ACN only, c) SNF from untransformed 
yeast culture treated with 80ºC and elastase, d) SNF from untransformed yeast culture treated 
with 80ºC only, e) SNF from positive transformed yeast culture treated with 80ºC and 
elastase, and f) SNF from positive transformed yeast culture treated with 80ºC only. 
Positive identification of fusion protein using proteomics 
According to the Thermo Proteome Discoverer 1.3, the proteins recovered from the 
acrylamide gel band corresponded to the provided sequence of the fusion protein with a 
Mascot/Sequest score of p = 1353.74. Also, proteins were considered positive when they 
were identified with at least two tryptic peptides per protein. Amino acid sequences indicated 
in red of the collagen-linker-protegrin fusion protein were positively identified: 
 
a) b) 
c) d) 
e) f) 
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Only the unique linker sequence and half of the protegrin sequence were identified from the 
sample. 
Discussion 
Combining a collagen α-chain with an antimicrobial peptide (AMP) in a wound dressing can 
have a positive impact on wound treatment. The collagen part can aid in wound healing and 
the AMP in fighting infectious agents present in the wound. Expressing these two peptides as 
a fusion protein extracellularly in Hansenula polymorpha, would ease downstream 
purification from the supernatant culture fluid (SNF). 
The design of the fusion protein is novel and it has not been expressed in any 
expression system. Therefore, the authors had no idea how this fusion protein will perform 
once it is expressed in the culture SNF. Theoretically, the MW of the fusion protein is 7.23 
kDa. Tricine-SDS PAGE gels revealed the expression of a single protein specie < 10 kDa in 
positive transformed H. polymorpha cultures (Fig. 6.6 A). Since this protein specie was 
absent in yeast cultures transformed with vectors without the fusion insert, one can assume 
that the single protein specie is the putative fusion protein. Absence of any other protein 
species in cultures transformed without vector DNA, verified the presence of endogenous 
proteins in the yeast cultures. The slower migration pattern of the fusion protein at a distance 
equals <10 kDa could be attributed to the enrichment of proline amino acids in the collagen. 
It is known that excessive proline residues in a protein can cause structural rigidity to the 
primary sequence causing a decrease in the electrophoretic mobility of the protein (Dr Vishal 
Singh Negi, University of Hawaiʻi at Mānoa, Peronal communication). Yet, positive 
identification of the fusion protein still needed to be confirmed. Absence of expression in 
Pichia pastoris cultures indicated that this yeast either failed to express the fusion protein or 
the putative protein could have been encapsulated in inclusion bodies that were not isolated 
LC-MS identified a dominant species of 7 608.23 Da that could represent the fusion 
protein if the protein was inefficiently cleaved (Fig. 6.7). Yeast endo-protease Kex2 removes 
the α-factor secretion signal sequence from the fusion protein, and thereby releases the mature 
form of the secreted protein (Julius et al., 1984). Cleavage occurs at the * of the amino acid 
sequence E-K-R-*-E-A-E-A. The E-A repeats are then further trimmed by the STE13 
protease. Often the cleavage by Kex2 and/or STE13 is not efficient, leaving unwanted 
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overhangs at the amino terminus of the expressed proteins (Brake et al., 1984; Ghosalk ar, 
Sahai and Srivastava, 2008). This could have resulted in the larger protein species. Initially, 
large unwanted proteins present in the SNF were removed through precipitation using AcN 
and heat, but smaller peptides could still be present. LC-MS showed a variety of smaller 
peptides present suggesting additional purification steps were needed before subjecting the 
SNF to LC-MS. One option is to purify the peptide of interest using high-performance liquid 
chromatography (HPLC) by separating the fusion protein peak from the rest of the other 
impurities. 
In order to purify the putative fusion polypeptide, large quantities of this construct 
were needed and were therefore expressed in 1.3 L bioreactors. Due to the long methanol 
induction phase during the fermentation process (5 days), the culture fluid showed an increase 
of contaminating proteins present while the putative polypeptide band decreased (Fig. 6.6 B). 
This could be attributed to the secretion of endogenous proteins in the culture fluid, including 
proteases, during the extended growth curve. The latter could be detrimental to proteins 
present with the greatest impact on smaller proteins and peptides such as the putative fusion 
protein. Maximum yield of the putative protein was expressed after the first day of methanol 
induction, after which the yield started to decline. 
Growth inhibition zones on M. luteus bacterial plates would usually indicate the 
presence of activated protegrin. However, clear inhibition zones were also detected when 
untransformed H. polymorpha cultures (NCYC) were spotted onto bacterial growth. Since no 
fusion protein was secreted in untransformed cultures, these inhibition zones suggest the 
possible secretion of endogenous antimicrobial agents in yeast. However, no natural host 
defense peptides have been found in any yeast. Yet, there are reports of proteases present in 
yeast cultures that could acted on the M. luteus bacteria and leave inhibition zones (Wang, Li 
and Wang, 2016). This data reiterated the need to include additional purification steps before 
analysing to remove any possible proteases. 
Digesting the acrylamide gel band that correspond to the mass of the putative fusion 
protein, followed by proteomic analysis, revealed the possible identification of the fusion 
protein. Although only half of the protegrin sequence and the unique linker sequence were 
identified from the sample, the Mascot/Sequest score of 1353.74 was significant. Also, the 
fusion protein was identified with two tryptic peptides. Together with the SDS-PAGE results, 
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this is the first evidence of the possible successful expression of a recombinant collagen-
protegrin fusion protein in yeast. 
 
Future work 
In order to obtain the fusion protein in bulk, it has to be cultured in bioreactors and soon after 
methanol induction, to harvest the SNF. Purification of the fusion proteins from SNF needs to 
be further optimized. Size-exclusion chromatography followed by ion-exchange 
chromatography will be considered in the process to separate the fusion protein from the rest 
of the contaminating proteins present in the culture SNF.  
Once the fusion protein is purified, it will be confirmed using liquid chromatography–mass 
spectrometry (LC-MC) and antimicrobial activity needs to be re-accesed.  
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Chapter 7 
Conclusions 
Self-assembly of biological systems is a ubiquitous phenomenon in nature. It describes the 
spontaneous association of numerous individual entities through non-covalent interactions, 
including hydrogen and ionic bonds, and hydrophobic and van der Waals interactions, into 
well-defined structures without instructions from an external source. Although these 
interactions are weak, in large numbers they dominate in large numbers the structural and 
conformational behavior of the assembly (Zhang, 2002). The spectrum of such self-assembly 
structural proteins include viral proteins which self-assemble into VLPs (López-Sagaseta et 
al,. 2016) and α-chains that form procollagen (Köster et al., 2008).  
Many viruses encode proteins which self-assemble into nanoparticles and thereby 
encapsulate the viral genome as a prerequisite for infection. If these proteins assemble in the 
absence of the viral genome, non-infectious non-replicating VLPs are obtained that closely 
resemble intact virions (López-Sagaseta et al., 2016). Due to their close resemblance with 
infectious virions, some VLPs have been developed into successful vaccine candidates, such 
as the current RV and HPV vaccines (Plotkin, 2014). Thus, the first two aims of this thesis 
were to express structural proteins involved in VLP formation of both HPV and RV in two 
methylotrophic yeasts, P. pastoris_KM71 and H. polymorpha_NCYC495. Expressions were 
performed in shake flasks and subsequently scaled-up to bioreactors.  
The first aim of this PhD study was to express a codon-optimized human 
papillomavirus-16 L1/L2 chimeric (SAF) protein intracellularly in two methylotrophic yeasts, 
P. pastoris and H. polymorpha. Firstly, two different feeding strategies in fed-batch cultures 
of P. pastoris MutS expressing SAF, were evaluated: a predetermined feed rate versus feeding 
based on the oxygen consumption by maintaining constant dissolved oxygen levels. We have 
adopted a closed-loop proportional-integral (PI) controller to maintain a constant DO of 30%. 
Our results were consistent with Kotzé et al. (2011) that the DO stat control was the preferred 
feeding strategy compared to the predetermined feeding option in P. pastoris Mut+ (X-33) 
cultures. They showed that the DO controlled feeding produced both higher volumetric 
production as well as biomass of HPV type 16 L1 protein. Our MutS cultures also showed a 
significant increase in biomass when methanol was fed using the DO stat control. In other 
studies the predetermined feeding strategy was superior over other methods of methanol 
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feeding only because the culture growth rate was kept constant (Trinh, Phue and Shiloach, 
2003; Minning et al., 2001). In our study the growth rate was neither monitored nor 
maintained but rather the DO value was indicative of how much methanol to add to the 
culture. However, our data confirmed that of Chung (2000) that the DO stat method was 
found to be effective in cultures growing under a single carbon source (Chung, 2000). In our 
study methanol was the sole carbon source during the induction of the recombinant HPV 
L1/L2 chimeric proteins. 
Secondly, we used the DO stat feeding strategy to compare the biomass yield, 
methanol consumption and SAF production in two P. pastoris strains, namely KM71 (MutS) 
and GS115 (Mut+). Methanol served both as inducer of recombinant protein expression as 
well as carbon source. In general, MutS strains have a slower growth rate, lower productivity 
and hence, a slower methanol consumption rate than Mut+ strains (Chiruvolu, Gregg and 
Meagher, 1997; Cregg and Madden, 1988; Kim et al., 2009; Romanos, Scorer and Clare, 
1992; van den Burg, de Wit and Vervoort, 2001). Maintaining optimum methanol 
concentrations (preferably at 4 g.L-1) is critical during the successful product formation in P. 
pastoris fermentation. Accumulation of raw methanol is toxic to yeast cells (Cregg et al., 
1989) moreover, excess of methanol oxidation by-products can lead to cellular stress and 
ultimately cell death (Couderc and Baratti, 1980; Cregg and Madden, 1988; Kern et al., 2007; 
van der Klei, Bystrykh and Harder, 1990; Zhang et al., 2000). When methanol levels are too 
low, it may not be enough to initiate transcription (Cereghino and Cregg, 2000) as well as 
reduce the productivity by triggering the proteolytic degradation of the recombinant proteins 
(Kupcsulik et al., 2001). Smaller culture volumes require slower flow rates of methanol 
addition and therefore, accurate controling of methanol levels is more challenging. 
Overfeeding can easily occur and thereby cell growth can be inhibited. The latter cause the 
DO to increase further which results in more overfeeding. 
Higher biomass concentration and methanol feeding rate in P. pastoris Mut+ cultures 
confirmed that P. pastoris Mut+ strains had faster growth rates on methanol than P. pastoris 
MutS strains. Higher methanol concumption has proved to be easier to control. However, SAF 
protein concentration and protein yield on methanol substrate were almost double of what 
was obtained for the Mut+ strain making MutS an attractive host for the production of 
recombinant proteins. Several other studies support MutS strains to be superior in the 
production of some recombinant proteins (Krainer et al., 2012; Orman, Calik and Ozdamar, 
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2009; Pla et al., 2006). Scaling up the expression of SAF to 10 L bioreactors resulted in a 2-
fold higher SAF concentrations than in the 1.3 L-cultures.  
Thirdly, we evaluated the expression of HPV type 16 L1/L2 chimeric proteins in P. 
pastoris_KM71 (MutS) versus H. polymorhpa strain NCYC495 in bioreactors. H. 
polymorpha exceeded the expression levels of SAF per biomass in P. pastoris_KM71 by 
more than 5-fold. However, when H. polymorpha was compared with P. pastoris wild type 
X33 (Mut+) for the production of mammalian proteins, P. pastoris yielded more than 3-fold 
more protein than H. polymorpha (Mack et al., 2009). Our results showed the maximum 
concentration SAF protein expressed in both yeasts ever reported before, 48.96 mg.L-1 and 
132.10 mg.L-1 in P. pastoris_KM71 and H. polymorpha, respectively. Previously the highest 
concentration HPV-16 L1 protein reported in those two platforms was 14.2 mg.L-1 (Bazan et 
al., 2009) and 78.6 mg.L-1 (Li et al., 2009), respectively.  
Western blot analysis showed more degradation of expressed proteins in H. polymorpha 
cultures than observed in P. pastoris cultures (Mack et al., 2009). Increased methanol 
utilization and higher culturing temperature during H. polymorpha fermentation could have 
stressed the yeast cells and triggered excess protease production which resulted in more 
degradation. Despite the observed degradation, H. polymorpha still produced higher yields of 
SAF per methanol substrate than P. pastoris. 
The SAF protein was semi-purified from the yeast cell lysate using either 
chromatography or sucrose density gradient, and then subjected to electronmicroscopy. Upon 
transmission electron microscopy (TEM), mostly secondary structures ~10nm in diameter 
were observed with the occasional formation of T=1 VLPs (25-30nm in diameter). Although 
HPV16 L1 has been expressed in H. polymorpha before, our study is the first report showing 
the formation of T=1 VLPs in this methylotrophic yeast (Liu, Yang and Yao, 2014; Li et al., 
2009). Chimeric SAF proteins displaying L2 epitopes offer simultaneously high titres of L1  
specific neutralizing antibodies as well as cross-neutralizing antibodies against L2. Although 
capsomeres offer lower immunogenicity than VLPs, it still offer great potential in future 
vaccine preparations (Fligge et al., 2001; Rose et al., 1998; Thönes et al., 2008). 
The second aim of this PhD study was to express a codon-optimized RV VP6 protein, 
of which the sequence derived from an emerging South African RV strain, intracellularly in 
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E. coli and yields were then compared with that observed in the two methylotrophic yeasts, P. 
pastoris_KM71 and H. polymorpha. E. coli is the most widely used prokaryotic system for 
the expression of heterologous proteins. In our RV VP6 expressions, E. coli showed higher 
volumetric and specific productivities, in both shake-flasks and bioreactors, compare to the 
methylotrophic yeasts P. pastoris and H. polymorpha. Shorter culture times contributed to 
these higher productivities in E. coli. Both yeasts reached maximum VP6 production after 4 
days post-induction in bioreactors whereas bacteria reached it after only 4 hours. Although E. 
coli had a lower biomass than yeasts in shake-flasks, it produced the highest VP6 yield per 
biomass.  
Expression of a recombinant protein may impart a metabolic burden on the 
microorganism causing a decrease in growth rate (Bentley et al., 1990). Therefore, high cell-
density culture methods were designed to boost E. coli growth (Korz et al., 1995). LB media 
can support cell densities of OD600 up to 7.0 in shake-flask cultures (Sezonov, Joseleau-Petit 
and D’Ari, 2007). However, scaled-up cultures in bioreactors with cell densities of OD600 > 
60, require high cell-density media that was buffered to keep the pH constant for maximum 
protein production. Growing the cultures to higher densities in bioreactors increased both the 
biomass and the volumetric yield of the VP6 protein across all three expression platforms. 
VP6 products was almost directly proportional to biomass in all three expression systems 
(Fig. 5.3). Bioreactors provided a controlled environment not only with adapted media but 
also good aeration and oxygen supplementation. Unlike in shake flask expressions, ideal 
culture conditions in bioreactors favored H. polymorpha for high VP6 yield per culture 
volume (3350.717 mg.L-1) as well as yield per unit biomass (0.037 g.g-1) that outperformed 
both E. coli as well as P. pastoris_KM71. The latter MutS phenotype has a slower growth rate 
which metabolizes methanol poorly, making the addition of methanol in smaller cultures 
more challenging.  
Despite E. coli’s poor performance in comparison with methylotrophic yeasts, the E. 
coli VP6 levels produced in our study were the highest ever reported. Despite good yields of 
RV VP6 in E. coli, all the protein expressed by E. coli BL21 (DE3) in our study was 
deposited into insoluble aggregates known as inclusion bodies. This usually happens as a 
result of misfolded proteins which is biologically inactivate (Villaverde and Carrio, 2003). 
The insoluble nature of VP6 in E. coli is likely due to the native trimetric conformation 
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assumed by the protein (Mathieu et al., 2001), which might prove too difficult for E. coli to 
process. 
Reducing the rate of protein production in E. coli grants newly transcribed proteins 
the opportunity to fold properly. The most common way of slowing down the production rate 
is to lower the culture temperature from 37ºC to 20ºC during the induction phase (Schein and 
Noteborn 1988). In our study, the low culture temperature still resulted in the formation of 
inclusion bodies. Misfolded VP6 proteins, with their distinct β-barrel domain (Mathieu et al., 
2001), found in inclusion bodies resembles amyloid structures which are associated with 
pathological disorders such as Alzheimer and Parkinson disease. Misfolded proteins in 
insoluble inclusion bodies might be cytotoxic for any human use. According to literature, 
inclusion bodies could be solubilized and the VP6 retrieved, refolded and self-assembled into 
VLP’s (Zhao et al., 2011). However, isolation from inclusion bodies and refolding the 
recombinant proteins can be challenging resulting in low yields of correctly folded proteins 
(Lilie, Schwarz and Rudolp, 1998). In contrast to bacterial expressions, VP6 proteins 
expressed in yeast were found to be soluble upon analysis making methylotrophic yeast very 
desirable for expression recombinant proteins.  
Since methanol was used to induce the production process, the amount of methanol 
used played an important role in determining the expression platform of choice. Our 
bioreactor studies showed that P. pastoris used almost double the amount of methanol than 
H. polymorpha to induce expression, contributing to almost 4 times less VP6 yield per 
substrate (Yp/s) than H. polymorpha (Chapter 5, Table 5.1). Therefore, H. polymorpha was 
more methanol-effective in producing large-scale rotavirus VP6 than P. pastoris. This is the 
first report of VP6 expressed in methylotrophic yeast and holds the promise for the 
inexpensive production of VP6 either as a potential antigen, or possible vaccine candidate or 
drug delivery mechanism (Zhao et al., 2011).  
In addition, the same recombinant technology was applied to express a novel 
antimicrobial peptide (AMP)-collagen fusion peptide possibly used in the treatment of burn 
wounds. Once this fusion protein is expressed, it can be purified and applied in wound 
dressings. We hypothesize that the collagen part of the fusion protein will associate with the 
collagen in the wound encouraging wound healing. As part of the natural immune response, 
elastases present in the wound will release the AMP from the collagen targeting invading 
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bacteria. Although SDS-PAGE results showed the presence of a single correct-sized protein 
band and LC-MS presented a dominant species relating to the putative collagen-AMP fusion 
protein, these results were not conclusive. Preliminary proteomic data is the first evidence of 
the possible successful expression of a recombinant collagen-protegrin fusion protein in 
yeast. 
Current vaccines against both HPV and RV are still relevant in terms of circulating 
genotypes but as new genotypes emerge vaccines will need to be updated. This was obtained 
through the inclusion of the cross-neutralizing L2 epitope in HPV L1 VLPs, and a VP6 
protein isolated from a local gastroenteritis patient in RV secondary structures. 
In conclusion, this PhD study confirmed that methyloptrophic yeasts remains a very 
promising producer of frecombinant proteins, and even more so self-assembling proteins. 
Despite E. coli’s good yields, these proteins are often deposited into insoluble aggregates 
which require downstream purification. Methylotrophic yeast, in particular H. polymorpha, 
showed increased production of structural viral proteins, RV VP6 and HPV type 16 SAF. H. 
polymorpha not only exceeded the expression of viral proteins in E. coli and P. pastoris 
strains, KM and GS115, but was also more methanol-effective in producing large-scale viral 
proteins. Purifying the HPV-16 SAF protein from H. polymorpha cultures resulted in the 
formation of capsomeres (10nm in diameter) and the occasional putative T=1 VLPs (25-30nm 
in diameter). Large-scale expression in H. polymorpha holds promise for the manufacturing 
of cheaper vaccines in developing countries as it resulted in increased level of expressed viral 
proteins. Methanol is highly flammable and hazardous and, therefore, undesirable for large-
scale fermentations. Effective alternatives for induction are needed to replace methanol for 
industrial scale fermentations (Stadlmayr et al., 2010). Alternative inducible promoters, such 
as the constitutively GAP promoter, can be induced without methanol and provides 
continuous transcription of the gene of interest. 
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DO graph representing a typical yeast fermentation. Initially, the bioreactor’s DO sensor is calibrated using nitrogen until 
the DO is 0% and pure oxygen (O2) to saturate it to 100%. Therefore, the DO will be near 100% at the beginning of the 
fermentation process and starts to decline after inoculation when the yeast metabolizes the access glycerol in the media and 
consumes O2. 1) DO is high at the beginning of the fermentation process. 2) After 24 hours post-inoculation, the glycerol in 
the media is depleted and the DO starts to increase. This spike indicates the end of the batch phase, beginning of the 
glycerol fed-batch phase. 3) When the glycerol feed is interrupted and the DO shows an increase, it indicates glycerol is 
limited and the methanol fed-batch phase can immence (48 h post-inoculation). 4) The end of the fermentation process is 
indicated by an increase in DO. 
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Appendix B 
Comparing cytosolic expression to peroxisomal targeting of the chimeric L1 / L2 ( 
ChiΔH-L2 ) gene from human papillomavirus type 16 in the methylotrophic yeasts 
Pichia pastoris and Hansenula polymorpha* 
Smith JJ, Burke A, Bredell H, van Zyl WH and Görgens JF. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Reproduced with permission of John Wiley and Sons from: Smith JJ, Burke A, Bredell H, 
van Zyl WH and Görgens JF. (2012) Yeast 29, 385–393 
https://www.ncbi.nlm.nih.gov/pubmed/22926974 
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